patient#Identification#MAARS identifier (MAARS_identifier)	patient#Identification#Date of first visit (Date_of_first_visit)	patient#Identification#Institution (Institution)	patient#Identification#Physician (Physician)	patient#Inclusion/Exclusion criteria#Inclusion criteria#Written informed consent (Written_informed_consent)	patient#Inclusion/Exclusion criteria#Inclusion criteria#18 years old or more (18_years_old_or_more)	patient#Inclusion/Exclusion criteria#Inclusion criteria#Psoriasis patients with plaque-type psoriasis, diagnosed for at least 6 months (Psoriasis_patients_with_plaque-type_psoriasis,_diagnosed_for_at_least_6_months)	patient#Inclusion/Exclusion criteria#Exclusion criteria#Subject unable to give written informed consent (Subject_unable_to_give_written_informed_consent)	patient#Inclusion/Exclusion criteria#Exclusion criteria#Psoriasis patients: patient has generalised pustular psoriasis (Psoriasis_patients:_patient_has_generalised_pustular_psoriasis)	patient#Inclusion/Exclusion criteria#Exclusion criteria#Psoriasis patients: localised pustular psoriasis (Psoriasis_patients:_localised_pustular_psoriasis)	patient#Inclusion/Exclusion criteria#Exclusion criteria#Psoriasis patients: palmoplantar psoriasis (Psoriasis_patients:_palmoplantar_psoriasis)	patient#Inclusion/Exclusion criteria#Exclusion criteria#Psoriasis patients: acrodermatitis continua (Psoriasis_patients:_acrodermatitis_continua)	patient#Inclusion/Exclusion criteria#Exclusion criteria#Drug induced psoriasis (Drug_induced_psoriasis)	patient#Inclusion/Exclusion criteria#Exclusion criteria#Subjects who have received treatment at the biopsy site at least 2 weeks prior to screening (Subjects_who_have_received_treatment_at_the_biopsy_site_at_least_2_weeks_prior_to_screening)	patient#Inclusion/Exclusion criteria#Exclusion criteria#Subjects who have received systemic antibiotics within the previous 4 weeks prior to screening (Subjects_who_have_received_systemic_antibiotics_within_the_previous_4_weeks_prior_to_screening)	patient#Inclusion/Exclusion criteria#Exclusion criteria#Subjects who have received systemic immunosupressive therapy within the previous 12 weeks prior to screening (Subjects_who_have_received_systemic_immunosupressive_therapy_within_the_previous_12_weeks_prior_to_screening)	patient#Inclusion/Exclusion criteria#Exclusion criteria#Subjects who have received systemic biologic agents within the previous 12 weeks prior to screening (Subjects_who_have_received_systemic_biologic_agents_within_the_previous_12_weeks_prior_to_screening)	patient#Diagnostic & Phenotypic Data#Year of birth (Year_of_birth)	patient#Diagnostic & Phenotypic Data#Gender (Gender)	patient#Diagnostic & Phenotypic Data#Ethnicity/Family History#Ethnicity (Ethnicity)	patient#Diagnostic & Phenotypic Data#Ethnicity/Family History#Family History of Psoriasis (Family_History_of_Psoriasis)	patient#Diagnostic & Phenotypic Data#Ethnicity/Family History#Known Allergies (Known_Allergies)	patient#Diagnostic & Phenotypic Data#Ethnicity/Family History#Sampling area photography (Sampling_area_photography)	patient#Diagnostic & Phenotypic Data#Psoriasis Patients#Year of Diagnosis (Year_of_Diagnosis)	patient#Diagnostic & Phenotypic Data#Psoriasis Patients#Year first seen by specialist (Year_first_seen_by_specialist)	patient#Diagnostic & Phenotypic Data#Psoriasis Patients#Histologically confirmed (Histologically_confirmed)	patient#Diagnostic & Phenotypic Data#Psoriasis Patients#Date of PAD (Date_of_PAD)	patient#Diagnostic & Phenotypic Data#Psoriasis Patients#Smoking (Smoking)	patient#Diagnostic & Phenotypic Data#Psoriasis Patients#Psoriatic Arthritis (Psoriatic_Arthritis)	patient#Diagnostic & Phenotypic Data#Psoriasis Patients#Psoriatic Arthritis Confirmed by Rheumatologist (Psoriatic_Arthritis_Confirmed_by_Rheumatologist)	patient#Diagnostic & Phenotypic Data#Psoriasis Patients#History of Koebner (History_of_Koebner)	patient#Diagnostic & Phenotypic Data#Psoriasis Patients#History of Inpatient Management (History_of_Inpatient_Management)	patient#Diagnostic & Phenotypic Data#Psoriasis Patients#(Inpatient) If yes, No. of Admissions ((Inpatient)_If_yes,_No._of_Admissions)	patient#Diagnostic & Phenotypic Data#Psoriasis Patients#Chronic Plaque (Chronic_Plaque)	patient#Diagnostic & Phenotypic Data#Psoriasis Patients#Chronic Plaque Small (<3cm in Diameter) (Chronic_Plaque_Small_(<3cm_in_Diameter))	patient#Diagnostic & Phenotypic Data#Psoriasis Patients#Chronic Plaque Large (>3cm in Diameter) (Chronic_Plaque_Large_(>3cm_in_Diameter))	patient#Diagnostic & Phenotypic Data#Psoriasis Patients#Flex/Intertriginous (Flex/Intertriginous)	patient#Diagnostic & Phenotypic Data#Psoriasis Patients#Seborrhoeic Psoriasis (Seborrhoeic_Psoriasis)	patient#Diagnostic & Phenotypic Data#Psoriasis Patients#Scalp (Scalp)	patient#Diagnostic & Phenotypic Data#Psoriasis Patients#Palms/Soles (Non Pustular) (Palms/Soles_(Non_Pustular))	patient#Diagnostic & Phenotypic Data#Psoriasis Patients#Guttate psoriasis (Guttate_psoriasis)	patient#Diagnostic & Phenotypic Data#Psoriasis Patients#Unstable Psoriasis (Unstable_Psoriasis)	patient#Diagnostic & Phenotypic Data#Psoriasis Patients#Erythrodermic (Erythrodermic)	patient#Diagnostic & Phenotypic Data#Psoriasis Patients#Nails affected (Nails_affected)	patient#Malignancies - skin#1#(mal.sk.) Skin Cancer ((mal.sk.) Skin Cancer)	patient#Malignancies - skin#2#(mal.sk.) Skin Cancer ((mal.sk.) Skin Cancer)	patient#Malignancies - skin#3#(mal.sk.) Skin Cancer ((mal.sk.) Skin Cancer)	patient#Malignancies - skin#4#(mal.sk.) Skin Cancer ((mal.sk.) Skin Cancer)	patient#Malignancies - skin#5#(mal.sk.) Skin Cancer ((mal.sk.) Skin Cancer)	patient#Malignancies - skin#1#(mal.sk.) Treated ((mal.sk.) Treated)	patient#Malignancies - skin#2#(mal.sk.) Treated ((mal.sk.) Treated)	patient#Malignancies - skin#3#(mal.sk.) Treated ((mal.sk.) Treated)	patient#Malignancies - skin#4#(mal.sk.) Treated ((mal.sk.) Treated)	patient#Malignancies - skin#5#(mal.sk.) Treated ((mal.sk.) Treated)	patient#Malignancies - skin#1#(mal.sk.) Treatement date ((mal.sk.) Treatement date)	patient#Malignancies - skin#2#(mal.sk.) Treatement date ((mal.sk.) Treatement date)	patient#Malignancies - skin#3#(mal.sk.) Treatement date ((mal.sk.) Treatement date)	patient#Malignancies - skin#4#(mal.sk.) Treatement date ((mal.sk.) Treatement date)	patient#Malignancies - skin#5#(mal.sk.) Treatement date ((mal.sk.) Treatement date)	patient#Malignancies - other#1#(mal.oth.) Other Cancer ((mal.oth.) Other Cancer)	patient#Malignancies - other#2#(mal.oth.) Other Cancer ((mal.oth.) Other Cancer)	patient#Malignancies - other#3#(mal.oth.) Other Cancer ((mal.oth.) Other Cancer)	patient#Malignancies - other#1#(mal.oth.) Treated ((mal.oth.) Treated)	patient#Malignancies - other#2#(mal.oth.) Treated ((mal.oth.) Treated)	patient#Malignancies - other#3#(mal.oth.) Treated ((mal.oth.) Treated)	patient#Malignancies - other#1#(mal.oth.) Treatement date ((mal.oth.) Treatement date)	patient#Malignancies - other#2#(mal.oth.) Treatement date ((mal.oth.) Treatement date)	patient#Malignancies - other#3#(mal.oth.) Treatement date ((mal.oth.) Treatement date)	patient#Concomitant Medication#1#(med.) Medication name ((med.) Medication name)	patient#Concomitant Medication#2#(med.) Medication name ((med.) Medication name)	patient#Concomitant Medication#3#(med.) Medication name ((med.) Medication name)	patient#Concomitant Medication#4#(med.) Medication name ((med.) Medication name)	patient#Concomitant Medication#5#(med.) Medication name ((med.) Medication name)	patient#Concomitant Medication#6#(med.) Medication name ((med.) Medication name)	patient#Concomitant Medication#7#(med.) Medication name ((med.) Medication name)	patient#Concomitant Medication#8#(med.) Medication name ((med.) Medication name)	patient#Concomitant Medication#9#(med.) Medication name ((med.) Medication name)	patient#Concomitant Medication#1#(med.) Dose (mg) ((med.) Dose (mg))	patient#Concomitant Medication#2#(med.) Dose (mg) ((med.) Dose (mg))	patient#Concomitant Medication#3#(med.) Dose (mg) ((med.) Dose (mg))	patient#Concomitant Medication#4#(med.) Dose (mg) ((med.) Dose (mg))	patient#Concomitant Medication#5#(med.) Dose (mg) ((med.) Dose (mg))	patient#Concomitant Medication#6#(med.) Dose (mg) ((med.) Dose (mg))	patient#Concomitant Medication#7#(med.) Dose (mg) ((med.) Dose (mg))	patient#Concomitant Medication#8#(med.) Dose (mg) ((med.) Dose (mg))	patient#Concomitant Medication#9#(med.) Dose (mg) ((med.) Dose (mg))	patient#Concomitant Medication#1#(med.) Freq ((med.) Freq)	patient#Concomitant Medication#2#(med.) Freq ((med.) Freq)	patient#Concomitant Medication#3#(med.) Freq ((med.) Freq)	patient#Concomitant Medication#4#(med.) Freq ((med.) Freq)	patient#Concomitant Medication#5#(med.) Freq ((med.) Freq)	patient#Concomitant Medication#6#(med.) Freq ((med.) Freq)	patient#Concomitant Medication#7#(med.) Freq ((med.) Freq)	patient#Concomitant Medication#8#(med.) Freq ((med.) Freq)	patient#Concomitant Medication#9#(med.) Freq ((med.) Freq)	patient#Concomitant Medication#1#(med.) Start date ((med.) Start date)	patient#Concomitant Medication#2#(med.) Start date ((med.) Start date)	patient#Concomitant Medication#3#(med.) Start date ((med.) Start date)	patient#Concomitant Medication#4#(med.) Start date ((med.) Start date)	patient#Concomitant Medication#5#(med.) Start date ((med.) Start date)	patient#Concomitant Medication#6#(med.) Start date ((med.) Start date)	patient#Concomitant Medication#7#(med.) Start date ((med.) Start date)	patient#Concomitant Medication#8#(med.) Start date ((med.) Start date)	patient#Concomitant Medication#9#(med.) Start date ((med.) Start date)	patient#Concomitant Medication#1#(med.) Ongoing ((med.) Ongoing)	patient#Concomitant Medication#2#(med.) Ongoing ((med.) Ongoing)	patient#Concomitant Medication#3#(med.) Ongoing ((med.) Ongoing)	patient#Concomitant Medication#4#(med.) Ongoing ((med.) Ongoing)	patient#Concomitant Medication#5#(med.) Ongoing ((med.) Ongoing)	patient#Concomitant Medication#6#(med.) Ongoing ((med.) Ongoing)	patient#Concomitant Medication#7#(med.) Ongoing ((med.) Ongoing)	patient#Concomitant Medication#8#(med.) Ongoing ((med.) Ongoing)	patient#Concomitant Medication#9#(med.) Ongoing ((med.) Ongoing)	patient#Concomitant Medication#1#(med.) End Date ((med.) End Date)	patient#Concomitant Medication#2#(med.) End Date ((med.) End Date)	patient#Concomitant Medication#3#(med.) End Date ((med.) End Date)	patient#Concomitant Medication#4#(med.) End Date ((med.) End Date)	patient#Concomitant Medication#5#(med.) End Date ((med.) End Date)	patient#Concomitant Medication#6#(med.) End Date ((med.) End Date)	patient#Concomitant Medication#7#(med.) End Date ((med.) End Date)	patient#Concomitant Medication#8#(med.) End Date ((med.) End Date)	patient#Concomitant Medication#9#(med.) End Date ((med.) End Date)	patient#Psoriasis Treatment#1#(PSO tr.) Past treatment name (including UV) ((PSO tr.) Past treatment name (including UV))	patient#Psoriasis Treatment#2#(PSO tr.) Past treatment name (including UV) ((PSO tr.) Past treatment name (including UV))	patient#Psoriasis Treatment#3#(PSO tr.) Past treatment name (including UV) ((PSO tr.) Past treatment name (including UV))	patient#Psoriasis Treatment#4#(PSO tr.) Past treatment name (including UV) ((PSO tr.) Past treatment name (including UV))	patient#Psoriasis Treatment#5#(PSO tr.) Past treatment name (including UV) ((PSO tr.) Past treatment name (including UV))	patient#Psoriasis Treatment#6#(PSO tr.) Past treatment name (including UV) ((PSO tr.) Past treatment name (including UV))	patient#Psoriasis Treatment#7#(PSO tr.) Past treatment name (including UV) ((PSO tr.) Past treatment name (including UV))	patient#Psoriasis Treatment#8#(PSO tr.) Past treatment name (including UV) ((PSO tr.) Past treatment name (including UV))	patient#Psoriasis Treatment#9#(PSO tr.) Past treatment name (including UV) ((PSO tr.) Past treatment name (including UV))	patient#Psoriasis Treatment#10#(PSO tr.) Past treatment name (including UV) ((PSO tr.) Past treatment name (including UV))	patient#Psoriasis Treatment#11#(PSO tr.) Past treatment name (including UV) ((PSO tr.) Past treatment name (including UV))	patient#Psoriasis Treatment#1#(PSO tr.) Dose ((PSO tr.) Dose)	patient#Psoriasis Treatment#2#(PSO tr.) Dose ((PSO tr.) Dose)	patient#Psoriasis Treatment#3#(PSO tr.) Dose ((PSO tr.) Dose)	patient#Psoriasis Treatment#4#(PSO tr.) Dose ((PSO tr.) Dose)	patient#Psoriasis Treatment#5#(PSO tr.) Dose ((PSO tr.) Dose)	patient#Psoriasis Treatment#6#(PSO tr.) Dose ((PSO tr.) Dose)	patient#Psoriasis Treatment#7#(PSO tr.) Dose ((PSO tr.) Dose)	patient#Psoriasis Treatment#8#(PSO tr.) Dose ((PSO tr.) Dose)	patient#Psoriasis Treatment#9#(PSO tr.) Dose ((PSO tr.) Dose)	patient#Psoriasis Treatment#10#(PSO tr.) Dose ((PSO tr.) Dose)	patient#Psoriasis Treatment#11#(PSO tr.) Dose ((PSO tr.) Dose)	patient#Psoriasis Treatment#1#(PSO tr.) Freq ((PSO tr.) Freq)	patient#Psoriasis Treatment#2#(PSO tr.) Freq ((PSO tr.) Freq)	patient#Psoriasis Treatment#3#(PSO tr.) Freq ((PSO tr.) Freq)	patient#Psoriasis Treatment#4#(PSO tr.) Freq ((PSO tr.) Freq)	patient#Psoriasis Treatment#5#(PSO tr.) Freq ((PSO tr.) Freq)	patient#Psoriasis Treatment#6#(PSO tr.) Freq ((PSO tr.) Freq)	patient#Psoriasis Treatment#7#(PSO tr.) Freq ((PSO tr.) Freq)	patient#Psoriasis Treatment#8#(PSO tr.) Freq ((PSO tr.) Freq)	patient#Psoriasis Treatment#9#(PSO tr.) Freq ((PSO tr.) Freq)	patient#Psoriasis Treatment#10#(PSO tr.) Freq ((PSO tr.) Freq)	patient#Psoriasis Treatment#11#(PSO tr.) Freq ((PSO tr.) Freq)	patient#Psoriasis Treatment#1#(PSO tr.) Start date ((PSO tr.) Start date)	patient#Psoriasis Treatment#2#(PSO tr.) Start date ((PSO tr.) Start date)	patient#Psoriasis Treatment#3#(PSO tr.) Start date ((PSO tr.) Start date)	patient#Psoriasis Treatment#4#(PSO tr.) Start date ((PSO tr.) Start date)	patient#Psoriasis Treatment#5#(PSO tr.) Start date ((PSO tr.) Start date)	patient#Psoriasis Treatment#6#(PSO tr.) Start date ((PSO tr.) Start date)	patient#Psoriasis Treatment#7#(PSO tr.) Start date ((PSO tr.) Start date)	patient#Psoriasis Treatment#8#(PSO tr.) Start date ((PSO tr.) Start date)	patient#Psoriasis Treatment#9#(PSO tr.) Start date ((PSO tr.) Start date)	patient#Psoriasis Treatment#10#(PSO tr.) Start date ((PSO tr.) Start date)	patient#Psoriasis Treatment#11#(PSO tr.) Start date ((PSO tr.) Start date)	patient#Psoriasis Treatment#1#(PSO tr.) Ongoing ((PSO tr.) Ongoing)	patient#Psoriasis Treatment#2#(PSO tr.) Ongoing ((PSO tr.) Ongoing)	patient#Psoriasis Treatment#3#(PSO tr.) Ongoing ((PSO tr.) Ongoing)	patient#Psoriasis Treatment#4#(PSO tr.) Ongoing ((PSO tr.) Ongoing)	patient#Psoriasis Treatment#5#(PSO tr.) Ongoing ((PSO tr.) Ongoing)	patient#Psoriasis Treatment#6#(PSO tr.) Ongoing ((PSO tr.) Ongoing)	patient#Psoriasis Treatment#7#(PSO tr.) Ongoing ((PSO tr.) Ongoing)	patient#Psoriasis Treatment#8#(PSO tr.) Ongoing ((PSO tr.) Ongoing)	patient#Psoriasis Treatment#9#(PSO tr.) Ongoing ((PSO tr.) Ongoing)	patient#Psoriasis Treatment#10#(PSO tr.) Ongoing ((PSO tr.) Ongoing)	patient#Psoriasis Treatment#11#(PSO tr.) Ongoing ((PSO tr.) Ongoing)	patient#Psoriasis Treatment#1#(PSO tr.) End Date ((PSO tr.) End Date)	patient#Psoriasis Treatment#2#(PSO tr.) End Date ((PSO tr.) End Date)	patient#Psoriasis Treatment#3#(PSO tr.) End Date ((PSO tr.) End Date)	patient#Psoriasis Treatment#4#(PSO tr.) End Date ((PSO tr.) End Date)	patient#Psoriasis Treatment#5#(PSO tr.) End Date ((PSO tr.) End Date)	patient#Psoriasis Treatment#6#(PSO tr.) End Date ((PSO tr.) End Date)	patient#Psoriasis Treatment#7#(PSO tr.) End Date ((PSO tr.) End Date)	patient#Psoriasis Treatment#8#(PSO tr.) End Date ((PSO tr.) End Date)	patient#Psoriasis Treatment#9#(PSO tr.) End Date ((PSO tr.) End Date)	patient#Psoriasis Treatment#10#(PSO tr.) End Date ((PSO tr.) End Date)	patient#Psoriasis Treatment#11#(PSO tr.) End Date ((PSO tr.) End Date)	patient#Psoriasis Treatment#1#(PSO tr.) Responder ((PSO tr.) Responder)	patient#Psoriasis Treatment#2#(PSO tr.) Responder ((PSO tr.) Responder)	patient#Psoriasis Treatment#3#(PSO tr.) Responder ((PSO tr.) Responder)	patient#Psoriasis Treatment#4#(PSO tr.) Responder ((PSO tr.) Responder)	patient#Psoriasis Treatment#5#(PSO tr.) Responder ((PSO tr.) Responder)	patient#Psoriasis Treatment#6#(PSO tr.) Responder ((PSO tr.) Responder)	patient#Psoriasis Treatment#7#(PSO tr.) Responder ((PSO tr.) Responder)	patient#Psoriasis Treatment#8#(PSO tr.) Responder ((PSO tr.) Responder)	patient#Psoriasis Treatment#9#(PSO tr.) Responder ((PSO tr.) Responder)	patient#Psoriasis Treatment#10#(PSO tr.) Responder ((PSO tr.) Responder)	patient#Psoriasis Treatment#11#(PSO tr.) Responder ((PSO tr.) Responder)	patient#Other concurrent chronic diseases#1#(dis.) Disease name ((dis.) Disease name)	patient#Other concurrent chronic diseases#2#(dis.) Disease name ((dis.) Disease name)	patient#Other concurrent chronic diseases#3#(dis.) Disease name ((dis.) Disease name)	patient#Other concurrent chronic diseases#4#(dis.) Disease name ((dis.) Disease name)	patient#Other concurrent chronic diseases#5#(dis.) Disease name ((dis.) Disease name)	patient#Other concurrent chronic diseases#1#(dis.) Freq ((dis.) Freq)	patient#Other concurrent chronic diseases#2#(dis.) Freq ((dis.) Freq)	patient#Other concurrent chronic diseases#3#(dis.) Freq ((dis.) Freq)	patient#Other concurrent chronic diseases#4#(dis.) Freq ((dis.) Freq)	patient#Other concurrent chronic diseases#5#(dis.) Freq ((dis.) Freq)	patient#Other concurrent chronic diseases#1#(dis.) Start date ((dis.) Start date)	patient#Other concurrent chronic diseases#2#(dis.) Start date ((dis.) Start date)	patient#Other concurrent chronic diseases#3#(dis.) Start date ((dis.) Start date)	patient#Other concurrent chronic diseases#4#(dis.) Start date ((dis.) Start date)	patient#Other concurrent chronic diseases#5#(dis.) Start date ((dis.) Start date)	patient#Other concurrent chronic diseases#1#(dis.) Ongoing ((dis.) Ongoing)	patient#Other concurrent chronic diseases#2#(dis.) Ongoing ((dis.) Ongoing)	patient#Other concurrent chronic diseases#3#(dis.) Ongoing ((dis.) Ongoing)	patient#Other concurrent chronic diseases#4#(dis.) Ongoing ((dis.) Ongoing)	patient#Other concurrent chronic diseases#5#(dis.) Ongoing ((dis.) Ongoing)	patient#Other concurrent chronic diseases#1#(dis.) End Date ((dis.) End Date)	patient#Other concurrent chronic diseases#2#(dis.) End Date ((dis.) End Date)	patient#Other concurrent chronic diseases#3#(dis.) End Date ((dis.) End Date)	patient#Other concurrent chronic diseases#4#(dis.) End Date ((dis.) End Date)	patient#Other concurrent chronic diseases#5#(dis.) End Date ((dis.) End Date)	patient#Psoriasis Area and Severity Index (PASI) Score#Date completed (Date_completed)	patient#Psoriasis Area and Severity Index (PASI) Score#Please state the areas involved (Please_state_the_areas_involved)	patient#Psoriasis Area and Severity Index (PASI) Score#areas involved (picture) (areas_involved_(picture))	patient#Psoriasis Area and Severity Index (PASI) Score#HEAD#HEAD - Erythema (E) (HEAD_-_Erythema_(E))	patient#Psoriasis Area and Severity Index (PASI) Score#HEAD#HEAD - Induration (I) (HEAD_-_Induration_(I))	patient#Psoriasis Area and Severity Index (PASI) Score#HEAD#HEAD - Scaling (S) (HEAD_-_Scaling_(S))	patient#Psoriasis Area and Severity Index (PASI) Score#HEAD#HEAD - Sum (E+I+S)= (HEAD_-_Sum_(E+I+S)=)	patient#Psoriasis Area and Severity Index (PASI) Score#HEAD#HEAD - Area(1 palm x 10) (HEAD_-_Area(1_palm_x_10))	patient#Psoriasis Area and Severity Index (PASI) Score#HEAD#HEAD - Sum x Area= (HEAD_-_Sum_x_Area=)	patient#Psoriasis Area and Severity Index (PASI) Score#HEAD#HEAD - Total (Sum x Area)x0.1= (HEAD_-_Total_(Sum_x_Area)x0.1=)	patient#Psoriasis Area and Severity Index (PASI) Score#TRUNK#TRUNK - Erythema (E) (TRUNK_-_Erythema_(E))	patient#Psoriasis Area and Severity Index (PASI) Score#TRUNK#TRUNK - Induration (I) (TRUNK_-_Induration_(I))	patient#Psoriasis Area and Severity Index (PASI) Score#TRUNK#TRUNK - Scaling (S) (TRUNK_-_Scaling_(S))	patient#Psoriasis Area and Severity Index (PASI) Score#TRUNK#TRUNK - Sum (E+I+S)= (TRUNK_-_Sum_(E+I+S)=)	patient#Psoriasis Area and Severity Index (PASI) Score#TRUNK#TRUNK - Area(1 palm x 3.3) (TRUNK_-_Area(1_palm_x_3.3))	patient#Psoriasis Area and Severity Index (PASI) Score#TRUNK#TRUNK - Sum x Area= (TRUNK_-_Sum_x_Area=)	patient#Psoriasis Area and Severity Index (PASI) Score#TRUNK#TRUNK - Total (Sum x Area)x0.3= (TRUNK_-_Total_(Sum_x_Area)x0.3=)	patient#Psoriasis Area and Severity Index (PASI) Score#UPPER LIMBS#UPPER LIMBS - Erythema (E) (UPPER_LIMBS_-_Erythema_(E))	patient#Psoriasis Area and Severity Index (PASI) Score#UPPER LIMBS#UPPER LIMBS - Induration (I) (UPPER_LIMBS_-_Induration_(I))	patient#Psoriasis Area and Severity Index (PASI) Score#UPPER LIMBS#UPPER LIMBS - Scaling (S) (UPPER_LIMBS_-_Scaling_(S))	patient#Psoriasis Area and Severity Index (PASI) Score#UPPER LIMBS#UPPER LIMBS - Sum (E+I+S)= (UPPER_LIMBS_-_Sum_(E+I+S)=)	patient#Psoriasis Area and Severity Index (PASI) Score#UPPER LIMBS#UPPER LIMBS - Area(1 palm x 5) (UPPER_LIMBS_-_Area(1_palm_x_5))	patient#Psoriasis Area and Severity Index (PASI) Score#UPPER LIMBS#UPPER LIMBS - Sum x Area= (UPPER_LIMBS_-_Sum_x_Area=)	patient#Psoriasis Area and Severity Index (PASI) Score#UPPER LIMBS#UPPER LIMBS - Total (Sum x Area)x0.2= (UPPER_LIMBS_-_Total_(Sum_x_Area)x0.2=)	patient#Psoriasis Area and Severity Index (PASI) Score#LOWER LIMBS#LOWER LIMBS - Erythema (E) (LOWER_LIMBS_-_Erythema_(E))	patient#Psoriasis Area and Severity Index (PASI) Score#LOWER LIMBS#LOWER LIMBS - Induration (I) (LOWER_LIMBS_-_Induration_(I))	patient#Psoriasis Area and Severity Index (PASI) Score#LOWER LIMBS#LOWER LIMBS - Scaling (S) (LOWER_LIMBS_-_Scaling_(S))	patient#Psoriasis Area and Severity Index (PASI) Score#LOWER LIMBS#LOWER LIMBS - Sum (E+I+S)= (LOWER_LIMBS_-_Sum_(E+I+S)=)	patient#Psoriasis Area and Severity Index (PASI) Score#LOWER LIMBS#LOWER LIMBS - Area(1 palm x 2.5) (LOWER_LIMBS_-_Area(1_palm_x_2.5))	patient#Psoriasis Area and Severity Index (PASI) Score#LOWER LIMBS#LOWER LIMBS - Sum x Area= (LOWER_LIMBS_-_Sum_x_Area=)	patient#Psoriasis Area and Severity Index (PASI) Score#LOWER LIMBS#LOWER LIMBS - Total (Sum x Area)x0.4= (LOWER_LIMBS_-_Total_(Sum_x_Area)x0.4=)	patient#Psoriasis Area and Severity Index (PASI) Score#PASI Score Total (TotalHead + TotalTrunk + TotalUpperLimbs + TotalLowerLimbs)#PASI Score= (PASI_Score=)	patient#Psoriasis Area and Severity Index (PASI) Score#Psoriasis Severity Index (PSI)#PSI - Erythema (PSI_-_Erythema)	patient#Psoriasis Area and Severity Index (PASI) Score#Psoriasis Severity Index (PSI)#PSI - Induration (PSI_-_Induration)	patient#Psoriasis Area and Severity Index (PASI) Score#Psoriasis Severity Index (PSI)#PSI - Scaling (PSI_-_Scaling)	patient#Psoriasis Area and Severity Index (PASI) Score#Psoriasis Severity Index (PSI)#PSI Total (PSI_Total)	patient#Psoriasis Area and Severity Index (PASI) Score#Please state the areas used for sampling#Lesional skin (Lesional_skin)	patient#Psoriasis Area and Severity Index (PASI) Score#Please state the areas used for sampling#Lesion Frequency (Lesion_Frequency)	patient#Psoriasis Area and Severity Index (PASI) Score#Evidence of superinfection:#a)(superinfection) clinical (a)(superinfection)_clinical)	patient#Psoriasis Area and Severity Index (PASI) Score#Evidence of superinfection:#b)(superinfection) microbiological - bacterial (b)(superinfection)_microbiological_-_bacterial)	patient#Psoriasis Area and Severity Index (PASI) Score#Evidence of superinfection:#c)(superinfection) microbiological - viral (c)(superinfection)_microbiological_-_viral)	patient#Psoriasis Area and Severity Index (PASI) Score#Evidence of superinfection:#Non-lesional skin (Non-lesional_skin)	patient#Clinical Assessment#Date of Assessment (Date_of_Assessment)	patient#Clinical Assessment#Global Assessment Score (Global_Assessment_Score)	patient#Clinical Assessment#Comments on samples and sampling (Comments_on_samples_and_sampling)	patient#Curated Items#Known_Allergies_v2 (Known_Allergies_v2)	patient#Curated Items#Concomitant_Medication_v2 (Concomitant_Medication_v2)	patient#Curated Items#Other_concurrent_chronic_diseases_v2 (Other_concurrent_chronic_diseases_v2)	patient#Curated Items#PSO_Past_treatment_name_v2 (PSO_Past_treatment_name_v2)	patient#Curated Items#Excluded (Excluded)	patient#Curated Items#Exclusion comments (Exclusion_comments)	involved skin swipe#involved skin swipe#MAARS Sample identifier (MAARS_Sample_identifier)	involved skin swipe#involved skin swipe#Sampling date (Sampling_date)	involved skin swipe#involved skin swipe#Excluded (Excluded)	involved skin swipe#involved skin swipe#Exclusion comments (Exclusion_comments)	uninvolved skin swipe#uninvolved skin swipe#MAARS Sample identifier (MAARS_Sample_identifier)	uninvolved skin swipe#uninvolved skin swipe#Sampling date (Sampling_date)	uninvolved skin swipe#uninvolved skin swipe#Excluded (Excluded)	uninvolved skin swipe#uninvolved skin swipe#Exclusion comments (Exclusion_comments)	involved skin biopsy#involved skin biopsy#MAARS Sample identifier (MAARS_Sample_identifier)	involved skin biopsy#involved skin biopsy#Sampling date (Sampling_date)	involved skin biopsy#involved skin biopsy#Excluded (Excluded)	involved skin biopsy#involved skin biopsy#Exclusion comments (Exclusion_comments)	uninvolved skin biopsy#uninvolved skin biopsy#MAARS Sample identifier (MAARS_Sample_identifier)	uninvolved skin biopsy#uninvolved skin biopsy#Sampling date (Sampling_date)	uninvolved skin biopsy#uninvolved skin biopsy#Excluded (Excluded)	uninvolved skin biopsy#uninvolved skin biopsy#Exclusion comments (Exclusion_comments)	frozen biopsy (lesional)#frozen biopsy (lesional)#MAARS Sample identifier (MAARS_Sample_identifier)	frozen biopsy (lesional)#frozen biopsy (lesional)#Sampling date (Sampling_date)	frozen biopsy (lesional)#frozen biopsy (lesional)#Excluded (Excluded)	frozen biopsy (lesional)#frozen biopsy (lesional)#Exclusion comments (Exclusion_comments)	frozen biopsy (nonlesional)#frozen biopsy (nonlesional)#MAARS Sample identifier (MAARS_Sample_identifier)	frozen biopsy (nonlesional)#frozen biopsy (nonlesional)#Sampling date (Sampling_date)	frozen biopsy (nonlesional)#frozen biopsy (nonlesional)#Excluded (Excluded)	frozen biopsy (nonlesional)#frozen biopsy (nonlesional)#Exclusion comments (Exclusion_comments)	microbiome biopsy (lesional)#microbiome biopsy (lesional)#MAARS Sample identifier (MAARS_Sample_identifier)	microbiome biopsy (lesional)#microbiome biopsy (lesional)#Sampling date (Sampling_date)	microbiome biopsy (lesional)#microbiome biopsy (lesional)#Excluded (Excluded)	microbiome biopsy (lesional)#microbiome biopsy (lesional)#Exclusion comments (Exclusion_comments)	microbiome biopsy (nonlesional)#microbiome biopsy (nonlesional)#MAARS Sample identifier (MAARS_Sample_identifier)	microbiome biopsy (nonlesional)#microbiome biopsy (nonlesional)#Sampling date (Sampling_date)	microbiome biopsy (nonlesional)#microbiome biopsy (nonlesional)#Excluded (Excluded)	microbiome biopsy (nonlesional)#microbiome biopsy (nonlesional)#Exclusion comments (Exclusion_comments)	blood for genomic DNA#blood for genomic DNA#MAARS Sample identifier (MAARS_Sample_identifier)	blood for genomic DNA#blood for genomic DNA#Sampling date (Sampling_date)	blood for genomic DNA#blood for genomic DNA#Excluded (Excluded)	blood for genomic DNA#blood for genomic DNA#Exclusion comments (Exclusion_comments)	blood for PBMC#blood for PBMC#MAARS Sample identifier (MAARS_Sample_identifier)	blood for PBMC#blood for PBMC#Sampling date (Sampling_date)	blood for PBMC#blood for PBMC#Excluded (Excluded)	blood for PBMC#blood for PBMC#Exclusion comments (Exclusion_comments)	plasma#plasma#MAARS Sample identifier (MAARS_Sample_identifier)	plasma#plasma#Sampling date (Sampling_date)	plasma#plasma#Excluded (Excluded)	plasma#plasma#Exclusion comments (Exclusion_comments)
MAARS_1_002	28/11/11	HHU	Baran	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1959	Female	White				1974	1974	No		Unknown 	No	No	No	Present		Present	Present	Present	No	No	No	No	No	No	No	No																																																													Yes																		UVB - Ultraviolet B phototherapy																																												No																																	Depression	Migrene														Yes	Yes									28/11/11	arms ; head ; legs		2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	1.2	2 (moderate)	2 (moderate)	2 (moderate)	6	1 (1%-9%)	6	1.8	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	2.4	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	4.8	10.2	4 (Red colouration)	4 (Moderate elevation)	4 (Moderate)	12	lower back	Chronic(>1week)				upper back	28/11/11	moderate-severe				Others ; Others	Phototherapy			MAARS_1_002_01	28/11/11			MAARS_1_002_02	28/11/11			MAARS_1_002_03	28/11/11			MAARS_1_002_04	28/11/11			MAARS_1_002_05	28/11/11			MAARS_1_002_06	28/11/11			MAARS_1_002_10	28/11/11			MAARS_1_002_11	28/11/11			MAARS_1_002_07	28/11/11			MAARS_1_002_08	28/11/11			MAARS_1_002_09	28/11/11		
MAARS_1_004	09/12/11	HHU	Baran	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1955	Male	White				1992	1992	No		No	No	No	No	No		Present	Present	Past	No	No	No	No	No	No	No	No						No	No	No	No	No									No	No	No				Thyroid hormones	Angiotensin receptor blockers								75	300																										Yes	Yes																																																																																														Hypertension	Thyroid dysfunction	hepatic cirrhosis	Thrombocytopenia												Yes										09/12/11	 buttocks ;  lower back ; arms ; head ; legs ; trunk		1 (slight)	2 (moderate)	1 (slight)	4	2 (10%-29%)	8	0.8	2 (moderate)	1 (slight)	2 (moderate)	5	3 (30%-49%)	15	4.5	1 (slight)	2 (moderate)	2 (moderate)	5	2 (10%-29%)	10	2	2 (moderate)	1 (slight)	1 (slight)	4	2 (10%-29%)	8	3.2	10.5	4 (Red colouration)	2 (Slight definite elevation)	2 (Mild)	8	lower back	Chronic(>1week)				upper back	09/12/11	moderate			Thyroid hormones ; Anti-Hypertensive	Hypertension ; Thyroid dysfunction ; Others ; Others				MAARS_1_004_01	09/12/11			MAARS_1_004_02	09/12/11			MAARS_1_004_03	09/12/11			MAARS_1_004_04	09/12/11			MAARS_1_004_05	09/12/11			MAARS_1_004_06	09/12/11			MAARS_1_004_10	09/12/11			MAARS_1_004_11	09/12/11			MAARS_1_004_07	09/12/11			MAARS_1_004_08	09/12/11			MAARS_1_004_09	09/12/11		
MAARS_1_005	04/01/12	HHU	Baran	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1974	Male	Asian - Other				2008	2008	Yes		No	No	No	No	Past		Present	Present	No	No	No	No	No	No	No	No	No																																																																															Methotrexate	Fumaric acid																																											No	No																					No	No																																			04/01/12	arms ; legs ; lower back		3 (severe)	2 (moderate)	3 (severe)	8	2 (10%-29%)	16	1.6	3 (severe)	1 (slight)	2 (moderate)	6	3 (30%-49%)	18	5.4	2 (moderate)	2 (moderate)	3 (severe)	7	3 (30%-49%)	21	4.2	1 (slight)	3 (severe)	2 (moderate)	6	3 (30%-49%)	18	7.2	18.4	4 (Red colouration)	4 (Moderate elevation)	4 (Moderate)	12	lower back	Chronic(>1week)				upper back	04/01/12	moderate-severe					Methotrexate ; Fumaric acid			MAARS_1_005_01	04/01/12			MAARS_1_005_02	04/01/12			MAARS_1_005_03	04/01/12			MAARS_1_005_04	04/01/12			MAARS_1_005_05	04/01/12			MAARS_1_005_06	04/01/12			MAARS_1_005_10	04/01/12			MAARS_1_005_11	04/01/12			MAARS_1_005_07	04/01/12			MAARS_1_005_08	04/01/12			MAARS_1_005_09	04/01/12		
MAARS_1_006	05/01/12	HHU	Jahn	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1975	Male	White				2007	2007	Yes		No	No	No	No	No		Present	Present	No	No	No	No	No	No	No	No	No																																																																																																																																																																																					05/01/12	arms ; legs ; lower back		2 (moderate)	2 (moderate)	1 (slight)	5	2 (10%-29%)	10	1	3 (severe)	1 (slight)	2 (moderate)	6	2 (10%-29%)	12	3.6	3 (severe)	2 (moderate)	2 (moderate)	7	2 (10%-29%)	14	2.8	1 (slight)	2 (moderate)	2 (moderate)	5	2 (10%-29%)	10	4	11.4	4 (Red colouration)	2 (Slight definite elevation)	2 (Mild)	8	lower back	Chronic(>1week)				upper back	05/01/12	moderate								MAARS_1_006_01	05/01/12			MAARS_1_006_02	05/01/12			MAARS_1_006_03	05/01/12			MAARS_1_006_04	05/01/12			MAARS_1_006_05	05/01/12			MAARS_1_006_06	05/01/12			MAARS_1_006_10	05/01/12			MAARS_1_006_11	05/01/12			MAARS_1_006_07	05/01/12			MAARS_1_006_08	05/01/12			MAARS_1_006_09	05/01/12		
MAARS_1_007	18/01/12	HHU	Baran	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1975	Male	White				1999	2000	Yes		Unknown 	No	No	No	No		Present	Present	Past	No	No	No	No	No	No	No	No																									Other anti-epileptic drugs									400																											Yes																																																																																															Epilepsy															Yes										18/01/12	 buttocks ;  lower back ; arms ; legs		0 (none)	0 (none)	0 (none)	0	0 (0%)	0	0	1 (slight)	2 (moderate)	2 (moderate)	5	2 (10%-29%)	10	3.0	2 (moderate)	2 (moderate)	1 (slight)	5	2 (10%-29%)	10	2.0	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	4.8	9.8	2 (Pink colouration)	2 (Slight definite elevation)	2 (Mild)	6	lower back	Chronic(>1week)				upper back	18/01/12	moderate			Others	Others				MAARS_1_007_01	09/12/11			MAARS_1_007_02	09/12/11			MAARS_1_007_03	09/12/11			MAARS_1_007_04	09/12/11			MAARS_1_007_05	09/12/11			MAARS_1_007_06	09/12/11			MAARS_1_007_10	09/12/11			MAARS_1_007_11	09/12/11			MAARS_1_007_07	09/12/11			MAARS_1_007_08	09/12/11			MAARS_1_007_09	09/12/11		
MAARS_1_009	16/02/12	HHU	Baran	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1959	Female	White				1970	1975	Yes		No	No	No	No	No		Present	No	Present	No	No	No	No	No	No	No	No																									neuroleptics	Antidepressant - Other								50									1																		Yes																		Methotrexate	Fumaric acid																																																																												Depression															Yes										16/02/12	head ; legs ; posterior thigh ; trunk		2 (moderate)	3 (severe)	2 (moderate)	7	1 (1%-9%)	7	0.7	1 (slight)	2 (moderate)	3 (severe)	6	2 (10%-29%)	12	3.6	2 (moderate)	1 (slight)	2 (moderate)	7	2 (10%-29%)	14	2.8	3 (severe)	2 (moderate)	1 (slight)	6	2 (10%-29%)	12	4.8	11.9	2 (Pink colouration)	2 (Slight definite elevation)	2 (Mild)	6	lower back	Chronic(>1week)				upper back	16/02/12	moderate			Others ; Others	Others	Methotrexate ; Fumaric acid			MAARS_1_009_01	16/02/12			MAARS_1_009_02	16/02/12			MAARS_1_009_03	16/02/12			MAARS_1_009_04	16/02/12			MAARS_1_009_05	16/02/12			MAARS_1_009_06	16/02/12			MAARS_1_009_10	16/02/12			MAARS_1_009_11	16/02/12			MAARS_1_009_07	16/02/12			MAARS_1_009_08	16/02/12			MAARS_1_009_09	16/02/12		
MAARS_1_010	17/12/12	HHU	Jahn	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1955	Male	White				2007	2007	Yes		Yes	No	No	No	No		Present	Present	Present	No	No	No	No	No	No	No	No																									Proton pump inhibitors	Ibuprofen																																			Yes																		UVB - Ultraviolet B phototherapy																						10																						No																						No											Diabetes (non-insulin)	Prostata hyperplasia														Yes	Yes									17/02/12	arms ; legs ; lower back ; trunk		3 (severe)	2 (moderate)	2 (moderate)	7	3 (30%-49%)	21	2.1	3 (severe)	3 (severe)	3 (severe)	9	3 (30%-49%)	27	8.1	3 (severe)	3 (severe)	3 (severe)	9	3 (30%-49%)	27	5.4	3 (severe)	3 (severe)	3 (severe)	9	3 (30%-49%)	27	10.8	26.4	4 (Red colouration)	4 (Moderate elevation)	2 (Mild)	10	lower back	Chronic(>1week)				upper back	17/02/12	Severe			Others ; Anti-Inflammatory(non steroid)	Diabetes (non-insulin) ; Others	Phototherapy			MAARS_1_010_01	17/02/12			MAARS_1_010_02	17/02/12			MAARS_1_010_03	17/02/12			MAARS_1_010_04	17/02/12			MAARS_1_010_05	17/02/12			MAARS_1_010_06	17/02/12			MAARS_1_010_10	17/02/12			MAARS_1_010_11	17/02/12			MAARS_1_010_07	17/02/12			MAARS_1_010_08	17/02/12			MAARS_1_010_09	17/02/12		
MAARS_1_013	29/02/12	HHU	Baran	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1952	Male	White			1005080/archive/1000867/MAARS_1_013-Wed_Feb_27_16:12:53_CET_2013.jpeg	1969	1973	Yes		No	No	No	No	No		Present	No	Present	No	No	No	No	No	No	No	No																																																																																																																																																																																					29/02/12			0 (none)	0 (none)	0 (none)	0	0 (0%)	0	0	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	3.6	3 (severe)	2 (moderate)	2 (moderate)	7	3 (30%-49%)	21	4.2	2 (moderate)	2 (moderate)	3 (severe)	7	2 (10%-29%)	14	5.6	13.4	4 (Red colouration)	2 (Slight definite elevation)	2 (Mild)	8	lower back	Chronic(>1week)				lower back	29/02/12	moderate-severe								MAARS_1_013_01	09/12/11			MAARS_1_013_02	09/12/11			MAARS_1_013_03	09/12/11	Yes	"pilot Affymetrix analysis (PCA, Curie): PSO_LES clusters with Control"	MAARS_1_013_04	09/12/11			MAARS_1_013_05	09/12/11			MAARS_1_013_06	09/12/11			MAARS_1_013_10	09/12/11			MAARS_1_013_11	09/12/11			MAARS_1_013_07	09/12/11			MAARS_1_013_08	09/12/11			MAARS_1_013_09	09/12/11		
MAARS_1_015	12/03/12	HHU	Baran	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1969	Male	White				1999	1999	Yes		No	No	No	No	Past		Present	Present	Present	No	No	No	No	No	No	No	No																																																																															UVB - Ultraviolet B phototherapy																																												No																						Yes											Unknown 															No										12/03/12	 buttocks ;  lower back ; arms ; head ; legs ; posterior thigh ; trunk		2 (moderate)	2 (moderate)	2 (moderate)	6	3 (30%-49%)	18	1.8	2 (moderate)	3 (severe)	2 (moderate)	7	3 (30%-49%)	21	6.3	3 (severe)	3 (severe)	3 (severe)	9	3 (30%-49%)	27	5.4	3 (severe)	3 (severe)	3 (severe)	9	3 (30%-49%)	27	10.8	24.3	2 (Pink colouration)	2 (Slight definite elevation)	3 (Mild-Moderate)	7	lower back	Chronic(>1week)					12/03/12	moderate-severe					Phototherapy			MAARS_1_015_01	12/03/12			MAARS_1_015_02	12/03/12			MAARS_1_015_03	12/03/12			MAARS_1_015_04	12/03/12			MAARS_1_015_05	12/03/12			MAARS_1_015_06	12/03/12			MAARS_1_015_10	12/03/12			MAARS_1_015_11	12/03/12			MAARS_1_015_07	12/03/12			MAARS_1_015_08	12/03/12			MAARS_1_015_09	12/03/12		
MAARS_1_018	15/03/12	HHU	Jahn	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1969	Male	White				1982	1982	No		No	Past	No	No	Past		Present	Present	Present	No	No	No	No	No	No	No	No																																																																															Fumaric acid	Methotrexate	UVB - Ultraviolet B phototherapy																																										No	No	No																				No	No	No																																		15/03/12	arms ; buttocks ; legs ; trunk		3 (severe)	2 (moderate)	2 (moderate)	7	2 (10%-29%)	14	1.4	3 (severe)	2 (moderate)	2 (moderate)	7	3 (30%-49%)	21	6.3	2 (moderate)	2 (moderate)	3 (severe)	7	3 (30%-49%)	21	4.2	1 (slight)	2 (moderate)	3 (severe)	6	2 (10%-29%)	12	4.8	16.7	4 (Red colouration)	4 (Moderate elevation)	4 (Moderate)	12	lower back	Chronic(>1week)					15/03/12	moderate-severe					Fumaric acid ; Methotrexate ; Phototherapy			MAARS_1_018_01	15/03/12			MAARS_1_018_02	15/03/12			MAARS_1_018_03	15/03/12			MAARS_1_018_04	15/03/12			MAARS_1_018_05	15/03/12			MAARS_1_018_06	15/03/12			MAARS_1_018_10	15/03/12			MAARS_1_018_11	15/03/12			MAARS_1_018_07	15/03/12			MAARS_1_018_08	15/03/12			MAARS_1_018_09	15/03/12		
MAARS_1_019	20/03/12	HHU	Homey	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1991	Male	White				2012	2012	Yes		Unknown 	No	No	No	No		Present	Present	Present	No	No	No	No	No	No	No	No						No	No	No	No	No									No	No	No																																																																																																																																																																20/03/12	arms ; head ; legs ; trunk		2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	1.2	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	3.6	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	2.4	2 (moderate)	3 (severe)	2 (moderate)	7	2 (10%-29%)	14	5.6	12.8	2 (Pink colouration)	2 (Slight definite elevation)	2 (Mild)	6	lower back	Chronic(>1week)					20/03/12	moderate								MAARS_1_019_01	20/03/12			MAARS_1_019_02	20/03/12			MAARS_1_019_03	20/03/12			MAARS_1_019_04	20/03/12			MAARS_1_019_05	20/03/12			MAARS_1_019_06	20/03/12			MAARS_1_019_10	20/03/12			MAARS_1_019_11	20/03/12			MAARS_1_019_07	20/03/12			MAARS_1_019_08	20/03/12			MAARS_1_019_09	20/03/12		
MAARS_1_020	01/03/12	HHU	Jahn	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1948	Male	White				1960	1960	No		No	No	No	No	Past		Present	Present	Present	No	No	No	No	No	No	No	No																									Metformin	Insulin Humilin	ACE inhibitors	Statins	Beta-blockers	Anticoagulants																																																	Potent corticosteroids (topical)																																																																													Hypertension	Diabetes (non-insulin)	Obesity	myocardial infarction																						01/03/12	arms ; head ; legs ; lower back ; trunk		3 (severe)	3 (severe)	4 (very severe)	10	4 (50%-69%)	40	4	4 (very severe)	4 (very severe)	4 (very severe)	12	4 (50%-69%)	48	14.4	4 (very severe)	4 (very severe)	4 (very severe)	12	4 (50%-69%)	48	9.6	4 (very severe)	4 (very severe)	4 (very severe)	12	4 (50%-69%)	48	19.2	47.2	6 (Very red colouration)	6 (Marked elevation)	6 (Severe)	18	lower back	Chronic(>1week)					21/03/12	Severe			Others ; Insulin ; Anti-Hypertensive ; Statins ; Anti-Hypertensive ; Others	Hypertension ; Diabetes (non-insulin) ; Others ; Others	Local Corticosteroids			MAARS_1_020_01	21/03/12			MAARS_1_020_02				MAARS_1_020_03				MAARS_1_020_04				MAARS_1_020_05				MAARS_1_020_06				MAARS_1_020_10				MAARS_1_020_11				MAARS_1_020_07				MAARS_1_020_08				MAARS_1_020_09			
MAARS_1_021	22/03/12	HHU	Jahn	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1951	Female	White				1960	1965	No		No	Present	Present	No	Past		Present	Present	Present	No	No	No	No	No	No	No	No																									Statins	Metformin	Calcium Channel Blockers							60	500	5							1	2	1																Yes	Yes	Yes																Methotrexate	Acitretin																																																																												Diabetes (non-insulin)	Hypertension																								22/03/12	arms ; buttocks ; legs		2 (moderate)	1 (slight)	1 (slight)	4	2 (10%-29%)	8	0.8	2 (moderate)	2 (moderate)	3 (severe)	7	2 (10%-29%)	14	4.2	2 (moderate)	2 (moderate)	3 (severe)	7	2 (10%-29%)	14	2.8	3 (severe)	2 (moderate)	2 (moderate)	8	2 (10%-29%)	14	5.6	13.4	4 (Red colouration)	2 (Slight definite elevation)	2 (Mild)	8	lower back	Chronic(>1week)				lower back	22/03/12	moderate-severe			Statins ; Others ; Anti-Hypertensive	Diabetes (non-insulin) ; Hypertension	Methotrexate ; Retinoids			MAARS_1_021_01	22/03/12			MAARS_1_021_02	22/03/12			MAARS_1_021_03	22/03/12			MAARS_1_021_04	22/03/12			MAARS_1_021_05	22/03/12			MAARS_1_021_06	22/03/12			MAARS_1_021_10	22/03/12			MAARS_1_021_11	22/03/12			MAARS_1_021_07	22/03/12			MAARS_1_021_08	22/03/12			MAARS_1_021_09	22/03/12		
MAARS_1_024	04/04/12	HHU	Jahn	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1967	Male	White				1988	1988	No		No	No	No	No	Past		Present	Present	Present	No	No	No	No	No	No	No	No																																																																															Methotrexate	Fumaric acid	Cyclosporin																																																																											Obesity																									04/04/12	arms ; buttocks ; head ; legs ; posterior thigh ; trunk		2 (moderate)	2 (moderate)	2 (moderate)	6	1 (1%-9%)	6	0.6	3 (severe)	3 (severe)	3 (severe)	9	3 (30%-49%)	27	8.1	3 (severe)	3 (severe)	3 (severe)	9	3 (30%-49%)	27	5.4	3 (severe)	3 (severe)	3 (severe)	9	3 (30%-49%)	27	10.8	24.9	4 (Red colouration)	4 (Moderate elevation)	4 (Moderate)	12	lower back	Chronic(>1week)				upper back	04/04/12	Severe				Others	Methotrexate ; Fumaric acid ; Cyclosporin			MAARS_1_024_01	04/04/12			MAARS_1_024_02	04/04/12			MAARS_1_024_03	04/04/12			MAARS_1_024_04	04/04/12			MAARS_1_024_05	04/04/12			MAARS_1_024_06	04/04/12			MAARS_1_024_10	04/04/12			MAARS_1_024_11	04/04/12			MAARS_1_024_07	04/04/12			MAARS_1_024_08	04/04/12			MAARS_1_024_09	04/04/12		
MAARS_1_026	11/04/12	HHU	Baran	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1972	Male	White				2000	2000	Yes		Yes	No	No	No	Past		Present	No	Present	No	No	No	No	No	No	No	No																																																																															UVB - Ultraviolet B phototherapy																																																																																																						11/04/12	arms ; buttocks ; legs ; lower back		2 (moderate)	1 (slight)	2 (moderate)	5	2 (10%-29%)	10	1	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	3.6	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	2.4	2 (moderate)	2 (moderate)	3 (severe)	7	2 (10%-29%)	14	5.6	12.6	4 (Red colouration)	3	3 (Mild-Moderate)	10	lower back	Chronic(>1week)					11/04/12	moderate					Phototherapy			MAARS_1_026_01				MAARS_1_026_02				MAARS_1_026_03				MAARS_1_026_04				MAARS_1_026_05				MAARS_1_026_06				MAARS_1_026_10				MAARS_1_026_11				MAARS_1_026_07				MAARS_1_026_08				MAARS_1_026_09			
MAARS_1_030	13/04/12	HHU	Jahn	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1949	Male	White				2009	2010	No		Unknown 	No	No	No	No		Present	No	Present	Present	No	No	No	No	No	No	No																									ACE inhibitors	Anticoagulants	Diuretics	Proton pump inhibitors	Statins																																																		vitamin D analogs	Potent corticosteroids (topical)	UVB - Ultraviolet B phototherapy																																																																											Hypertension																									13/04/12	legs ; lower back ; trunk		0 (none)	0 (none)	0 (none)	0	0 (0%)	0	0	1 (slight)	1 (slight)	1 (slight)	3	2 (10%-29%)	6	1.8	0 (none)	0 (none)	0 (none)	0	0 (0%)	0	0	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	4.8	6.6	2 (Pink colouration)	2 (Slight definite elevation)	2 (Mild)	6	lower back	Chronic(>1week)					13/04/12	mild			Anti-Hypertensive ; Others ; Anti-Hypertensive ; Others ; Statins	Hypertension	Vitamin D analogs ; Local Corticosteroids ; Phototherapy			MAARS_1_030_01				MAARS_1_030_02				MAARS_1_030_03				MAARS_1_030_04				MAARS_1_030_05				MAARS_1_030_06				MAARS_1_030_10				MAARS_1_030_11				MAARS_1_030_07				MAARS_1_030_08				MAARS_1_030_09			
MAARS_1_032	20/04/12	HHU	Jahn	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1969	Male	White				2000	2000	No		Unknown 	No	No	No	Present		Present	No	Present	No	No	No	No	No	No	No	No																																																																															Potent corticosteroids (topical)	vitamin D analogs																																																																																																					20/04/12	arms ; head ; legs ; trunk		1 (slight)	2 (moderate)	1 (slight)	5	2 (10%-29%)	10	1	2 (moderate)	3 (severe)	3 (severe)	8	3 (30%-49%)	24	7.2	3 (severe)	2 (moderate)	2 (moderate)	7	3 (30%-49%)	21	4.2	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	4.8	17.2	4 (Red colouration)	2 (Slight definite elevation)	4 (Moderate)	10	lower back	Chronic(>1week)					20/04/12	moderate-severe					Local Corticosteroids ; Vitamin D analogs			MAARS_1_032_01				MAARS_1_032_02				MAARS_1_032_03				MAARS_1_032_04				MAARS_1_032_05				MAARS_1_032_06				MAARS_1_032_10				MAARS_1_032_11				MAARS_1_032_07				MAARS_1_032_08				MAARS_1_032_09			
MAARS_1_037	26/04/12	HHU	Baran	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1955	Male	White				2001	2001	Yes		No	No	No	No	Present		Present	No	Present	No	No	No	No	No	No	No	No																									ACE inhibitors	Diuretics																																																					Potent corticosteroids (topical)	vitamin D analogs																																																																												Hypertension	COPD																								26/04/12	arms ; buttocks ; legs ; trunk		2 (moderate)	0 (none)	1 (slight)	3	1 (1%-9%)	3	0.3	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	3.6	2 (moderate)	3 (severe)	2 (moderate)	7	2 (10%-29%)	14	2.8	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	4.8	11.5	4 (Red colouration)	4 (Moderate elevation)	2 (Mild)	10	lower back	Chronic(>1week)					26/04/12	moderate			Anti-Hypertensive ; Anti-Hypertensive	Hypertension ; Others	Local Corticosteroids ; Vitamin D analogs			MAARS_1_037_01	26/04/12			MAARS_1_037_02	26/04/12			MAARS_1_037_03				MAARS_1_037_04				MAARS_1_037_05				MAARS_1_037_06				MAARS_1_037_10				MAARS_1_037_11				MAARS_1_037_07				MAARS_1_037_08				MAARS_1_037_09			
MAARS_1_047	11/05/12	HHU	Jahn	Yes	Yes	No	No	No	No	No	No	No	No	No	No	No	1982	Male	White		penicillin		2012	2012	No		No	No	No	No	No		Present	Present	Present	Present	No	Present	No	Present	Present	No	No																																																																															Moderate corticosteroids (topical)																						1x											01/04/2012											No											23/04/2012											No																																				11/05/12	arms ; buttocks ; head ; legs ; lower back ; posterior thigh ; trunk		1 (slight)	1 (slight)	2 (moderate)	4	2 (10%-29%)	8	0.8	2 (moderate)	2 (moderate)	1 (slight)	5	3 (30%-49%)	15	4.5	2 (moderate)	2 (moderate)	2 (moderate)	6	3 (30%-49%)	18	3.6	3 (severe)	2 (moderate)	2 (moderate)	7	4 (50%-69%)	28	11.4	20.1	4 (Red colouration)	4 (Moderate elevation)	2 (Mild)	10	upper back	Chronic(>1week)				lower back	11/05/12	moderate-severe		Drug Allergy			Local Corticosteroids	Yes	"Patient doesn't match one inclusion criteria: The value is 'No' for the inclusion criteria 'Psoriasis patients with plaque-type psoriasis, diagnosed for at least 6 months'.  - excluded by Micha and colleagues(12/03/14)"	MAARS_1_047_01	11/05/12			MAARS_1_047_02	11/05/12			MAARS_1_047_03	11/05/12			MAARS_1_047_04	11/05/12			MAARS_1_047_05	11/05/12			MAARS_1_047_06	11/05/12			MAARS_1_047_10	11/05/12			MAARS_1_047_11	11/05/12			MAARS_1_047_07	11/05/12			MAARS_1_047_08	11/05/12			MAARS_1_047_09	11/05/12		
MAARS_1_049	11/05/12	HHU	Homey	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1973	Male	White				1995	1995	No		No	Past	Past	No	Past		Present	No	Present	Present	No	Present	No	No	No	No	Present																																																																															Fumaric acid	Methotrexate	Biologic's	Moderate corticosteroids (topical)	vitamin D analogs	Moderate corticosteroids (topical)	Moderate corticosteroids (topical)	Moderate corticosteroids (topical)	UVB - Ultraviolet B phototherapy																																																																																														11/05/12	head ; legs ; lower back ; trunk		2 (moderate)	2 (moderate)	2 (moderate)	6	3 (30%-49%)	18	1.8	3 (severe)	3 (severe)	3 (severe)	9	4 (50%-69%)	36	10.8	3 (severe)	3 (severe)	3 (severe)	9	4 (50%-69%)	36	7.2	3 (severe)	3 (severe)	3 (severe)	9	4 (50%-69%)	36	14.4	34.2	4 (Red colouration)	4 (Moderate elevation)	4 (Moderate)	12	lower back	Chronic(>1week)					11/05/12	moderate-severe					Fumaric acid ; Methotrexate ; Others ; Local Corticosteroids ; Vitamin D analogs ; Local Corticosteroids ; Local Corticosteroids ; Local Corticosteroids ; Phototherapy			MAARS_1_049_01	11/05/12			MAARS_1_049_02	11/05/12			MAARS_1_049_03	11/05/12			MAARS_1_049_04	11/05/12			MAARS_1_049_05	11/05/12			MAARS_1_049_06	11/05/12			MAARS_1_049_10	11/05/12			MAARS_1_049_11	11/05/12			MAARS_1_049_07	11/05/12			MAARS_1_049_08	11/05/12			MAARS_1_049_09	11/05/12		
MAARS_1_054	16/05/12	HHU	Jahn	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1980	Female	White				1991	1991	No		No	No	No	No	Past		Present	Present	Present	Past	No	Present	No	No	Past	No	Present																									Thyroid hormones									112									1									01/01/2000									Yes																		Moderate corticosteroids (topical)	UVB - Ultraviolet B phototherapy	Fumaric acid																																	01/01/2006											No										01/12/2011											Yes	No									Thyroid dysfunction																									16/05/12	arms ; buttocks ; head ; legs ; lower back ; posterior thigh ; trunk		2 (moderate)	2 (moderate)	3 (severe)	7	5 (70%-89%)	35	3.5	3 (severe)	2 (moderate)	3 (severe)	8	3 (30%-49%)	24	7.2	2 (moderate)	2 (moderate)	2 (moderate)	6	3 (30%-49%)	18	3.6	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	4.8	19.1	4 (Red colouration)	4 (Moderate elevation)	2 (Mild)	10	lower back	Chronic(>1week)				lower back	16/05/12	moderate-severe			Thyroid hormones	Thyroid dysfunction	Local Corticosteroids ; Phototherapy ; Fumaric acid			MAARS_1_054_01	16/05/12			MAARS_1_054_02	16/05/12			MAARS_1_054_03	16/05/12			MAARS_1_054_04	16/05/12			MAARS_1_054_05	16/05/12			MAARS_1_054_06	16/05/12			MAARS_1_054_10	16/05/12			MAARS_1_054_11	16/05/12			MAARS_1_054_07	16/05/12			MAARS_1_054_08	16/05/12			MAARS_1_054_09	16/05/12		
MAARS_1_058	21/05/12	HHU	Baran	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1975	Male	White				1995	1995	Yes		No	No	No	No	Present		Present	Present	Present	No	No	No	No	No	No	No	No																																																																															UVB - Ultraviolet B phototherapy																																	01/01/2011											No																						No																																				21/05/12	arms ; buttocks ; head ; legs ; lower back ; trunk		1 (slight)	1 (slight)	1 (slight)	3	1 (1%-9%)	3	0.3	3 (severe)	2 (moderate)	3 (severe)	8	2 (10%-29%)	16	4.8	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	2.4	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	4.8	12.3	2 (Pink colouration)	2 (Slight definite elevation)	2 (Mild)	6	lower back	Chronic(>1week)				upper back	21/05/12	moderate-severe					Phototherapy			MAARS_1_058_01				MAARS_1_058_02	21/05/12			MAARS_1_058_03				MAARS_1_058_04				MAARS_1_058_05				MAARS_1_058_06				MAARS_1_058_10				MAARS_1_058_11				MAARS_1_058_07				MAARS_1_058_08				MAARS_1_058_09			
MAARS_1_061	23/05/12	HHU	Jahn	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1936	Male	White	Son			1964	1985	Yes		No	No	No	No	No		Present	Present	Present	No	Present	Present	No	No	No	No	No	lentigo maligna	Spinocellular Ca				Yes	Yes				01/09/2003	01/01/2007													ACE inhibitors	Diuretics																																																					UVB - Ultraviolet B phototherapy	Moderate corticosteroids (topical)	Acitretin	vitamin D analogs	Biologic's																																								No	No	No	No	No																													Hypertension	Prostata hyperplasia																								23/05/12	arms ; buttocks ; head ; legs ; lower back ; posterior thigh ; trunk		1 (slight)	1 (slight)	1 (slight)	3	3 (30%-49%)	9	0.9	2 (moderate)	3 (severe)	3 (severe)	8	4 (50%-69%)	32	9.6	2 (moderate)	3 (severe)	3 (severe)	8	5 (70%-89%)	40	8.0	2 (moderate)	2 (moderate)	2 (moderate)	6	5 (70%-89%)	30	12.0	30.5	4 (Red colouration)	4 (Moderate elevation)	4 (Moderate)	12	lower back	Chronic(>1week)				lower back	23/05/12	Severe			Anti-Hypertensive ; Anti-Hypertensive	Hypertension ; Others	Phototherapy ; Local Corticosteroids ; Retinoids ; Vitamin D analogs ; Others			MAARS_1_061_01	23/05/12			MAARS_1_061_02	23/05/12			MAARS_1_061_03	23/05/12			MAARS_1_061_04	23/05/12			MAARS_1_061_05	23/05/12			MAARS_1_061_06	23/05/12			MAARS_1_061_10	23/05/12			MAARS_1_061_11	23/05/12			MAARS_1_061_07	23/05/12			MAARS_1_061_08	23/05/12			MAARS_1_061_09	23/05/12		
MAARS_1_062	23/05/12	HHU	Jahn	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1948	Male	White		Pollen		1982	1982	No		No	Past	Past	No	Past		Present	Present	Present	Present	No	Past	No	No	No	No	Past																																																																															vitamin D analogs	Methotrexate	PUVA - psoralen + UVA (ultraviolet A-phototherapy)																																																																																																				23/05/12	arms ; buttocks ; head ; legs ; lower back ; trunk		1 (slight)	1 (slight)	1 (slight)	3	2 (10%-29%)	6	0.6	2 (moderate)	3 (severe)	3 (severe)	8	2 (10%-29%)	16	4.8	3 (severe)	3 (severe)	3 (severe)	9	2 (10%-29%)	18	3.6	3 (severe)	3 (severe)	3 (severe)	9	3 (30%-49%)	27	10.8	19.8	4 (Red colouration)	6 (Marked elevation)	6 (Severe)	16	lower back	Chronic(>1week)				lower back	23/05/12	moderate-severe		Pollen			Vitamin D analogs ; Methotrexate ; Photochemotherapy			MAARS_1_062_01	23/05/12			MAARS_1_062_02	23/05/12			MAARS_1_062_03	23/05/12			MAARS_1_062_04	23/05/12			MAARS_1_062_05	23/05/12			MAARS_1_062_06	23/05/12			MAARS_1_062_10	23/05/12			MAARS_1_062_11	23/05/12			MAARS_1_062_07	23/05/12			MAARS_1_062_08	23/05/12			MAARS_1_062_09	23/05/12		
MAARS_1_066	01/06/12	HHU	Jahn	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1960	Male	White	Mother			1967	1967	Yes		No	No	No	Past	Past	20	Present	Present	Past	Present	No	Present	Present	Present	Past	No	No																									Acetylsalicylic acid	Statins	ACE inhibitors	Metformin																																																			Potent corticosteroids (topical)	Dithranol-minute																																																																												Hypertension	Diabetes (non-insulin)	hypercholesterolemia	diabetes insipidus																						01/06/12	arms ; head ; legs ; lower back ; posterior thigh ; trunk		1 (slight)	1 (slight)	3 (severe)	4	2 (10%-29%)	8	0.8	2 (moderate)	2 (moderate)	2 (moderate)	6	3 (30%-49%)	18	5.4	3 (severe)	2 (moderate)	2 (moderate)	7	3 (30%-49%)	21	4.2	3 (severe)	2 (moderate)	2 (moderate)	7	3 (30%-49%)	21	8.4	18.8	4 (Red colouration)	4 (Moderate elevation)	4 (Moderate)	12	lower back	Chronic(>1week)					01/06/12	moderate-severe			Anti-Inflammatory(non steroid) ; Statins ; Anti-Hypertensive ; Others	Hypertension ; Diabetes (non-insulin) ; Others ; Others	Local Corticosteroids ; Dithranol-minute			MAARS_1_066_01	01/06/12			MAARS_1_066_02	01/06/12			MAARS_1_066_03	01/06/12			MAARS_1_066_04	01/06/12			MAARS_1_066_05	01/06/12			MAARS_1_066_06	01/06/12			MAARS_1_066_10	01/06/12			MAARS_1_066_11	01/06/12			MAARS_1_066_07	01/06/12			MAARS_1_066_08	01/06/12			MAARS_1_066_09	01/06/12		
MAARS_1_071	06/06/12	HHU	Jahn	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1961	Male	White	Daughter ; Sister			1999	1999	No		No	Past	No	No	No		Present	Present	Present	No	No	Present	No	No	No	No	Past																																																																															Very potent corticosteroids (topical)	Potent corticosteroids (topical)																																																																																																					06/06/12	arms ; buttocks ; head ; legs ; lower back ; posterior thigh ; trunk		1 (slight)	1 (slight)	1 (slight)	3	2 (10%-29%)	6	0.6	3 (severe)	4 (very severe)	3 (severe)	10	4 (50%-69%)	40	12.0	3 (severe)	3 (severe)	4 (very severe)	10	4 (50%-69%)	40	8.0	3 (severe)	3 (severe)	3 (severe)	9	3 (30%-49%)	27	10.8	31.4	6 (Very red colouration)	6 (Marked elevation)	4 (Moderate)	16	lower back	Chronic(>1week)				lower back	06/06/12	moderate-severe					Local Corticosteroids ; Local Corticosteroids			MAARS_1_071_01	06/06/12			MAARS_1_071_02	06/06/12			MAARS_1_071_03	06/06/12			MAARS_1_071_04	06/06/12			MAARS_1_071_05	06/06/12			MAARS_1_071_06	06/06/12			MAARS_1_071_10	06/06/12			MAARS_1_071_11	06/06/12			MAARS_1_071_07	06/06/12			MAARS_1_071_08	06/06/12			MAARS_1_071_09	06/06/12		
MAARS_1_078	15/06/12	HHU	Lee	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1962	Male	White	Mother ; Daughter			1979	1979	No		Yes	Present	Present	Past	No		Present	Present	Present	No	Present	Present	No	No	No	No	Present																																																																															UVB - Ultraviolet B phototherapy																																																																																																						15/06/12	arms ; buttocks ; head ; legs ; lower back ; posterior thigh ; trunk		1 (slight)	1 (slight)	1 (slight)	3	1 (1%-9%)	3	0.3	3 (severe)	3 (severe)	3 (severe)	9	4 (50%-69%)	36	10.8	2 (moderate)	2 (moderate)	2 (moderate)	6	4 (50%-69%)	24	4.8	2 (moderate)	2 (moderate)	2 (moderate)	6	4 (50%-69%)	24	9.6	25.5	4 (Red colouration)	2 (Slight definite elevation)	4 (Moderate)	10	lower back	Chronic(>1week)					15/06/12	moderate-severe					Phototherapy			MAARS_1_078_01	15/06/12			MAARS_1_078_02	15/06/12			MAARS_1_078_03	15/06/12			MAARS_1_078_04	15/06/12			MAARS_1_078_05	15/06/12			MAARS_1_078_06	15/06/12			MAARS_1_078_10	15/06/12			MAARS_1_078_11	15/06/12			MAARS_1_078_07	15/06/12			MAARS_1_078_08	15/06/12			MAARS_1_078_09	15/06/12		
MAARS_1_079	20/06/12	HHU	Lee	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1953	Male	White				2005	2005	No		Yes	Present	Present	No	No		Present	No	Present	Present	No	No	No	No	No	No	Present																									Beta-blockers	Allopurinol-gout medicin																																																					Potent corticosteroids (topical)	UVB - Ultraviolet B phototherapy	Methotrexate	Fumaric acid																																																																										Hypertension																									20/06/12	arms ; buttocks ; legs ; lower back ; posterior thigh ; trunk		1 (slight)	1 (slight)	1 (slight)	3	1 (1%-9%)	3	0.3	3 (severe)	3 (severe)	3 (severe)	9	5 (70%-89%)	45	13.5	3 (severe)	3 (severe)	3 (severe)	9	4 (50%-69%)	36	7.2	3 (severe)	3 (severe)	3 (severe)	9	5 (70%-89%)	45	18	39.0	4 (Red colouration)	4 (Moderate elevation)	4 (Moderate)	12	lower back	Chronic(>1week)					20/06/12	moderate-severe			Anti-Hypertensive ; Others	Hypertension	Local Corticosteroids ; Phototherapy ; Methotrexate ; Fumaric acid			MAARS_1_079_01	20/06/12			MAARS_1_079_02	20/06/12			MAARS_1_079_03	20/06/12			MAARS_1_079_04	20/06/12			MAARS_1_079_05	20/06/12			MAARS_1_079_06	20/06/12			MAARS_1_079_10	20/06/12			MAARS_1_079_11	20/06/12			MAARS_1_079_07	20/06/12			MAARS_1_079_08	20/06/12			MAARS_1_079_09	20/06/12		
MAARS_1_081	22/06/12	HHU	Lee	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1972	Male	White				2000	2000	Yes		Yes	No	No	No	No		Present	Present	Present	Present	No	Present	No	No	No	No	Present																																																																															PUVA - psoralen + UVA (ultraviolet A-phototherapy)	Dithranol-minute																																																																																																					22/06/12	arms ; buttocks ; head ; legs ; lower back ; posterior thigh ; trunk		1 (slight)	1 (slight)	1 (slight)	3	2 (10%-29%)	6	0.6	3 (severe)	3 (severe)	3 (severe)	9	3 (30%-49%)	27	8.1	3 (severe)	3 (severe)	3 (severe)	9	3 (30%-49%)	27	5.4	3 (severe)	3 (severe)	3 (severe)	9	3 (30%-49%)	27	10.8	24.9	4 (Red colouration)	4 (Moderate elevation)	4 (Moderate)	12	lower back	Chronic(>1week)					22/06/12	moderate-severe					Photochemotherapy ; Dithranol-minute			MAARS_1_081_01	22/06/12			MAARS_1_081_02	22/06/12			MAARS_1_081_03	22/06/12			MAARS_1_081_04	22/06/12			MAARS_1_081_05	22/06/12			MAARS_1_081_06	22/06/12			MAARS_1_081_10	22/06/12			MAARS_1_081_11	22/06/12			MAARS_1_081_07	22/06/12			MAARS_1_081_08	22/06/12			MAARS_1_081_09	22/06/12		
MAARS_1_084	29/06/12	HHU	Jahn	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1973	Male	White	Father	dust mites ; Pollen		1985	1985	No		No	Past	Past	Present	No		Present	Present	Present	Past	No	Present	No	No	No	No	Present																																																																															Methotrexate	Fumaric acid	Potent corticosteroids (topical)	UVB - Ultraviolet B phototherapy																																									No	No																																																									29/06/12	arms ; head ; legs ; lower back		2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	1.2	2 (moderate)	2 (moderate)	2 (moderate)	6	1 (1%-9%)	6	1.8	2 (moderate)	2 (moderate)	3 (severe)	7	2 (10%-29%)	14	2.8	3 (severe)	2 (moderate)	3 (severe)	8	4 (50%-69%)	32	12.8	18.6	4 (Red colouration)	4 (Moderate elevation)	2 (Mild)	10	lower back	Chronic(>1week)					29/06/12	moderate		House dust mite ; Pollen			Methotrexate ; Fumaric acid ; Local Corticosteroids ; Phototherapy			MAARS_1_084_01	29/06/12			MAARS_1_084_02	29/06/12			MAARS_1_084_03	29/06/12			MAARS_1_084_04	29/06/12			MAARS_1_084_05	29/06/12			MAARS_1_084_06	29/06/12			MAARS_1_084_10	29/06/12			MAARS_1_084_11	29/06/12			MAARS_1_084_07	29/06/12			MAARS_1_084_08	29/06/12			MAARS_1_084_09	29/06/12		
MAARS_1_086	04/07/12	HHU	Baran	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1967	Male	White				1982	1982	No		No	Present	Present	Present	Present		Present	Present	Present	No	No	No	No	No	No	No	Present																									ACE inhibitors																																																						UVB - Ultraviolet B phototherapy																																																																													Hypertension																									04/07/12	arms ; head ; legs ; lower back		0 (none)	0 (none)	0 (none)	0	0 (0%)	0	0	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	3.6	1 (slight)	2 (moderate)	1 (slight)	4	2 (10%-29%)	8	1.6	1 (slight)	2 (moderate)	1 (slight)	4	2 (10%-29%)	8	3.2	8.4	2 (Pink colouration)	2 (Slight definite elevation)	1 (No evidence-Mild)	5	buttocks	Chronic(>1week)				lower back	04/07/12	mild			Anti-Hypertensive	Hypertension	Phototherapy			MAARS_1_086_01	04/07/12			MAARS_1_086_02	04/07/12			MAARS_1_086_03	04/07/12			MAARS_1_086_04	04/07/12			MAARS_1_086_05	04/07/12			MAARS_1_086_06	04/07/12			MAARS_1_086_10	04/07/12			MAARS_1_086_11	04/07/12			MAARS_1_086_07	04/07/12			MAARS_1_086_08	04/07/12			MAARS_1_086_09	04/07/12		
MAARS_1_087	04/07/12	HHU	Jahn	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1957	Male	White	Father ; Son ; Brother	Pollen		1960	1960	Yes		No	Present	Past	No	No		Present	No	Present	No	No	Present	No	No	No	No	Present																																																																															UVB - Ultraviolet B phototherapy																																																																																																						04/07/12	head ; lower back ; trunk		1 (slight)	2 (moderate)	3 (severe)	6	2 (10%-29%)	12	1.2	3 (severe)	2 (moderate)	3 (severe)	9	2 (10%-29%)	18	5.4	2 (moderate)	2 (moderate)	2 (moderate)	6	1 (1%-9%)	6	1.2	1 (slight)	1 (slight)	1 (slight)	3	1 (1%-9%)	3	1.2	9.0	4 (Red colouration)	4 (Moderate elevation)	4 (Moderate)	12	lower back	Chronic(>1week)				lower back	04/07/12	moderate		Pollen			Phototherapy			MAARS_1_087_01	04/07/12			MAARS_1_087_02	04/07/12			MAARS_1_087_03	04/07/12			MAARS_1_087_04	04/07/12			MAARS_1_087_05	04/07/12			MAARS_1_087_06	04/07/12			MAARS_1_087_10	04/07/12			MAARS_1_087_11	04/07/12			MAARS_1_087_07	04/07/12			MAARS_1_087_08	04/07/12			MAARS_1_087_09	04/07/12		
MAARS_1_089	11/07/12	HHU	Baran	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1956	Male	White				2012	2012	Yes		Yes	No	No	No	No		Present	No	Present	No	No	No	No	No	No	No	No																																																																															UVB - Ultraviolet B phototherapy	Moderate corticosteroids (topical)																																																																																																					11/07/12	arms ; buttocks ; legs ; lower back ; trunk		0 (none)	0 (none)	0 (none)	0	0 (0%)	0	0	2 (moderate)	1 (slight)	2 (moderate)	5	2 (10%-29%)	10	3	3 (severe)	2 (moderate)	2 (moderate)	7	2 (10%-29%)	14	2.8	2 (moderate)	3 (severe)	1 (slight)	6	2 (10%-29%)	12	4.8	10.6	2 (Pink colouration)	1	2 (Mild)	5	lower back	Chronic(>1week)				upper back	11/07/12	moderate					Phototherapy ; Local Corticosteroids			MAARS_1_089_01	11/07/12			MAARS_1_089_02	11/07/12			MAARS_1_089_03	11/07/12			MAARS_1_089_04	11/07/12			MAARS_1_089_05	11/07/12			MAARS_1_089_06	11/07/12			MAARS_1_089_10	11/07/12			MAARS_1_089_11	11/07/12			MAARS_1_089_07	11/07/12			MAARS_1_089_08	11/07/12			MAARS_1_089_09	11/07/12		
MAARS_1_091	20/07/12	HHU	Baran	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1977	Male	White		wheat		1990	1990	No		Yes	No	No	No	No		Present	No	Present	No	No	No	No	No	No	No	No																																																																																																																																																																																					20/07/12	arms ; legs ; lower back		0 (none)	0 (none)	0 (none)	0	0 (0%)	0	0	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	3.6	1 (slight)	2 (moderate)	2 (moderate)	5	1 (1%-9%)	5	1.0	2 (moderate)	2 (moderate)	2 (moderate)	6	3 (30%-49%)	18	7.2	11.8	2 (Pink colouration)	2 (Slight definite elevation)	2 (Mild)	6	lower back	Chronic(>1week)				upper back	20/07/12	moderate		Food						MAARS_1_091_01	20/07/12			MAARS_1_091_02	20/07/12			MAARS_1_091_03	20/07/12			MAARS_1_091_04	20/07/12			MAARS_1_091_05	20/07/12			MAARS_1_091_06	20/07/12			MAARS_1_091_10	20/07/12			MAARS_1_091_11	20/07/12			MAARS_1_091_07	20/07/12			MAARS_1_091_08	20/07/12			MAARS_1_091_09	20/07/12		
MAARS_1_092	27/07/12	HHU	Baran	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1949	Female	White				2000	2000	No		Unknown 	No	No	No	No		Present	Present	Present	No	No	No	No	No	No	No	Unknown 																																																																																																																																																																																					27/07/12	arms ; head ; legs ; lower back ; trunk		2 (moderate)	2 (moderate)	2 (moderate)	6	3 (30%-49%)	18	1.8	3 (severe)	2 (moderate)	2 (moderate)	7	2 (10%-29%)	14	4.2	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	2.4	3 (severe)	3 (severe)	2 (moderate)	8	3 (30%-49%)	24	9.6	18	3	3	2 (Mild)	8	lower back	Chronic(>1week)					27/07/12	moderate								MAARS_1_092_01	27/07/12			MAARS_1_092_02	27/07/12			MAARS_1_092_03	27/07/12			MAARS_1_092_04	27/07/12			MAARS_1_092_05	27/07/12			MAARS_1_092_06	27/07/12			MAARS_1_092_10	27/07/12			MAARS_1_092_11	27/07/12			MAARS_1_092_07	27/07/12			MAARS_1_092_08	27/07/12			MAARS_1_092_09	27/07/12		
MAARS_1_094	10/08/12	HHU	Baran	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1961	Male	White	Mother			1982	1982	Yes		No	No	No	No	No		Present	No	Present	No	No	No	No	No	No	No	No																																																																															Methotrexate	Fumaric acid																																																																																																					10/08/12	buttocks ; legs ; lower back ; trunk		0 (none)	0 (none)	0 (none)	0	0 (0%)	0	0	3 (severe)	2 (moderate)	2 (moderate)	7	2 (10%-29%)	14	4.2	2 (moderate)	1 (slight)	2 (moderate)	5	2 (10%-29%)	10	2.0	1 (slight)	2 (moderate)	1 (slight)	4	2 (10%-29%)	8	3.2	9.4	3	2 (Slight definite elevation)	1 (No evidence-Mild)	6	lower back	Chronic(>1week)				upper back	10/08/12	moderate					Methotrexate ; Fumaric acid			MAARS_1_094_01	10/08/12			MAARS_1_094_02	10/08/12			MAARS_1_094_03	10/08/12			MAARS_1_094_04	10/08/12			MAARS_1_094_05	10/08/12			MAARS_1_094_06	10/08/12			MAARS_1_094_10	10/08/12			MAARS_1_094_11	10/08/12			MAARS_1_094_07	10/08/12			MAARS_1_094_08	10/08/12			MAARS_1_094_09	10/08/12		
MAARS_1_095	28/08/12	HHU	Lee	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1986	Female	White Mixed				1995	1995	No		No	Present	No	No	Past		Present	Present	Present	No	No	No	No	No	No	No	Present																									Metformin	Angiotensin receptor blockers	Proton pump inhibitors																																																				Fumaric acid																																												No																						Yes											Diabetes (non-insulin)	Hypertension	Obesity																							28/08/12	arms ; buttocks ; legs ; lower back ; posterior thigh ; trunk		2 (moderate)	1 (slight)	1 (slight)	4	1 (1%-9%)	4	0.4	3 (severe)	3 (severe)	3 (severe)	9	4 (50%-69%)	36	10.8	3 (severe)	2 (moderate)	2 (moderate)	7	4 (50%-69%)	28	5.6	3 (severe)	2 (moderate)	2 (moderate)	7	4 (50%-69%)	28	11.2	28	3	2 (Slight definite elevation)	2 (Mild)	7	lower back	Chronic(>1week)					28/08/12	moderate-severe			Others ; Anti-Hypertensive ; Others	Diabetes (non-insulin) ; Hypertension ; Others	Fumaric acid			MAARS_1_095_01	28/08/12			MAARS_1_095_02	28/08/12			MAARS_1_095_03	28/08/12			MAARS_1_095_04	28/08/12			MAARS_1_095_05	28/08/12			MAARS_1_095_06	28/08/12			MAARS_1_095_10	28/08/12			MAARS_1_095_11	28/08/12			MAARS_1_095_07	28/08/12			MAARS_1_095_08	28/08/12			MAARS_1_095_09	28/08/12		
MAARS_1_099	04/09/12	HHU	Lee	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1960	Male	White				2000	2000	No		No	Present	No	Present	No		Present	Present	Present	Present	No	Present	Past	No	No	No	Present																									Beta-blockers	Statins	Metformin	Diuretics	ACE inhibitors	Proton pump inhibitors	Anticoagulants																																																vitamin D analogs	UVB - Ultraviolet B phototherapy																																																																												Diabetes (non-insulin)	Hypertension	sarcoidosis																							04/09/12	arms ; buttocks ; legs		0 (none)	0 (none)	0 (none)	0	0 (0%)	0	0	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	3.6	1 (slight)	2 (moderate)	2 (moderate)	5	2 (10%-29%)	10	2.0	2 (moderate)	2 (moderate)	2 (moderate)	6	3 (30%-49%)	18	7.2	12.8	2 (Pink colouration)	2 (Slight definite elevation)	2 (Mild)	6	lower back	Chronic(>1week)					04/09/12	moderate			Anti-Hypertensive ; Statins ; Others ; Anti-Hypertensive ; Anti-Hypertensive ; Others ; Others	Diabetes (non-insulin) ; Hypertension ; Others	Vitamin D analogs ; Phototherapy			MAARS_1_099_01	04/09/12			MAARS_1_099_02	04/09/12			MAARS_1_099_03	04/09/12			MAARS_1_099_04	04/09/12			MAARS_1_099_05	04/09/12			MAARS_1_099_06	04/09/12			MAARS_1_099_10	04/09/12			MAARS_1_099_11	04/09/12			MAARS_1_099_07	04/09/12			MAARS_1_099_08	04/09/12			MAARS_1_099_09	04/09/12		
MAARS_1_104	27/09/12	HHU	Jahn	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1972	Male	White	Sister			2000	2009	No		No	No	No	No	No		Present	Present	Present	No	No	No	No	No	No	No	No																																																																															Moderate corticosteroids (topical)																																																																																																						27/09/12	arms ; buttocks ; head ; legs ; lower back ; posterior thigh ; trunk		2 (moderate)	2 (moderate)	2 (moderate)	6	4 (50%-69%)	24	2.4	2 (moderate)	2 (moderate)	2 (moderate)	6	1 (1%-9%)	6	1.8	2 (moderate)	2 (moderate)	2 (moderate)	6	3 (30%-49%)	18	3.6	2 (moderate)	2 (moderate)	2 (moderate)	6	1 (1%-9%)	6	2.4	10.2	4 (Red colouration)	4 (Moderate elevation)	2 (Mild)	10	upper back	Chronic(>1week)				upper back	27/09/12	moderate					Local Corticosteroids			MAARS_1_104_01	27/09/12			MAARS_1_104_02	27/09/12			MAARS_1_104_03	27/09/12			MAARS_1_104_04	27/09/12			MAARS_1_104_05	27/09/12			MAARS_1_104_06	27/09/12			MAARS_1_104_10	27/09/12			MAARS_1_104_11	27/09/12			MAARS_1_104_07	27/09/12			MAARS_1_104_08	27/09/12			MAARS_1_104_09	27/09/12		
MAARS_1_106	26/10/12	HHU	Baran	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1965	Male	White				2008	2008	No		No	Present	No	No	No		Present	Present	Present	No	No	No	No	No	No	No	Present																																																																															Fumaric acid											200											1-0-0											01/01/2011											No																						No																																				25/10/12	arms ; buttocks ; head ; legs ; lower back ; posterior thigh ; trunk		2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	1.2	3 (severe)	3 (severe)	3 (severe)	9	3 (30%-49%)	27	8.1	2 (moderate)	2 (moderate)	3 (severe)	7	2 (10%-29%)	14	2.8	3 (severe)	3 (severe)	3 (severe)	9	2 (10%-29%)	18	7.2	19.3	6 (Very red colouration)	4 (Moderate elevation)	4 (Moderate)	14	lower back	Chronic(>1week)				lower back	25/10/12	moderate-severe					Fumaric acid			MAARS_1_106_01	25/10/12			MAARS_1_106_02	25/10/12			MAARS_1_106_03	25/10/12			MAARS_1_106_04	25/10/12			MAARS_1_106_05	25/10/12			MAARS_1_106_06	25/10/12			MAARS_1_106_10	25/10/12			MAARS_1_106_11	25/10/12							MAARS_1_106_08	25/10/12			MAARS_1_106_09	25/10/12		
MAARS_1_111	21/11/12	HHU	Jahn	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1988	Female	White				2004	2004	No		No	No	No	Past	No		Present	Present	Present	No	No	Present	No	No	No	No	Unknown 																																																																															UVB - Ultraviolet B phototherapy	Moderate corticosteroids (topical)																																																																																																					21/11/12	arms ; buttocks ; head ; legs ; lower back ; posterior thigh ; trunk		3 (severe)	2 (moderate)	3 (severe)	8	5 (70%-89%)	40	4	3 (severe)	3 (severe)	3 (severe)	9	4 (50%-69%)	36	10.8	3 (severe)	2 (moderate)	3 (severe)	8	3 (30%-49%)	24	4.8	3 (severe)	2 (moderate)	3 (severe)	8	2 (10%-29%)	16	6.4	26.0	4 (Red colouration)	4 (Moderate elevation)	6 (Severe)	14	lower back	Chronic(>1week)				lower back	21/11/12	moderate-severe					Phototherapy ; Local Corticosteroids			MAARS_1_111_01	21/11/12			MAARS_1_111_02	21/11/12			MAARS_1_111_03	21/11/12			MAARS_1_111_04	21/11/12			MAARS_1_111_05	21/11/12			MAARS_1_111_06	21/11/12			MAARS_1_111_10	21/11/12			MAARS_1_111_11	21/11/12			MAARS_1_111_07	21/11/12			MAARS_1_111_08	21/11/12			MAARS_1_111_09	21/11/12		
MAARS_1_114	22/01/13	HHU	Baran	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1987	Male	White				2005	2005	Yes		Yes	No	No	No	No		Present	Present	Present	No	No	No	No	No	No	No	Present																																																																															UVB - Ultraviolet B phototherapy	Moderate corticosteroids (topical)																																											No	No																																																									22/01/13	arms ; buttocks ; head ; legs ; lower back ; posterior thigh ; trunk		4 (very severe)	4 (very severe)	4 (very severe)	12	3 (30%-49%)	36	3.6	4 (very severe)	4 (very severe)	4 (very severe)	12	4 (50%-69%)	48	14.4	4 (very severe)	4 (very severe)	4 (very severe)	12	2 (10%-29%)	24	4.8	4 (very severe)	4 (very severe)	4 (very severe)	12	2 (10%-29%)	24	9.6	32.4	6 (Very red colouration)	6 (Marked elevation)	6 (Severe)	18	lower back	Chronic(>1week)				lower back	22/01/13	Severe					Phototherapy ; Local Corticosteroids			MAARS_1_114_01	22/01/13			MAARS_1_114_02	22/01/13			MAARS_1_114_03	22/01/13			MAARS_1_114_04	22/01/13			MAARS_1_114_05	22/01/13			MAARS_1_114_06	22/01/13			MAARS_1_114_10	22/01/13			MAARS_1_114_11	22/01/13			MAARS_1_114_07	22/01/13			MAARS_1_114_08	22/01/13			MAARS_1_114_09	22/01/13		
MAARS_1_115	24/01/13	HHU	Jahn	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1959	Male	Indian				2009	2009	Yes		No	Present	No	Present	Present		Present	Present	Present	No	No	Present	No	No	No	No	No																									neuroleptics																																																						Moderate corticosteroids (topical)	vitamin D analogs																																																																												paranoid schizophrenia																									24/01/13	arms ; buttocks ; head ; legs ; lower back ; posterior thigh ; trunk		2 (moderate)	2 (moderate)	2 (moderate)	6	3 (30%-49%)	18	1.8	3 (severe)	3 (severe)	3 (severe)	9	4 (50%-69%)	36	10.8	3 (severe)	3 (severe)	3 (severe)	9	3 (30%-49%)	27	5.4	3 (severe)	3 (severe)	3 (severe)	9	3 (30%-49%)	27	10.8	28.8	6 (Very red colouration)	6 (Marked elevation)	6 (Severe)	18	lower back	Chronic(>1week)				lower back	24/01/13	Severe			Others	Others	Local Corticosteroids ; Vitamin D analogs			MAARS_1_115_01	24/01/13			MAARS_1_115_02	24/01/13			MAARS_1_115_03	24/01/13			MAARS_1_115_04	24/01/13			MAARS_1_115_05	24/01/13			MAARS_1_115_06	24/01/13			MAARS_1_115_10	24/01/13			MAARS_1_115_11	24/01/13			MAARS_1_115_07	24/01/13			MAARS_1_115_08	24/01/13			MAARS_1_115_09	24/01/13		
MAARS_1_117	04/02/13	HHU	Baran	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1976	Male	White				2012	2012	No		No	No	No	No	Present		Present	Present	Present	No	No	No	No	No	No	No	No																																																																															Moderate corticosteroids (topical)																																																																													splenomegaly																									04/02/13	arms ; buttocks ; head ; legs ; lower back ; posterior thigh ; trunk		2 (moderate)	2 (moderate)	2 (moderate)	6	3 (30%-49%)	18	1.8	4 (very severe)	4 (very severe)	4 (very severe)	12	4 (50%-69%)	48	14.4	4 (very severe)	4 (very severe)	4 (very severe)	12	4 (50%-69%)	48	9.6	3 (severe)	4 (very severe)	4 (very severe)	11	3 (30%-49%)	33	13.2	39.0	6 (Very red colouration)	6 (Marked elevation)	6 (Severe)	18	upper back	Chronic(>1week)				upper back	04/02/13	Severe				Others	Local Corticosteroids			MAARS_1_117_01	04/02/13			MAARS_1_117_02	04/02/13			MAARS_1_117_03	04/02/13			MAARS_1_117_04	04/02/13			MAARS_1_117_05	04/02/13			MAARS_1_117_06	04/02/13			MAARS_1_117_10	04/02/13			MAARS_1_117_11	04/02/13			MAARS_1_117_07	04/02/13			MAARS_1_117_08	04/02/13			MAARS_1_117_09	04/02/13		
MAARS_1_118	04/02/13	HHU	Jahn	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1963	Male	White				1983	1990	No		Yes	No	No	No	No		Present	No	Present	No	No	Past	No	No	No	No	Present																																																																															Dithranol-minute	UVB - Ultraviolet B phototherapy	Moderate corticosteroids (topical)	vitamin D analogs																																																																										alcohol abusus																									04/02/13	arms ; buttocks ; head ; legs ; lower back ; posterior thigh ; trunk		2 (moderate)	2 (moderate)	2 (moderate)	6	3 (30%-49%)	18	1.8	3 (severe)	3 (severe)	3 (severe)	9	4 (50%-69%)	36	10.8	4 (very severe)	4 (very severe)	4 (very severe)	12	3 (30%-49%)	36	7.2	3 (severe)	4 (very severe)	3 (severe)	10	3 (30%-49%)	30	12.0	31.8	6 (Very red colouration)	6 (Marked elevation)	6 (Severe)	18	upper back	Chronic(>1week)				upper back	04/02/13	Severe				Others	Dithranol-minute ; Phototherapy ; Local Corticosteroids ; Vitamin D analogs			MAARS_1_118_01	04/02/13			MAARS_1_118_02	04/02/13			MAARS_1_118_03	04/02/13			MAARS_1_118_04	04/02/13			MAARS_1_118_05	04/02/13			MAARS_1_118_06	04/02/13			MAARS_1_118_10	04/02/13			MAARS_1_118_11	04/02/13			MAARS_1_118_07	04/02/13			MAARS_1_118_08	04/02/13			MAARS_1_118_09	04/02/13		
MAARS_1_121	14/02/13	HHU	Jahn	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1962	Male	White				1977	1977	No		No	No	No	No	No		Present	Present	Present	Present	No	Present	No	No	No	No	No																									Metformin	neuroleptics																																																					Moderate corticosteroids (topical)	Dithranol-minute																																																																												Diabetes (non-insulin)	Unknown 																								15/02/13	arms ; buttocks ; head ; legs ; lower back ; posterior thigh ; trunk		1 (slight)	1 (slight)	1 (slight)	3	2 (10%-29%)	6	0.6	3 (severe)	2 (moderate)	2 (moderate)	7	3 (30%-49%)	21	6.3	3 (severe)	3 (severe)	2 (moderate)	8	4 (50%-69%)	32	6.4	3 (severe)	3 (severe)	2 (moderate)	8	5 (70%-89%)	40	16.0	29.3	4 (Red colouration)	4 (Moderate elevation)	4 (Moderate)	12	upper back	Chronic(>1week)				upper back	14/02/13	moderate-severe			Others ; Others	Diabetes (non-insulin)	Local Corticosteroids ; Dithranol-minute			MAARS_1_121_01	14/02/13			MAARS_1_121_02	14/02/13			MAARS_1_121_03	14/02/13			MAARS_1_121_04	14/02/13			MAARS_1_121_05	14/02/13			MAARS_1_121_06	14/02/13			MAARS_1_121_10	14/02/13			MAARS_1_121_11	14/02/13			MAARS_1_121_07	14/02/13			MAARS_1_121_08	14/02/13			MAARS_1_121_09	14/02/13		
MAARS_1_129	06/03/13	HHU	Baran	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1974	Male	White				2005	2005	No		No	No	No	No	No		Present	Present	Present	No	No	No	No	No	No	No	No																																																																															Moderate corticosteroids (topical)	UVB - Ultraviolet B phototherapy																																											No	No																																																									06/03/13	arms ; legs ; lower back ; trunk		0 (none)	0 (none)	0 (none)	0	0 (0%)	0	0	2 (moderate)	2 (moderate)	2 (moderate)	6	1 (1%-9%)	6	1.8	2 (moderate)	2 (moderate)	2 (moderate)	6	1 (1%-9%)	6	1.2	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	4.8	7.8	2 (Pink colouration)	2 (Slight definite elevation)	2 (Mild)	6	upper back	Chronic(>1week)				upper back	06/03/13	moderate					Local Corticosteroids ; Phototherapy			MAARS_1_129_01	06/03/13			MAARS_1_129_02	06/03/13			MAARS_1_129_03	06/03/13			MAARS_1_129_04	06/03/13			MAARS_1_129_05	06/03/13			MAARS_1_129_06	06/03/13			MAARS_1_129_10	06/03/13			MAARS_1_129_11	06/03/13			MAARS_1_129_07	06/03/13			MAARS_1_129_08	06/03/13			MAARS_1_129_09	06/03/13		
MAARS_1_135	11/06/13	HHU	Jahn	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1968	Male	White	Brother			1996	1996	Yes		Yes	No	No	Present	No		Present	Present	Present	No	No	Present	Past	Past	Past	Past	Present																									ACE inhibitors	Acetylsalicylic acid	Diuretics	Metformin	Beta-2-agonists	Antidiabetic drugs																																																	UVB - Ultraviolet B phototherapy	Moderate corticosteroids (topical)	Fumaric acid																																																																											Hypertension	COPD	Diabetes (non-insulin)																							11/06/13	arms ; buttocks ; head ; legs ; lower back ; posterior thigh ; trunk		2 (moderate)	2 (moderate)	3 (severe)	7	3 (30%-49%)	21	2.1	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	3.6	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	2.4	3 (severe)	2 (moderate)	2 (moderate)	7	3 (30%-49%)	21	8.4	16.5	3	4 (Moderate elevation)	4 (Moderate)	11	lower back	Chronic(>1week)				buttocks	11/06/13	moderate			Anti-Hypertensive ; Anti-Inflammatory(non steroid) ; Anti-Hypertensive ; Others ; Others ; Others	Hypertension ; Others ; Diabetes (non-insulin)	Phototherapy ; Local Corticosteroids ; Fumaric acid			MAARS_1_135_01	11/06/13			MAARS_1_135_02	11/06/13			MAARS_1_135_03	11/06/13			MAARS_1_135_04	11/06/13			MAARS_1_135_05	11/06/13			MAARS_1_135_06	11/06/13			MAARS_1_135_10	11/06/13			MAARS_1_135_11	11/06/13			MAARS_1_135_07	11/06/13			MAARS_1_135_08	11/06/13			MAARS_1_135_09	11/06/13		
MAARS_1_136	11/07/13	HHU	Baran	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1936	Female	White		penicillin ; Plasters		2006	2006	No		Unknown 	No	No	No	Present		Present	No	Present	No	No	Present	Present	No	No	No	Unknown 																									Acetylsalicylic acid		Antihistamines																																																				UVB - Ultraviolet B phototherapy	Neotigason	Potent corticosteroids (topical)	vitamin D analogs																																																																																																			11/07/13	arms ; buttocks ; head ; legs ; lower back ; posterior thigh ; trunk		2 (moderate)	2 (moderate)	2 (moderate)	6	4 (50%-69%)	24	2.4	3 (severe)	3 (severe)	3 (severe)	9	4 (50%-69%)	36	10.8	3 (severe)	3 (severe)	3 (severe)	9	4 (50%-69%)	36	7.2	3 (severe)	3 (severe)	3 (severe)	9	4 (50%-69%)	36	18	38.4	4 (Red colouration)	4 (Moderate elevation)	4 (Moderate)	12	lower back	Chronic(>1week)					11/07/13	Severe		Drug Allergy ; Contact Allergy	Anti-Inflammatory(non steroid) ; Others		Phototherapy ; Retinoids ; Local Corticosteroids ; Vitamin D analogs			MAARS_1_136_01	11/07/13			MAARS_1_136_02	11/07/13			MAARS_1_136_03	11/07/13			MAARS_1_136_04	11/07/13			MAARS_1_136_05	11/07/13			MAARS_1_136_06	11/07/13			MAARS_1_136_10	11/07/13			MAARS_1_136_11	11/07/13			MAARS_1_136_07	11/07/13			MAARS_1_136_08	11/07/13			MAARS_1_136_09	11/07/13		
MAARS_1_137	02/09/13	HHU	Jahn	Yes	Yes	Yes	No	No	No	No	No	No	No	No	Yes	No	1956	Female	White				2012	2012	Yes		No	No	No	No	No		Present	Present	Past	No	No	Present	No	Present	No	No	No																									ACE inhibitors	Proton pump inhibitors	NSAID																																																				UVB - Ultraviolet B phototherapy	Dithranol-minute	Cyclosporin	Methotrexate	Fumaric acid									75	15																																																						No	Yes	Yes							Hypertension	Arthrosis																								02/09/13	arms ; buttocks ; head ; legs ; lower back ; trunk		3 (severe)	3 (severe)	3 (severe)	9	5 (70%-89%)	45	4.5	2 (moderate)	2 (moderate)	2 (moderate)	6	4 (50%-69%)	24	7.2	2 (moderate)	2 (moderate)	2 (moderate)	6	3 (30%-49%)	18	3.6	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	4.8	20.1	4 (Red colouration)	4 (Moderate elevation)	3 (Mild-Moderate)	11	lower back	Chronic(>1week)					02/09/13	moderate			Anti-Hypertensive ; Others ; Anti-Inflammatory(non steroid)	Hypertension ; Others	Phototherapy ; Dithranol-minute ; Cyclosporin ; Methotrexate ; Fumaric acid	Yes	"Patient match one exclusion criteria. The value is 'Yes' for the exclusion criteria 'Subjects who have received systemic immunosupressive therapy within the previous 12 weeks prior to screening'.  - excluded by Micha and colleagues(12/03/14)"	MAARS_1_137_01	02/09/13			MAARS_1_137_02	02/09/13			MAARS_1_137_03	02/09/13			MAARS_1_137_04	02/09/13			MAARS_1_137_05	02/09/13			MAARS_1_137_06	02/09/13			MAARS_1_137_10	02/09/13			MAARS_1_137_11	02/09/13			MAARS_1_137_07	02/09/13			MAARS_1_137_08	02/09/13			MAARS_1_137_09	02/09/13		
MAARS_1_138	09/09/13	HHU	Baran	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1959	Female	White				2011	2012	No		Yes	Present	No	No	Present		Present	No	Present	No	No	Present	No	No	No	No	No																thyroid gland			Yes						Thyroid hormones									150																																													Potent corticosteroids (topical)																																																																																																						09/09/13	arms ; buttocks ; head ; legs ; lower back ; posterior thigh ; trunk		1 (slight)	1 (slight)	2 (moderate)	4	4 (50%-69%)	16	1.6	2 (moderate)	1 (slight)	2 (moderate)	5	4 (50%-69%)	20	6.0	1 (slight)	2 (moderate)	2 (moderate)	5	3 (30%-49%)	15	3.0	2 (moderate)	1 (slight)	2 (moderate)	5	2 (10%-29%)	10	4.0	14.6	2 (Pink colouration)	2 (Slight definite elevation)	2 (Mild)	6	lower back	Chronic(>1week)					09/09/13	moderate			Thyroid hormones		Local Corticosteroids			MAARS_1_138_01	09/09/13			MAARS_1_138_02	09/09/13			MAARS_1_138_03	09/09/13			MAARS_1_138_04	09/09/13			MAARS_1_138_05	09/09/13			MAARS_1_138_06	09/09/13			MAARS_1_138_10	09/09/13			MAARS_1_138_11	09/09/13			MAARS_1_138_07	09/09/13			MAARS_1_138_08	09/09/13			MAARS_1_138_09	09/09/13		
MAARS_2_001	23/02/12	KINGS	Barker	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1970	Male	White		Animal Hair		1991	1994	No		Unknown 	No	No	No	No		Present	Present	Present	Present	No	Present	No	No	No	No	Unknown 	Unknown 															Unknown 																																																															Potent corticosteroids (topical)																						prn											00/00/1991											Yes																						Yes											Unknown 																									23/02/12	 buttocks ;  lower back ; arms ; head ; legs ; posterior thigh ; trunk	1005080/archive/1000806/MAARS_2_001-Mon_Feb_25_13:13:51_CET_2013.pjpeg ; 1005080/archive/1000806/MAARS_2_001-Mon_Feb_25_13:14:00_CET_2013.pjpeg ; 1005080/archive/1000806/MAARS_2_001-Mon_Feb_25_13:14:26_CET_2013.pjpeg ; 1005080/archive/1000806/MAARS_2_001-Mon_Feb_25_13:14:55_CET_2013.pjpeg	1 (slight)	1 (slight)	1 (slight)	3	1 (1%-9%)	03	0.3	1 (slight)	1 (slight)	1 (slight)	3	1 (1%-9%)	03	0.9	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	2.4	3 (severe)	2 (moderate)	2 (moderate)	7	3 (30%-49%)	21	8.4	12.0	2 (Pink colouration)	4 (Moderate elevation)	4 (Moderate)	10	posterior thigh	Chronic(>1week)					23/02/12	moderate-severe		Animal			Local Corticosteroids			MAARS_2_001_01	23/02/12			MAARS_2_001_02	23/02/12			MAARS_2_001_03	23/02/12			MAARS_2_001_04	23/02/12			MAARS_2_001_05	23/02/12			MAARS_2_001_06	23/02/12											MAARS_2_001_07				MAARS_2_001_08	23/02/12			MAARS_2_001_09	23/02/12		
MAARS_2_002	23/02/12	KINGS	Barker	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1977	Male	Black - Other				1992	1992	No		Unknown 	No	No	Past	No		Present	Present	Present	Present	No	Present	Present	No	No	No	Unknown 	Unknown 															Unknown 																																																															UVB - Ultraviolet B phototherapy	Cyclosporin	Cyclosporin	Methotrexate	Steroids (p.o)	Acitretin							150	150										Daily	Daily	Weekly		Took for 4 months. (?when)							07/11/2007	10/07/2008	00/01/2004	00/00/2000							No	No	No	No	No	No							00/01/2008	00/10/2011	00/06/2004	00/00/2000							No	Yes	Yes	No	Yes	No						Unknown 																									23/02/12	 buttocks ;  lower back ; arms ; head ; legs ; posterior thigh ; trunk		1 (slight)	0 (none)	1 (slight)	2	1 (1%-9%)	2	0.2	1 (slight)	2 (moderate)	2 (moderate)	5	1 (1%-9%)	5	1.5	1 (slight)	2 (moderate)	2 (moderate)	5	2 (10%-29%)	10	2.0	2 (moderate)	2 (moderate)	2 (moderate)	6	3 (30%-49%)	18	7.2	10.9	2 (Pink colouration)	4 (Moderate elevation)	4 (Moderate)	10	lower back	Chronic(>1week)					23/02/12	moderate	Pt Forgot to keep sample area dry and stepped in the shower. Did not use any shower products as then remebered sample visit. Checked with Prof Barker, who advised sampling to proceed. No photography due to fault with camera.				Phototherapy ; Cyclosporin ; Cyclosporin ; Methotrexate ; Systemic Corticosteroids ; Retinoids			MAARS_2_002_01	23/02/12			MAARS_2_002_02	23/02/12			MAARS_2_002_03	23/02/12			MAARS_2_002_04	23/02/12			MAARS_2_002_05	23/02/12			MAARS_2_002_06	23/02/12											MAARS_2_002_07	23/02/12			MAARS_2_002_08	23/02/12			MAARS_2_002_09	23/02/12		
MAARS_2_004	05/03/12	KINGS	Barker	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1966	Male	White	Mother ; Brother		1005080/archive/1000812/MAARS_2_004-Mon_Feb_25_13:57:36_CET_2013.pjpeg ; 1005080/archive/1000812/MAARS_2_004-Mon_Feb_25_13:57:45_CET_2013.pjpeg ; 1005080/archive/1000812/MAARS_2_004-Mon_Feb_25_13:57:55_CET_2013.pjpeg ; 1005080/archive/1000812/MAARS_2_004-Mon_Feb_25_13:58:06_CET_2013.pjpeg	2009	2012	No		Unknown 	No	No	No	No		Present	Present	Present	Present	No	Present	No	No	No	No	Unknown 	Unknown 															Unknown 																																																															Potent corticosteroids (topical)	Tacrolimus cream	TAR (Topical)																				prn	prn	prn -shampo only									27/04/2011	20/02/2012										Yes	Yes	No																				No	Yes	No									Unknown 																									20/02/12	 buttocks ;  lower back ; arms ; head ; legs ; posterior thigh ; trunk		2 (moderate)	0 (none)	1 (slight)	3	1 (1%-9%)	3	0.3	3 (severe)	2 (moderate)	2 (moderate)	7	2 (10%-29%)	14	4.2	2 (moderate)	1 (slight)	1 (slight)	4	1 (1%-9%)	4	0.8	3 (severe)	2 (moderate)	2 (moderate)	7	2 (10%-29%)	14	5.6	10.9	4 (Red colouration)	4 (Moderate elevation)	4 (Moderate)	12	lower back	Chronic(>1week)					05/03/12	moderate					Local Corticosteroids ; Topical calcineurin inhibitors ; TAR (topical)			MAARS_2_004_01	05/03/12			MAARS_2_004_02	05/03/12			MAARS_2_004_03	05/03/12			MAARS_2_004_04	05/03/12			MAARS_2_004_05	05/03/12			MAARS_2_004_06	05/03/12											MAARS_2_004_07	05/03/12			MAARS_2_004_08	05/03/12			MAARS_2_004_09	05/03/12		
MAARS_2_006	12/03/12	KINGS	Barker	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1957	Male	White				1977	1998	No		Unknown 	No	No	No	No		Present	Present	Present	Present	No	Past	No	No	No	No	Unknown 	Unknown 															Unknown 																																																															Acitretin	Acitretin	Acitretin	Moderate corticosteroids (topical)	UVB - Ultraviolet B phototherapy	TLO1	Dithranol-minute	TAR (Topical)				40	40	50									daily	daily	alternate days	prn	5 courses	5 Courses	prn	prn -shampoo only				16/10/2006	12/11/2007	14/09/2009	00/00/1977	00/00/1999	00/00/1999						No	No	No	Yes	No	No	Yes	Yes				00/01/2007	00/02/2009	00/11/2009		00/02/2008	00/02/2008						Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes				Unknown 																									20/03/12	arms ; buttocks ; head ; legs ; lower back ; posterior thigh ; trunk		1 (slight)	0 (none)	1 (slight)	2	1 (1%-9%)	2	0.2	1 (slight)	1 (slight)	1 (slight)	3	2 (10%-29%)	6	1.8	1 (slight)	1 (slight)	2 (moderate)	4	2 (10%-29%)	8	1.6	2 (moderate)	2 (moderate)	1 (slight)	5	2 (10%-29%)	10	4.0	7.6	2 (Pink colouration)	2 (Slight definite elevation)	2 (Mild)	6	lower back	Chronic(>1week)					12/03/12	moderate					Retinoids ; Retinoids ; Retinoids ; Local Corticosteroids ; Phototherapy ; Others ; Dithranol-minute ; TAR (topical)			MAARS_2_006_01	12/03/12			MAARS_2_006_02	12/03/12			MAARS_2_006_03	12/03/12			MAARS_2_006_04	12/03/12			MAARS_2_006_05	12/03/12			MAARS_2_006_06	12/03/12											MAARS_2_006_07	12/03/12			MAARS_2_006_08	12/03/12			MAARS_2_006_09	12/03/12		
MAARS_2_008	19/03/12	KINGS	Barker	Yes	Yes	No	No	No	No	No	No	No	No	No	No	No	1951	Male	White	Mother ; Son ; Sister			1974	1978	No		Unknown 	Past	No	No	No		Present	Present	Present	Present	No	Present	No	Past	No	No	Unknown 	Unknown 															Unknown 									Iron and iron-folic acid combinations	Statins	ACE inhibitors	Lipid-regulating drugs (non-statin)						5	20		10						daily	daily	daily	daily															Yes	Yes	Yes	Yes															PUVA - psoralen + UVA (ultraviolet A-phototherapy)	Fumaric acid	PUVA - psoralen + UVA (ultraviolet A-phototherapy)	Acitretin	Methotrexate	TLO1	TLO1	TLO1	TLO1	TLO1	Potent corticosteroids (topical)		240		45	15							up to 17 treatments (2 seperate courses)	daily		daily	Weekly					Total = 139 Treatments in lifetime. Dose: 210.8j/cm2	prn	00/00/1989	29/04/2009	00/02/2011	08/05/2000	05/02/2001	08/01/1998	02/11/1998	00/06/2000	02/06/2005	01/04/2010		No	No	No	No	No	No	No	No	No	No	No	00/00/1994	21/06/2010	00/03/2011	00/01/2001	30/03/2010	11/06/1998	00/07/1999	00/09/2000	00/08/2005	00/06/2010		Yes	No	Yes		Yes	Yes	Yes	Yes	Yes	No	No	Unknown 																									23/02/12			1 (slight)	0 (none)	1 (slight)	2	1 (1%-9%)	2	0.2	3 (severe)	2 (moderate)	2 (moderate)	7	2 (10%-29%)	14	4.2	2 (moderate)	1 (slight)	1 (slight)	4	1 (1%-9%)	4	0.8	3 (severe)	2 (moderate)	2 (moderate)	7	2 (10%-29%)	14	5.6	10.8	2 (Pink colouration)	4 (Moderate elevation)	4 (Moderate)	10	lower back	Chronic(>1week)					19/03/12	moderate	Patient declined full body photo's.		Others ; Statins ; Anti-Hypertensive ; Others		Photochemotherapy ; Fumaric acid ; Photochemotherapy ; Retinoids ; Methotrexate ; Others ; Others ; Others ; Others ; Others ; Local Corticosteroids			MAARS_2_008_01	19/03/12			MAARS_2_008_02	19/03/12			MAARS_2_008_03	19/03/12			MAARS_2_008_04	19/03/12			MAARS_2_008_05	19/03/12			MAARS_2_008_06	19/03/12											MAARS_2_008_07	19/03/12			MAARS_2_008_08	19/03/12			MAARS_2_008_09	19/03/12		
MAARS_2_014	12/04/12	KINGS	Barker	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1967	Male	White	Father			1997	1997	No		Unknown 	No	No	Past	No		Present	Present	Present	Past	Past	Present	No	No	No	No	Unknown 	Unknown 															Unknown 																																																															UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy	PUVA - psoralen + UVA (ultraviolet A-phototherapy)	Acitretin	Acitretin	Methotrexate	Antimalarials	Steroids (p.o)	Potent corticosteroids (topical)														2 seperate courses: 1998 and 2001	3 seperate courses	2 seperate courses 2004 and 2005	daily 	daily	weekly			prn			00/01/1998	00/00/2002	00/00/2004	00/00/2004	00/00/2008	00/09/2007			00/00/1997			No	No		No	No	No	No	No	Yes			00/00/2001	00/00/2003	00/00/2005	00/00/2004	00/01/2009	00/08/2008						Yes	No	No	Yes	Yes	Yes	No	No	No			Unknown 																									22/03/12			1 (slight)	0 (none)	1 (slight)	2	1 (1%-9%)	2	0.2	3 (severe)	2 (moderate)	2 (moderate)	7	3 (30%-49%)	21	6.3	3 (severe)	1 (slight)	1 (slight)	5	2 (10%-29%)	10	2.0	3 (severe)	1 (slight)	1 (slight)	5	3 (30%-49%)	15	6.0	14.5	4 (Red colouration)	4 (Moderate elevation)	4 (Moderate)	12	lower back	Chronic(>1week)					12/04/12	moderate-severe					Phototherapy ; Phototherapy ; Photochemotherapy ; Retinoids ; Retinoids ; Methotrexate ; Others ; Systemic Corticosteroids ; Local Corticosteroids			MAARS_2_014_01	12/04/12			MAARS_2_014_02	12/04/12			MAARS_2_014_03	12/04/12			MAARS_2_014_04	12/04/12			MAARS_2_014_05	12/04/12			MAARS_2_014_06	12/04/12											MAARS_2_014_07	12/04/12			MAARS_2_014_08	12/04/12			MAARS_2_014_09	12/04/12		
MAARS_2_015	13/04/12	KINGS	Barker	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1943	Female	White				1976	1982	No		Unknown 	Present	Past	No	No		Present	Present	Present	Present	Past	Present	No	No	No	No	Unknown 	Unknown 															Unknown 																																																															PUVA - psoralen + UVA (ultraviolet A-phototherapy)	vitamin D analogs	TAR (Topical)																				6 week course	prn	prn									00/01/1999	00/00/1982	00/03/2012									No	Yes	Yes									00/02/1999											Yes	Yes	Yes									Unknown 																									13/04/12	arms ; buttocks ; head ; legs ; lower back ; trunk	1005080/archive/1000953/MAARS_2_015-Mon_Mar_04_12:03:27_CET_2013.bmp ; 1005080/archive/1000953/MAARS_2_015-Mon_Mar_04_12:03:59_CET_2013.bmp ; 1005080/archive/1000953/MAARS_2_015-Mon_Mar_04_12:04:12_CET_2013.pjpeg	1 (slight)	1 (slight)	1 (slight)	3	1 (1%-9%)	3	0.3	1 (slight)	2 (moderate)	3 (severe)	6	1 (1%-9%)	6	1.8	1 (slight)	2 (moderate)	2 (moderate)	5	1 (1%-9%)	5	1.0	2 (moderate)	1 (slight)	2 (moderate)	5	1 (1%-9%)	5	2.0	5.1	2 (Pink colouration)	6 (Marked elevation)	4 (Moderate)	12	lower back	Chronic(>1week)					13/04/12	moderate	Patient declined full body photo's				Photochemotherapy ; Vitamin D analogs ; TAR (topical)			MAARS_2_015_01	13/04/12			MAARS_2_015_02	13/04/12			MAARS_2_015_03	13/04/12			MAARS_2_015_04	13/04/12			MAARS_2_015_05	13/04/12			MAARS_2_015_06	13/04/12											MAARS_2_015_07	13/04/12			MAARS_2_015_08	13/04/12			MAARS_2_015_09	13/04/12		
MAARS_2_017	20/04/12	KINGS	Barker	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1981	Male	White	Father			1995	2000	No		Unknown 	No	No	No	No		Present	Present	Present	Past	No	Present	No	No	No	No	Unknown 	Unknown 															Unknown 																																																															UVB - Ultraviolet B phototherapy	Steroids (p.o)	Cyclosporin	Potent corticosteroids (topical)	Dithranol-minute																		2 courses: 2000 & 2002	daily: short course	daily	prn	prn							00/00/2000	00/00/2000	00/00/2011	00/00/1995	00/00/1995							No	No	No	No	No							00/00/2002	00/00/2000	00/10/2011	00/00/2011	00/00/2011							Yes	Yes	Yes	Yes	Yes							Unknown 																									13/04/12	 buttocks ;  lower back ; arms ; head ; legs ; posterior thigh ; trunk	1005080/archive/1000955/MAARS_2_017-Mon_Mar_04_12:09:04_CET_2013.pjpeg ; 1005080/archive/1000955/MAARS_2_017-Mon_Mar_04_12:09:25_CET_2013.bmp ; 1005080/archive/1000955/MAARS_2_017-Mon_Mar_04_12:09:45_CET_2013.bmp ; 1005080/archive/1000955/MAARS_2_017-Mon_Mar_04_12:10:08_CET_2013.bmp ; 1005080/archive/1000955/MAARS_2_017-Mon_Mar_04_12:10:29_CET_2013.bmp	2 (moderate)	1 (slight)	2 (moderate)	5	1 (1%-9%)	5	0.5	2 (moderate)	2 (moderate)	1 (slight)	5	2 (10%-29%)	10	3.0	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	2.4	3 (severe)	2 (moderate)	2 (moderate)	7	4 (50%-69%)	28	11.2	17.1	2 (Pink colouration)	4 (Moderate elevation)	4 (Moderate)	10	lower back	Chronic(>1week)					13/04/12	Severe					Phototherapy ; Systemic Corticosteroids ; Cyclosporin ; Local Corticosteroids ; Dithranol-minute			MAARS_2_017_01	20/04/12			MAARS_2_017_02	20/04/12			MAARS_2_017_03	20/04/12			MAARS_2_017_04	20/04/12			MAARS_2_017_05	20/04/12			MAARS_2_017_06	20/04/12											MAARS_2_017_07	20/04/12			MAARS_2_017_08	20/04/12			MAARS_2_017_09	20/04/12		
MAARS_2_019	30/04/12	KINGS	Barker	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1976	Male	White		Pollen		1995	1985	No		Unknown 	No	No	No	No		Present	Present	Present	Present	No	Present	No	No	No	No	Unknown 	Unknown 															Unknown 									Beta-blockers									50									daily									00/01/2011									Yes																		PUVA - psoralen + UVA (ultraviolet A-phototherapy)	UVB - Ultraviolet B phototherapy	Potent corticosteroids (topical)																				27 treatments	4 to 5 treatments	prn									00/00/1996	00/00/2001										No	No	Yes									00/00/1996	00/00/2001										Yes	No	Yes									Unknown 																									30/04/12	 buttocks ;  lower back ; arms ; head ; legs ; posterior thigh ; trunk	1005080/archive/1000957/MAARS_2_019-Mon_Mar_04_12:15:02_CET_2013.pjpeg ; 1005080/archive/1000957/MAARS_2_019-Mon_Mar_04_12:15:22_CET_2013.bmp ; 1005080/archive/1000957/MAARS_2_019-Mon_Mar_04_12:15:42_CET_2013.bmp	2 (moderate)	1 (slight)	1 (slight)	4	1 (1%-9%)	4	0.4	2 (moderate)	2 (moderate)	2 (moderate)	6	3 (30%-49%)	18	5.4	2 (moderate)	3 (severe)	2 (moderate)	7	3 (30%-49%)	21	4.2	3 (severe)	3 (severe)	2 (moderate)	8	3 (30%-49%)	24	9.6	19.6	4 (Red colouration)	4 (Moderate elevation)	4 (Moderate)	12	lower back	Chronic(>1week)					30/04/12	Severe	Participant declined full body photo's	Pollen	Anti-Hypertensive		Photochemotherapy ; Phototherapy ; Local Corticosteroids			MAARS_2_019_01	30/04/12			MAARS_2_019_02	30/04/12			MAARS_2_019_03	30/04/12			MAARS_2_019_04	30/04/12	Yes	"pilot Affymetrix analysis: Array QC (FIOS)  identified array QC failures"	MAARS_2_019_05	30/04/12			MAARS_2_019_06	30/04/12											MAARS_2_019_07	30/04/12			MAARS_2_019_08	30/04/12			MAARS_2_019_09	30/04/12		
MAARS_2_020	03/05/12	KINGS	Barker	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1943	Female	White	Sister	Ramipril		1998	2001	No		Unknown 	No	No	No	Past	1	Present	Present	Present	Present	No	Present	No	No	No	No	Unknown 	Unknown 															Unknown 									Benzodiazepines	Metformin	Statins	Angiotensin-II receptor antagonists	Diuretics	Calcium Channel Blockers	Antidepressant - Other			2	500	40	16	2.5	20	60			3 times daily	Twice daily	daily	daily	daily	Twice daily	daily												Yes	Yes	Yes	Yes	Yes	Yes	Yes												Cyclosporin	UVB - Ultraviolet B phototherapy	Fumaric acid	Fumaric acid	Dithranol-minute	Moderate corticosteroids (topical)	Potent corticosteroids (topical)	TAR (Topical)	vitamin D analogs															2 courses	daily	daily	prn	prn	prn	prn	prn			00/09/2003	00/00/2006	08/12/2009	22/06/2010	00/00/1998	00/00/1998	00/00/1998	00/00/1998	00/00/1998			No	No	No	No	No	Yes	Yes	No	Yes			00/12/2003	00/00/2008	00/03/2011	00/00/2010								Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes			Unknown 																									19/04/12	arms ; buttocks ; head ; legs ; lower back ; posterior thigh ; trunk		2 (moderate)	2 (moderate)	2 (moderate)	6	1 (1%-9%)	6	0.6	2 (moderate)	2 (moderate)	2 (moderate)	6	1 (1%-9%)	6	1.8	1 (slight)	1 (slight)	2 (moderate)	4	1 (1%-9%)	4	0.8	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	4.8	8.0	4 (Red colouration)	4 (Moderate elevation)	4 (Moderate)	12	lower back	Chronic(>1week)					03/04/12	moderate		Drug Allergy	Others ; Others ; Statins ; Anti-Hypertensive ; Anti-Hypertensive ; Anti-Hypertensive ; Others		Cyclosporin ; Phototherapy ; Fumaric acid ; Fumaric acid ; Dithranol-minute ; Local Corticosteroids ; Local Corticosteroids ; TAR (topical) ; Vitamin D analogs			MAARS_2_020_01	03/05/12			MAARS_2_020_02	03/05/12			MAARS_2_020_03	03/05/12			MAARS_2_020_04	03/05/12			MAARS_2_020_05	03/05/12			MAARS_2_020_06	03/05/12											MAARS_2_020_07	03/05/12			MAARS_2_020_08	03/05/12			MAARS_2_020_09	03/05/12		
MAARS_2_027	21/05/12	KINGS	Barker	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1939	Female	White Mixed	Brother ; Sister			1993	2004	No		Unknown 	Present	Present	No	No		Present	Present	Present	Present	No	Present	Present	No	No	No	Unknown 	Unknown 															Unknown 									Statins	ACE inhibitors	Diuretics	Proton pump inhibitors	Folice Acid	Antimalarials	NSAID	Opioid Analgesics		40	10	2.5	20	5	200				daily	daily	daily	daily	daily	daily	prn - daily	Patch - weekly								00/01/2012	00/10/2009		Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes											UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy	Potent corticosteroids (topical)	TAR (Topical)																			4 to 5 treatments	36 treatments	prn	prn								00/00/2004	00/00/2006										No	No	Yes	Yes								00/00/2004	00/00/2006										No	Yes	No	Yes								Unknown 																									21/05/12	arms ; buttocks ; head ; legs ; lower back ; posterior thigh ; trunk		3 (severe)	3 (severe)	3 (severe)	9	1 (1%-9%)	9	0.9	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	3.6	1 (slight)	2 (moderate)	2 (moderate)	5	2 (10%-29%)	10	2.0	3 (severe)	1 (slight)	2 (moderate)	6	2 (10%-29%)	12	4.8	11.3	4 (Red colouration)	4 (Moderate elevation)	2 (Mild)	10	lower back	Chronic(>1week)					21/05/12	moderate			Statins ; Anti-Hypertensive ; Anti-Hypertensive ; Others ; Others ; Others ; Anti-Inflammatory(non steroid) ; Others		Phototherapy ; Phototherapy ; Local Corticosteroids ; TAR (topical)			MAARS_2_027_01	21/05/12			MAARS_2_027_02	21/05/12			MAARS_2_027_03	21/05/12			MAARS_2_027_04	21/05/12			MAARS_2_027_05	21/05/12			MAARS_2_027_06	21/05/12											MAARS_2_027_07	21/05/12			MAARS_2_027_08	21/05/12			MAARS_2_027_09	21/05/12		
MAARS_2_029	24/05/12	KINGS	Barker	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1957	Male	White		Flu Vaccine		2007	2008	No		Unknown 	No	No	No	No		Present	Present	Present	Present	No	Present	No	No	No	No	Unknown 	Unknown 															Unknown 									Angiotensin-II receptor antagonists	ACE inhibitors	Diuretics	Statins	Metformin	Antidiabetic drugs	Insulin glargine			300	10	1.5	40	500	6	150			Daily	daily	daily	daily	daily	twice daily	twice daily			00/00/2006	00/00/2006	00/00/2006		00/06/2000	00/07/2011	00/07/2011			Yes	Yes	Yes	Yes	Yes	Yes	Yes												PUVA - psoralen + UVA (ultraviolet A-phototherapy)	Potent corticosteroids (topical)	Very potent corticosteroids (topical)	Methotrexate	Methotrexate	TAR (Topical)										5								prn 	prn - shampoo	n.d. (took for 6 weeks)	weekly (only 1 dose taken)	prn						00/11/2010	00/09/2008	00/05/2012		10/11/2011							No	Yes	Yes	No	No	No						00/01/2011				15/11/2011							No	Yes	Yes	Yes	No	Yes						Unknown 															Yes										03/05/12	buttocks ; head ; legs ; lower back ; posterior thigh ; trunk		1 (slight)	1 (slight)	1 (slight)	3	1 (1%-9%)	3	0.3	2 (moderate)	1 (slight)	2 (moderate)	5	1 (1%-9%)	5	1.5	0 (none)	0 (none)	0 (none)	0	0 (0%)	0	0	1 (slight)	1 (slight)	2 (moderate)	4	1 (1%-9%)	4	1.6	3.4	2 (Pink colouration)	4 (Moderate elevation)	2 (Mild)	8	lower back	Chronic(>1week)					24/05/12	mild	Check inclusion with Prof Barker; Advised to proceed to sampling with low PASI.	Drug Allergy	Anti-Hypertensive ; Anti-Hypertensive ; Anti-Hypertensive ; Statins ; Others ; Others ; Insulin		Photochemotherapy ; Local Corticosteroids ; Local Corticosteroids ; Methotrexate ; Methotrexate ; TAR (topical)			MAARS_2_029_01	24/05/12			MAARS_2_029_02	24/05/12			MAARS_2_029_03	24/05/12			MAARS_2_029_04	24/05/12			MAARS_2_029_05	24/05/12			MAARS_2_029_06	24/05/12											MAARS_2_029_07	24/05/12			MAARS_2_029_08	24/05/12			MAARS_2_029_09	24/05/12		
MAARS_2_031	28/05/12	KINGS	Barker	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1976	Male	White	Brother ; Sister			1982	1982	No		Unknown 	No	No	No	No		Present	Present	Present	No	No	No	No	No	No	No	Unknown 	Unknown 															Unknown 																																																															Methotrexate	UVB - Ultraviolet B phototherapy	Potent corticosteroids (topical)									10											weekly											00/00/2009											No	No	Yes									00/00/2011											No	No	Yes									Unknown 																									28/05/12	arms ; buttocks ; head ; legs ; lower back ; posterior thigh ; trunk		2 (moderate)	1 (slight)	1 (slight)	4	1 (1%-9%)	4	0.4	2 (moderate)	2 (moderate)	2 (moderate)	6	1 (1%-9%)	6	1.8	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	2.4	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	4.8	9.4	4 (Red colouration)	2 (Slight definite elevation)	2 (Mild)	8	lower back	Chronic(>1week)					28/05/12	moderate	No photography taken				Methotrexate ; Phototherapy ; Local Corticosteroids			MAARS_2_031_01	28/05/12			MAARS_2_031_02	28/05/12			MAARS_2_031_03	28/05/12			MAARS_2_031_04	28/05/12			MAARS_2_031_05	28/05/12			MAARS_2_031_06	28/05/12											MAARS_2_031_07	28/05/12			MAARS_2_031_08	28/05/12			MAARS_2_031_09	28/05/12		
MAARS_2_032	29/05/12	KINGS	Barker	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1953	Male	White	Father ; Brother			1967	1970	No		Unknown 	No	No	No	Past	1	Present	Present	Present	No	No	Present	Present	No	No	No	Unknown 	Unknown 															Unknown 																																																															PUVA - psoralen + UVA (ultraviolet A-phototherapy)	Potent corticosteroids (topical)	Tacrolimus cream	Dithranol-minute	vitamin D analogs	UVB - Ultraviolet B phototherapy	TAR (Topical)																multiple courses	prn	prn	prn	prn		prn					00/00/1980	00/00/1990	00/00/1990	00/00/1990	00/00/1990	00/00/1980	00/00/1990					No	No	No	No	No	No	No					00/00/1995	00/00/2010	00/00/2010	00/00/2010	00/00/2010	00/00/1995	00/00/2010					Yes	Yes	Yes	Yes	No	Yes	Yes					Unknown 																									29/05/12	arms ; buttocks ; head ; legs ; lower back ; posterior thigh ; trunk		1 (slight)	1 (slight)	2 (moderate)	4	1 (1%-9%)	4	0.4	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	3.6	2 (moderate)	2 (moderate)	2 (moderate)	6	3 (30%-49%)	18	3.6	2 (moderate)	2 (moderate)	2 (moderate)	6	3 (30%-49%)	18	7.2	14.8	2 (Pink colouration)	2 (Slight definite elevation)	2 (Mild)	6	lower back	Chronic(>1week)					29/05/12	moderate-severe					Photochemotherapy ; Local Corticosteroids ; Topical calcineurin inhibitors ; Dithranol-minute ; Vitamin D analogs ; Phototherapy ; TAR (topical)			MAARS_2_032_01	29/05/12			MAARS_2_032_02	29/05/12			MAARS_2_032_03	29/05/12			MAARS_2_032_04	29/05/12			MAARS_2_032_05	29/05/12			MAARS_2_032_06	29/05/12											MAARS_2_032_07	29/05/12			MAARS_2_032_08	29/05/12			MAARS_2_032_09	29/05/12		
MAARS_2_034	14/06/12	KINGS	Barker	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1948	Male	White		Plasters		1971	1981	No		Unknown 	No	No	Past	No		Present	Present	Present	Present	No	Past	No	No	No	No	Unknown 	Unknown 															Unknown 									Anticoagulants	ACE inhibitors	Statins	Beta-blockers	H2 receptor antagonists	Proton pump inhibitors				75	25	20	50	150	30				daily	daily	daily	daily	daily	daily													Yes	Yes	Yes	Yes	Yes	Yes													UVB - Ultraviolet B phototherapy	Acitretin	Potent corticosteroids (topical)	vitamin D analogs	Moderate corticosteroids (topical)	Hydroxycarbamide																	2 Courses = 36 treatments in total		prn	prn	prn							00/00/2011	00/10/2011	00/00/1981	00/03/2012	00/00/2010	00/05/2011						No	No	No	Yes	Yes	No						00/00/2011	00/11/2011	00/00/2010			00/01/2012						Yes	No	Yes	No	No	No						Unknown 																									07/06/12	arms ; buttocks ; head ; legs ; lower back ; posterior thigh ; trunk		3 (severe)	2 (moderate)	2 (moderate)	7	2 (10%-29%)	14	1.4	2 (moderate)	1 (slight)	1 (slight)	4	1 (1%-9%)	4	1.2	2 (moderate)	1 (slight)	1 (slight)	4	2 (10%-29%)	8	1.6	3 (severe)	2 (moderate)	2 (moderate)	7	2 (10%-29%)	14	5.6	9.8	2 (Pink colouration)	4 (Moderate elevation)	4 (Moderate)	10	lower back	Chronic(>1week)					14/06/12	moderate		Contact Allergy	Others ; Anti-Hypertensive ; Statins ; Anti-Hypertensive ; Others ; Others		Phototherapy ; Retinoids ; Local Corticosteroids ; Vitamin D analogs ; Local Corticosteroids ; Others			MAARS_2_034_01	14/06/12			MAARS_2_034_02	14/06/12			MAARS_2_034_03	14/06/12			MAARS_2_034_04	14/06/12			MAARS_2_034_05	14/06/12			MAARS_2_034_06	14/06/12											MAARS_2_034_07	14/06/12			MAARS_2_034_08	14/06/12			MAARS_2_034_09	14/06/12		
MAARS_2_035	19/06/12	KINGS	Barker	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1965	Female	Asian - Other		Codine		1987	1988	No		Unknown 	No	No	Present	No		Present	Present	Present	Present	Present	Present	Present	No	No	Present	Unknown 	Unknown 															Unknown 									Calcium Channel Blockers	Diuretics								5	2.5								daily	daily								00/00/2010	00/00/2010								Yes	Yes																	Cyclosporin	Methotrexate	UVB - Ultraviolet B phototherapy	Potent corticosteroids (topical)	TAR (Topical)							100	10										twice daily (had a 3/12 break in the middle)	weekly	4 courses	prn	prn							24/12/2010	00/00/2004	00/00/2008	00/00/1988	00/00/1988							No	No	No	No	No							14/02/2012	00/00/2004	00/00/2010	00/03/2012	00/03/2012							Yes	Yes	Yes	Yes	Yes							Unknown 																									19/06/12	arms ; buttocks ; head ; legs ; lower back ; posterior thigh ; trunk		2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	1.2	2 (moderate)	2 (moderate)	2 (moderate)	6	3 (30%-49%)	18	5.4	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	2.4	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	4.8	13.8	2 (Pink colouration)	2 (Slight definite elevation)	4 (Moderate)	8	lower back	Chronic(>1week)					19/06/12	moderate-severe		Drug Allergy	Anti-Hypertensive ; Anti-Hypertensive		Cyclosporin ; Methotrexate ; Phototherapy ; Local Corticosteroids ; TAR (topical)			MAARS_2_035_01	19/06/12			MAARS_2_035_02	19/06/12			MAARS_2_035_03	19/06/12			MAARS_2_035_04	19/06/12			MAARS_2_035_05	19/06/12			MAARS_2_035_06	19/06/12											MAARS_2_035_07	19/06/12			MAARS_2_035_08	19/06/12			MAARS_2_035_09	19/06/12		
MAARS_2_036	20/06/12	KINGS	Barker	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1980	Male	White		Pollen		2001	2012	No		Unknown 	Present	Present	No	No		Present	Present	Present	Present	Present	Present	No	No	No	No	Unknown 	Unknown 															Unknown 																																																															Moderate corticosteroids (topical)																						prn											00/00/2001											No											00/02/2012											No											Unknown 																									20/06/12	arms ; head ; legs ; lower back ; posterior thigh ; trunk		2 (moderate)	2 (moderate)	2 (moderate)	6	1 (1%-9%)	6	0.6	2 (moderate)	2 (moderate)	2 (moderate)	6	3 (30%-49%)	18	5.4	2 (moderate)	1 (slight)	2 (moderate)	5	1 (1%-9%)	5	1.0	3 (severe)	2 (moderate)	2 (moderate)	7	3 (30%-49%)	21	8.4	15.4	4 (Red colouration)	4 (Moderate elevation)	4 (Moderate)	12	lower back	Chronic(>1week)					20/06/12	moderate-severe		Pollen			Local Corticosteroids			MAARS_2_036_01	20/06/12			MAARS_2_036_02	20/06/12			MAARS_2_036_03	20/06/12			MAARS_2_036_04	20/06/12			MAARS_2_036_05	20/06/12			MAARS_2_036_06	20/06/12											MAARS_2_036_07	20/06/12			MAARS_2_036_08	20/06/12			MAARS_2_036_09	20/06/12		
MAARS_2_039	29/06/12	KINGS	Barker	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1981	Male	Black - Caribbean	Brother ; Sister	Pollen		2003	2003	No		Unknown 	No	No	No	No		Present	Present	Present	Present	No	Present	Present	No	No	No	Unknown 	Unknown 															Unknown 																																																															TLO1	Potent corticosteroids (topical)	Tacrolimus cream																					prn	prn									00/08/2003	00/06/2003	00/06/2012									No	Yes	Yes									00/11/2003											Yes	No	No									Unknown 																									29/06/12	arms ; buttocks ; head ; legs ; lower back ; posterior thigh ; trunk		1 (slight)	1 (slight)	2 (moderate)	4	3 (30%-49%)	12	01.2	2 (moderate)	1 (slight)	2 (moderate)	5	2 (10%-29%)	10	3.0	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	2.4	2 (moderate)	2 (moderate)	2 (moderate)	6	3 (30%-49%)	18	7.2	13.8	4 (Red colouration)	6 (Marked elevation)	6 (Severe)	18	lower back	Chronic(>1week)					29/06/12	moderate-severe		Pollen			Others ; Local Corticosteroids ; Topical calcineurin inhibitors			MAARS_2_039_01	29/06/12			MAARS_2_039_02	29/06/12			MAARS_2_039_03	29/06/12			MAARS_2_039_04	29/06/12			MAARS_2_039_05	29/06/12			MAARS_2_039_06	29/06/12											MAARS_2_039_07	29/06/12			MAARS_2_039_08	29/06/12			MAARS_2_039_09	29/06/12		
MAARS_2_043	06/07/12	KINGS	Barker	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1965	Male	White		Pollen		1983	1983	No		Unknown 	Past	Past	No	No		Present	Present	Present	Present	Past	Present	No	No	No	No	Unknown 	Unknown 															Unknown 																																																															UVB - Ultraviolet B phototherapy	vitamin D analogs																					6 courses, appx 30 treatments per time	prn										00/00/1983	00/00/1983										No	Yes										00/00/2010											Yes	Yes										Unknown 																									15/06/12	arms ; buttocks ; head ; legs ; lower back ; posterior thigh ; trunk		1 (slight)	1 (slight)	1 (slight)	3	1 (1%-9%)	4	0.4	2 (moderate)	1 (slight)	2 (moderate)	5	3 (30%-49%)	15	4.5	2 (moderate)	1 (slight)	1 (slight)	4	2 (10%-29%)	8	1.6	2 (moderate)	1 (slight)	2 (moderate)	5	3 (30%-49%)	15	6.0	12.5	2 (Pink colouration)	2 (Slight definite elevation)	4 (Moderate)	8	lower back	Chronic(>1week)					15/06/12	moderate-severe		Pollen			Phototherapy ; Vitamin D analogs			MAARS_2_043_01	06/07/12			MAARS_2_043_02	06/07/12			MAARS_2_043_03	06/07/12			MAARS_2_043_04	06/07/12			MAARS_2_043_05	06/07/12			MAARS_2_043_06	06/07/12											MAARS_2_043_07	06/07/12			MAARS_2_043_08	06/07/12			MAARS_2_043_09	06/07/12		
MAARS_2_044	09/07/12	KINGS	Barker	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1975	Female	White		almonds ; Lavender		2009	2010	No		Unknown 	No	No	No	No		Present	Present	Present	Present	Past	Present	Present	No	No	No	Unknown 	Unknown 															Unknown 																																																															UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy	Potent corticosteroids (topical)	Very potent corticosteroids (topical)	TAR (Topical)	vitamin D analogs																	30 treatments	30 Treatments	prn	shampoo - prn	prn	prn						00/03/2011	00/11/2011	00/03/2010	00/03/2012	00/12/2010	00/03/2011						No	No	Yes	Yes	Yes	Yes						00/06/2011	00/04/2012										Yes	Yes	No	No	No	No						Unknown 																									09/07/12	arms ; head ; legs ; lower back ; posterior thigh ; trunk		2 (moderate)	1 (slight)	2 (moderate)	5	2 (10%-29%)	10	1.0	1 (slight)	1 (slight)	1 (slight)	3	1 (1%-9%)	3	0.9	1 (slight)	1 (slight)	2 (moderate)	4	1 (1%-9%)	4	0.8	2 (moderate)	2 (moderate)	2 (moderate)	6	1 (1%-9%)	6	2.4	5.1	2 (Pink colouration)	2 (Slight definite elevation)	4 (Moderate)	8	lower back	Chronic(>1week)					09/07/12	mild	Declined full body photo's	Food ; Contact Allergy			Phototherapy ; Phototherapy ; Local Corticosteroids ; Local Corticosteroids ; TAR (topical) ; Vitamin D analogs			MAARS_2_044_01	09/07/12			MAARS_2_044_02	09/07/12			MAARS_2_044_03	09/07/12			MAARS_2_044_04	09/07/12			MAARS_2_044_05	09/07/12			MAARS_2_044_06	09/07/12											MAARS_2_044_07	09/07/12			MAARS_2_044_08	09/07/12			MAARS_2_044_09	09/07/12		
MAARS_2_050	19/07/12	KINGS	Barker	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1959	Male	White	Father			2002	2010	No		Unknown 	No	No	Past	No		Present	Present	Present	Present	Past	Present	No	No	No	No	Unknown 	Unknown 															Unknown 																																																															UVB - Ultraviolet B phototherapy	Potent corticosteroids (topical)	TAR (Topical)																				1 course: 20 treatments	prn	prn									00/00/2010	00/00/2002	00/00/2002									No	Yes	Yes									00/00/2010											Yes	Yes	Yes									Unknown 																									22/06/12	arms ; head ; legs ; lower back ; posterior thigh ; trunk		1 (slight)	0 (none)	1 (slight)	2	1 (1%-9%)	2	0.2	2 (moderate)	1 (slight)	1 (slight)	4	2 (10%-29%)	8	2.4	2 (moderate)	1 (slight)	1 (slight)	4	1 (1%-9%)	4	0.8	2 (moderate)	1 (slight)	1 (slight)	4	3 (30%-49%)	12	4.8	8.2	2 (Pink colouration)	2 (Slight definite elevation)	2 (Mild)	6	lower back	Chronic(>1week)					19/07/12	moderate	Patient declined full body photo's. History of Farther's Psoriasis is unconfirmed. Had 'it' but did not discess/see a Dr about it.				Phototherapy ; Local Corticosteroids ; TAR (topical)			MAARS_2_050_01	19/07/12			MAARS_2_050_02	19/07/12			MAARS_2_050_03	19/07/12			MAARS_2_050_04	19/07/12			MAARS_2_050_05	19/07/12			MAARS_2_050_06	19/07/12			MAARS_2_050_10	19/07/12			MAARS_2_050_11	19/07/12			MAARS_2_050_07	19/07/12			MAARS_2_050_08	19/07/12			MAARS_2_050_09	19/07/12		
MAARS_2_056	10/08/12	KINGS	Barker	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1975	Male	White	Father ; Brother	Pollen		2003	2004	No		Unknown 	No	No	Past	No		Present	Present	Present	Present	No	Present	Past	No	No	No	Unknown 	Unknown 															Unknown 																																																															UVB - Ultraviolet B phototherapy	Potent corticosteroids (topical)	vitamin D analogs	Moderate corticosteroids (topical)	TAR (Topical)	Dithranol-minute																	2 seperate courses	prn	prn	prn	prn	prn						00/00/2005	00/00/2003	00/02/2011	00/02/2011	00/02/2011							No	No	No	No	No	No						00/00/2006											Yes	No	No	No	No	No						Unknown 																									03/08/12	arms ; buttocks ; head ; legs ; lower back ; posterior thigh ; trunk		1 (slight)	2 (moderate)	3 (severe)	6	1 (1%-9%)	6	0.6	2 (moderate)	2 (moderate)	2 (moderate)	6	1 (1%-9%)	6	1.8	2 (moderate)	1 (slight)	2 (moderate)	5	1 (1%-9%)	5	1.0	2 (moderate)	2 (moderate)	2 (moderate)	6	1 (1%-9%)	6	2.4	5.8	2 (Pink colouration)	2 (Slight definite elevation)	2 (Mild)	6	lower back	Chronic(>1week)					10/08/12	mild	Father and brother history of psoriasis is unconfirmed. | |Patient reports having 'steroid injections' into his psoriasis in the USA in 2004-2005, agent unknown.	Pollen			Phototherapy ; Local Corticosteroids ; Vitamin D analogs ; Local Corticosteroids ; TAR (topical) ; Dithranol-minute			MAARS_2_056_01	10/08/12			MAARS_2_056_02	10/08/12			MAARS_2_056_03	10/08/12			MAARS_2_056_04	10/08/12			MAARS_2_056_05	10/08/12			MAARS_2_056_06	10/08/12			MAARS_2_056_10	10/08/12			MAARS_2_056_11	10/08/12			MAARS_2_056_07	10/08/12			MAARS_2_056_08	10/08/12			MAARS_2_056_09	10/08/12		
MAARS_2_065	23/08/12	KINGS	Barker	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1988	Female	White				2011	2011	No		Unknown 	Present	No	No	No		Present	Present	Past	Past	Present	Present	No	Past	No	No	Unknown 	Unknown 															Unknown 									Iron and iron-folic acid combinations									200									twice daily									20/08/2012									Yes																		UVB - Ultraviolet B phototherapy	Potent corticosteroids (topical)	vitamin D analogs	TAR (Topical)																			40 treatments	prn	prn	prn -shampoo								00/12/2012	00/07/2011	00/07/2011	00/07/2011								No	Yes	Yes	Yes								00/04/2012											Yes	Yes	Yes	Yes								Unknown 																									23/08/12	head ; legs ; lower back ; trunk		2 (moderate)	1 (slight)	2 (moderate)	5	1 (1%-9%)	5	0.5	1 (slight)	2 (moderate)	1 (slight)	4	1 (1%-9%)	4	1.2	0 (none)	0 (none)	0 (none)	0	0 (0%)	0	0.0	2 (moderate)	2 (moderate)	2 (moderate)	6	1 (1%-9%)	6	2.4	4.1	2 (Pink colouration)	2 (Slight definite elevation)	2 (Mild)	6	lower back	Chronic(>1week)					23/08/12	mild	Declined full body photo's.		Others		Phototherapy ; Local Corticosteroids ; Vitamin D analogs ; TAR (topical)			MAARS_2_065_01	23/08/12			MAARS_2_065_02	23/08/12			MAARS_2_065_03	23/08/12			MAARS_2_065_04	23/08/12			MAARS_2_065_05	23/08/12			MAARS_2_065_06	23/08/12			MAARS_2_065_10	23/08/12			MAARS_2_065_11	23/08/12			MAARS_2_065_07	23/08/12			MAARS_2_065_08	23/08/12			MAARS_2_065_09	23/08/12		
MAARS_2_067	29/08/12	KINGS	Barker	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1947	Male	White	Son ; Sister			1975	1975	No		Unknown 	Present	Present	No	Past		Present	Present	Present	Present	No	Present	No	No	No	No	Unknown 	Unknown 															Unknown 									Angiotensin-II receptor antagonists	Phosphodiesterase type-5 inhibitors	Omega 3							100	20								daily	prn	daily							00/04/2012									Yes	Yes	Yes																Moderate corticosteroids (topical)	UVB - Ultraviolet B phototherapy	Dithranol-minute	TAR (Topical)																			prn		prn (Intensive treatment yearly, for last 30 years)	prn (Intensive treatment yearly, for last 30 years)								00/00/1975	00/00/1998	00/00/1982	00/00/1982								Yes	No	Yes	Yes									00/00/1998										Yes	No	Yes	Yes								Unknown 																									29/08/12	arms ; buttocks ; head ; legs ; lower back ; posterior thigh ; trunk		1 (slight)	1 (slight)	1 (slight)	3	1 (1%-9%)	3	0.3	2 (moderate)	2 (moderate)	3 (severe)	7	2 (10%-29%)	14	4.2	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	2.4	2 (moderate)	3 (severe)	2 (moderate)	7	2 (10%-29%)	14	5.6	12.5	4 (Red colouration)	4 (Moderate elevation)	4 (Moderate)	12	lower back	Chronic(>1week)					29/08/12	moderate-severe			Anti-Hypertensive ; Others ; Others		Local Corticosteroids ; Phototherapy ; Dithranol-minute ; TAR (topical)			MAARS_2_067_01	29/08/12			MAARS_2_067_02	29/08/12			MAARS_2_067_03	29/08/12			MAARS_2_067_04	29/08/12			MAARS_2_067_05	29/08/12			MAARS_2_067_06	29/08/12			MAARS_2_067_10	29/08/12			MAARS_2_067_11	29/08/12			MAARS_2_067_07	29/08/12			MAARS_2_067_08	29/08/12			MAARS_2_067_09	29/08/12		
MAARS_2_069	29/08/12	KINGS	Barker	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1985	Male	White				1992	2005	No		Unknown 	No	No	No	No		Present	Present	Present	Present	No	Present	No	No	No	No	Unknown 	Unknown 															Unknown 																																																															UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy	Potent corticosteroids (topical)	vitamin D analogs	TAR (Topical)																		25 to 30 treatments	25 to 30 treatments	prn	prn	prn							00/08/2005	00/04/2007	00/00/1992	00/08/2012	00/00/1992							No	No	Yes	Yes	No							00/10/2005	00/06/2007										Yes	Yes	Yes	No	Yes							Unknown 																									29/08/12	arms ; head ; legs ; lower back ; posterior thigh ; trunk		1 (slight)	1 (slight)	1 (slight)	3	1 (1%-9%)	3	0.3	1 (slight)	1 (slight)	1 (slight)	3	1 (1%-9%)	3	0.9	2 (moderate)	1 (slight)	2 (moderate)	5	2 (10%-29%)	10	2.0	2 (moderate)	1 (slight)	1 (slight)	4	2 (10%-29%)	8	3.2	6.4	2 (Pink colouration)	2 (Slight definite elevation)	2 (Mild)	6	lower back	Chronic(>1week)					29/08/12	mild					Phototherapy ; Phototherapy ; Local Corticosteroids ; Vitamin D analogs ; TAR (topical)			MAARS_2_069_01	29/08/12			MAARS_2_069_02	29/08/12			MAARS_2_069_03	29/08/12			MAARS_2_069_04	29/08/12			MAARS_2_069_05	29/08/12			MAARS_2_069_06	29/08/12			MAARS_2_069_10	29/08/12			MAARS_2_069_11	29/08/12			MAARS_2_069_07	29/08/12			MAARS_2_069_08	29/08/12			MAARS_2_069_09	29/08/12		
MAARS_2_070	30/08/12	KINGS	Barker	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1970	Male	White				2002	2012	No		Unknown 	No	No	Past	No		Present	Present	Present	Present	Present	Present	Present	No	No	No	Unknown 	Unknown 															Unknown 																																																															Very potent corticosteroids (topical)	Potent corticosteroids (topical)	Moderate corticosteroids (topical)	vitamin D analogs	TAR (Topical)																		prn	prn	prn	prn	prn							00/00/2002	00/00/2002	00/00/2002	00/00/2002	00/00/2002							Yes	Yes	Yes	No	No																		Yes	Yes	Yes	Yes	Yes							Unknown 																									30/08/12	arms ; head ; legs ; lower back ; posterior thigh ; trunk		1 (slight)	1 (slight)	2 (moderate)	4	1 (1%-9%)	4	0.4	2 (moderate)	2 (moderate)	2 (moderate)	6	1 (1%-9%)	6	1.8	2 (moderate)	1 (slight)	3 (severe)	6	1 (1%-9%)	6	1.2	3 (severe)	3 (severe)	3 (severe)	9	1 (1%-9%)	9	3.6	7.0	4 (Red colouration)	4 (Moderate elevation)	4 (Moderate)	12	lower back	Chronic(>1week)					30/08/12	moderate					Local Corticosteroids ; Local Corticosteroids ; Local Corticosteroids ; Vitamin D analogs ; TAR (topical)			MAARS_2_070_01	30/08/12			MAARS_2_070_02	30/08/12			MAARS_2_070_03	30/08/12			MAARS_2_070_04	30/08/12			MAARS_2_070_05	30/08/12			MAARS_2_070_06	30/08/12			MAARS_2_070_10	30/08/12			MAARS_2_070_11	30/08/12			MAARS_2_070_07	30/08/12			MAARS_2_070_08	30/08/12			MAARS_2_070_09	30/08/12		
MAARS_2_074	06/09/12	KINGS	Barker	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1965	Male	White				1991	1992	No		Unknown 	Present	No	No	No		Present	Present	No	Present	Present	Present	Present	No	No	No	Unknown 	Unknown 															Unknown 																																																															PUVA - psoralen + UVA (ultraviolet A-phototherapy)	UVB - Ultraviolet B phototherapy	Methotrexate	Methotrexate	Acitretin	Cyclosporin	Steroids (p.o)	Moderate corticosteroids (topical)	Biologic's	Biologic's										25			1 course/12 treatments	multiple courses						prn	weekly	(as part of a clinical trial)		00/00/1996	00/00/2001	00/00/1993	00/00/1998	00/00/1995	00/00/1995		00/00/1975	00/00/2008	00/00/2004		No	No	No	No	No	No	No	Yes	No	No		00/00/1996	00/00/2002	00/00/1993	00/00/1999	00/00/1996	00/00/1996			00/05/2012	00/00/2044		Yes	Yes	Yes	Yes	Yes	Yes	No	Yes	Yes	Yes		Unknown 																									06/09/12	arms ; buttocks ; head ; legs ; lower back ; posterior thigh ; trunk		2 (moderate)	1 (slight)	2 (moderate)	5	1 (1%-9%)	5	0.5	2 (moderate)	1 (slight)	2 (moderate)	5	3 (30%-49%)	15	4.5	2 (moderate)	1 (slight)	1 (slight)	4	3 (30%-49%)	12	2.4	2 (moderate)	2 (moderate)	2 (moderate)	6	3 (30%-49%)	18	7.2	14.6	2 (Pink colouration)	2 (Slight definite elevation)	4 (Moderate)	8	lower back	Chronic(>1week)					06/09/12	moderate-severe					Photochemotherapy ; Phototherapy ; Methotrexate ; Methotrexate ; Retinoids ; Cyclosporin ; Systemic Corticosteroids ; Local Corticosteroids ; Others ; Others			MAARS_2_074_01	06/09/12			MAARS_2_074_02	06/09/12			MAARS_2_074_03	06/09/12			MAARS_2_074_04	06/09/12			MAARS_2_074_05	06/09/12			MAARS_2_074_06	06/09/12			MAARS_2_074_10	06/09/12			MAARS_2_074_11	06/09/12			MAARS_2_074_07	06/09/12			MAARS_2_074_08	06/09/12			MAARS_2_074_09	06/09/12		
MAARS_2_075	17/09/12	KINGS	Barker	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1961	Male	Black - Other				2004	2004	No		Unknown 	No	No	No	No		Present	Present	Present	No	No	Present	No	No	No	No	Unknown 	Unknown 															Unknown 																																																															Potent corticosteroids (topical)	TLO1	vitamin D analogs																				prn		prn									00/00/2010											Yes	No	No																				Yes	Yes	No									Unknown 																									17/09/12	arms ; buttocks ; head ; legs ; lower back ; posterior thigh ; trunk		1 (slight)	1 (slight)	1 (slight)	3	1 (1%-9%)	3	0.3	2 (moderate)	1 (slight)	2 (moderate)	5	1 (1%-9%)	5	1.5	2 (moderate)	3 (severe)	2 (moderate)	7	1 (1%-9%)	7	1.4	3 (severe)	3 (severe)	3 (severe)	9	1 (1%-9%)	9	3.6	6.8	4 (Red colouration)	2 (Slight definite elevation)	2 (Mild)	8	lower back	Chronic(>1week)					17/09/12	moderate	No photography taken.				Local Corticosteroids ; Others ; Vitamin D analogs			MAARS_2_075_01	17/09/12			MAARS_2_075_02	17/09/12			MAARS_2_075_03	17/09/12			MAARS_2_075_04	17/09/12			MAARS_2_075_05	17/09/12			MAARS_2_075_06	17/09/12			MAARS_2_075_10	17/09/12			MAARS_2_075_11	17/09/12			MAARS_2_075_07	17/09/12			MAARS_2_075_08	17/09/12			MAARS_2_075_09	17/09/12		
MAARS_2_081	17/10/12	KINGS	Barker	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1964	Male	White	Father ; Brother ; Sister	birch ; Grasses ; Pollen ; Elder ; Hazel tree		1985	1985	No		Unknown 	Present	No	No	No		Present	Present	Past	Past	Past	Present	Past	No	No	Past	Unknown 	Unknown 															Unknown 									Statins	Lipid-regulating drugs (non-statin)	Corticosteroids (Inhaler)	NSAID									500								twice daily	prn						00/11/2011	00/00/2007	00/00/2006	00/00/2009						Yes	Yes	Yes	Yes															PUVA - psoralen + UVA (ultraviolet A-phototherapy)	UVB - Ultraviolet B phototherapy	Potent corticosteroids (topical)	vitamin D analogs	TAR (Topical)																		3 courses = approx 105 sessions	4 courses in total	prn	prn (scalp)	prn.							30/11/1993	00/11/1999	00/00/1985	00/12/2011	00/12/2011							No	No	Yes	Yes	Yes							11/04/1996	00/12/2008										Yes	Yes	Yes	Yes	Yes							Unknown 																									17/10/12	arms ; buttocks ; head ; legs ; lower back ; posterior thigh ; trunk		1 (slight)	1 (slight)	1 (slight)	3	1 (1%-9%)	3	0.3	2 (moderate)	1 (slight)	2 (moderate)	5	2 (10%-29%)	10	3.0	1 (slight)	1 (slight)	1 (slight)	3	2 (10%-29%)	6	1.2	2 (moderate)	1 (slight)	2 (moderate)	5	1 (1%-9%)	5	2.0	6.5	4 (Red colouration)	2 (Slight definite elevation)	2 (Mild)	8	lower back	Chronic(>1week)					17/10/12	moderate		Pollen	Statins ; Others ; Others ; Anti-Inflammatory(non steroid)		Photochemotherapy ; Phototherapy ; Local Corticosteroids ; Vitamin D analogs ; TAR (topical)			MAARS_2_081_01	17/10/12			MAARS_2_081_02	17/10/12			MAARS_2_081_03	17/10/12			MAARS_2_081_04	17/10/12			MAARS_2_081_05	17/10/12			MAARS_2_081_06	17/10/12											MAARS_2_081_07	17/10/12			MAARS_2_081_08	17/10/12			MAARS_2_081_09	17/10/12		
MAARS_2_083	19/10/12	KINGS	Barker	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1974	Female	White	Mother ; Sister	nuts		1991	1997	No		Unknown 	Present	Present	No	No		Present	Present	Present	Present	Past	Present	No	No	No	No	Unknown 	Unknown 															Unknown 																																																															Potent corticosteroids (topical)	vitamin D analogs	Tacrolimus cream	TAR (Topical)																			prn	prn	prn	prn								00/00/1991	00/00/1991	00/00/1991	00/00/1991								Yes	Yes	Yes	Yes																			Yes	Yes	Yes	Yes								Unknown 																									19/10/12	arms ; head ; legs ; lower back ; posterior thigh ; trunk		2 (moderate)	1 (slight)	2 (moderate)	5	3 (30%-49%)	15	1.5	2 (moderate)	2 (moderate)	2 (moderate)	6	1 (1%-9%)	6	1.8	1 (slight)	1 (slight)	2 (moderate)	4	1 (1%-9%)	4	0.8	2 (moderate)	1 (slight)	1 (slight)	4	1 (1%-9%)	4	1.6	5.7	4 (Red colouration)	4 (Moderate elevation)	4 (Moderate)	12	lower back	Chronic(>1week)					19/10/12	mild	Declined full body photos.	Food			Local Corticosteroids ; Vitamin D analogs ; Topical calcineurin inhibitors ; TAR (topical)			MAARS_2_083_01	19/10/12			MAARS_2_083_02	19/10/12			MAARS_2_083_03	19/10/12			MAARS_2_083_04	19/10/12			MAARS_2_083_05	19/10/12			MAARS_2_083_06	19/10/12											MAARS_2_083_07	19/10/12			MAARS_2_083_08	19/10/12			MAARS_2_083_09	19/10/12		
MAARS_2_084	24/10/12	KINGS	Barker	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1968	Male	White		Diclofenac		2002	2005	No		Unknown 	No	No	Past	No		Present	Present	Present	Present	Present	Present	Present	No	No	No	Unknown 	Unknown 															Unknown 									Tramadol	Opioid Analgesics	Antidepressant - Other	Antiepilepsies (as pain relief)								75	100						prn	patch - weekly	Daily (pain relief)	daily															Yes	Yes	Yes	Yes															UVB - Ultraviolet B phototherapy	Tacrolimus cream	Potent corticosteroids (topical)	Very potent corticosteroids (topical)	Moderate corticosteroids (topical)	Dithranol-minute																	approx 5 treatments	prn	prn	prn	prn							00/00/2009	00/06/2012	00/06/2012		00/06/2012							No	Yes	Yes	No	Yes	No						00/00/2009			00/06/2012								No	Yes	Yes	Yes	Yes	No						Unknown 																									24/10/12	arms ; head ; legs ; lower back ; posterior thigh ; trunk		1 (slight)	1 (slight)	1 (slight)	3	1 (1%-9%)	3	0.3	1 (slight)	2 (moderate)	1 (slight)	4	1 (1%-9%)	4	1.2	1 (slight)	2 (moderate)	2 (moderate)	5	2 (10%-29%)	10	2.0	2 (moderate)	3 (severe)	2 (moderate)	7	2 (10%-29%)	14	5.6	9.1	2 (Pink colouration)	4 (Moderate elevation)	4 (Moderate)	10	lower back	Chronic(>1week)					24/10/12	moderate	Declined full body photo's.	Drug Allergy	Others ; Others ; Others ; Others		Phototherapy ; Topical calcineurin inhibitors ; Local Corticosteroids ; Local Corticosteroids ; Local Corticosteroids ; Dithranol-minute			MAARS_2_084_01	24/10/12			MAARS_2_084_02	24/10/12			MAARS_2_084_03	24/10/12			MAARS_2_084_04	24/10/12			MAARS_2_084_05	24/10/12			MAARS_2_084_06	24/10/12											MAARS_2_084_07	24/10/12			MAARS_2_084_08	24/10/12			MAARS_2_084_09	24/10/12		
MAARS_2_085	29/10/12	KINGS	Barker	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1983	Male	White				2006	2008	No		Unknown 	No	No	No	No		Present	Present	Present	Present	No	Present	No	No	No	No	Unknown 	Unknown 															Unknown 																																																															PUVA - psoralen + UVA (ultraviolet A-phototherapy)	UVB - Ultraviolet B phototherapy	Cyclosporin	Potent corticosteroids (topical)																			1 course = appx 20 treatments	1 course, appx 20 treatments		prn								00/00/2009	00/00/2011	00/00/2008	00/00/2006								No	No	No	Yes								00/00/2010	00/00/2011	00/00/2008									Yes	No	No	No								Unknown 																									29/10/12	arms ; buttocks ; head ; legs ; lower back ; posterior thigh ; trunk		1 (slight)	1 (slight)	2 (moderate)	4	1 (1%-9%)	4	0.4	2 (moderate)	2 (moderate)	2 (moderate)	6	1 (1%-9%)	6	1.8	2 (moderate)	2 (moderate)	3 (severe)	7	2 (10%-29%)	14	2.8	3 (severe)	2 (moderate)	3 (severe)	8	3 (30%-49%)	24	9.6	14.6	4 (Red colouration)	4 (Moderate elevation)	4 (Moderate)	12	lower back	Chronic(>1week)					29/10/12	moderate-severe					Photochemotherapy ; Phototherapy ; Cyclosporin ; Local Corticosteroids			MAARS_2_085_01	29/10/12			MAARS_2_085_02	29/10/12			MAARS_2_085_03	29/10/12			MAARS_2_085_04	29/10/12			MAARS_2_085_05	29/10/12			MAARS_2_085_06	29/10/12			MAARS_2_085_10	29/10/12			MAARS_2_085_11	29/10/12			MAARS_2_085_07	29/10/12			MAARS_2_085_08	29/10/12			MAARS_2_085_09	29/10/12		
MAARS_2_086	31/10/12	KINGS	Barker	Yes	Yes	Yes	No	No	No	No	No	No	No	2 weeks	No	No	1945	Female	White	Son	Metronidazole		1978		No		Unknown 	No	No	No	No		Present	Present	Present	Present	Past	Present	No	No	No	No	Unknown 	Unknown 															Unknown 									Statins	Metformin	venlafaxine	Insulin Lispro	Insulin Humilin					40	850		10	30					daily	3 times daily		3 times daily	Daily (nocte)							00/00/1987	00/00/2012	00/00/2012					Yes	Yes	Yes	Yes	Yes														Methotrexate	TLO1	UVB - Ultraviolet B phototherapy	Potent corticosteroids (topical)																				39 Treatments	2xcourses. ?TL01 or UVB?	prn								00/03/2006	00/03/2012		00/00/1978								No	No	No	Yes								00/09/2011	00/06/2012										Yes	Yes	Yes	Yes								Unknown 																									04/10/12	arms ; buttocks ; head ; legs ; lower back ; posterior thigh ; trunk		2 (moderate)	1 (slight)	2 (moderate)	5	2 (10%-29%)	10	1.0	3 (severe)	2 (moderate)	2 (moderate)	6	3 (30%-49%)	18	5.4	1 (slight)	2 (moderate)	2 (moderate)	5	1 (1%-9%)	5	1.0	2 (moderate)	2 (moderate)	2 (moderate)	6	1 (1%-9%)	6	2.4	9.8	4 (Red colouration)	4 (Moderate elevation)	4 (Moderate)	12	lower back	Chronic(>1week)					31/10/12	moderate-severe	Declined full body photo's.| |Patient had antibiotics prescribed 3/52 before sasmple visit by dentist, and "thinks" she finished them 'about' 2 weeks before sample visit.	Drug Allergy	Statins ; Others ; Others ; Insulin ; Insulin		Methotrexate ; Others ; Phototherapy ; Local Corticosteroids			MAARS_2_086_01	31/10/12			MAARS_2_086_02	31/10/12			MAARS_2_086_03	31/10/12			MAARS_2_086_04	31/10/12			MAARS_2_086_05	31/10/12			MAARS_2_086_06	31/10/12			MAARS_2_086_10	31/10/12			MAARS_2_086_11	31/10/12			MAARS_2_086_07	31/10/12			MAARS_2_086_08	31/10/12			MAARS_2_086_09	31/10/12		
MAARS_2_087	05/11/12	KINGS	Barker	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1974	Male	White				1988	1996	No		Unknown 	No	No	Past	No		Present	Present	Past	Present	Present	Present	Present	No	No	No	Unknown 	Unknown 															Unknown 																																																															UVB - Ultraviolet B phototherapy	vitamin D analogs	Potent corticosteroids (topical)	Moderate corticosteroids (topical)	TAR (Topical)																		2 courses	prn	prn	prn	prn							00/00/2007		00/00/1988	00/00/1988	00/10/2012							No	Yes	Yes	Yes	Yes																		Yes	Yes	Yes	Yes	Yes																																05/11/12	arms ; buttocks ; head ; legs ; lower back ; posterior thigh ; trunk		2 (moderate)	1 (slight)	1 (slight)	4	1 (1%-9%)	4	0.4	2 (moderate)	2 (moderate)	2 (moderate)	6	1 (1%-9%)	6	1.8	1 (slight)	1 (slight)	2 (moderate)	4	1 (1%-9%)	4	0.8	1 (slight)	1 (slight)	2 (moderate)	4	1 (1%-9%)	4	1.6	4.6	4 (Red colouration)	4 (Moderate elevation)	4 (Moderate)	12	lower back	Chronic(>1week)					05/11/12	mild					Phototherapy ; Vitamin D analogs ; Local Corticosteroids ; Local Corticosteroids ; TAR (topical)			MAARS_2_087_01	05/11/12			MAARS_2_087_02	05/11/12			MAARS_2_087_03	05/11/12			MAARS_2_087_04	05/11/12			MAARS_2_087_05	05/11/12			MAARS_2_087_06	05/11/12			MAARS_2_087_10	05/11/12			MAARS_2_087_11	05/11/12			MAARS_2_087_07	05/11/12			MAARS_2_087_08	05/11/12			MAARS_2_087_09	05/11/12		
MAARS_2_091	20/11/12	KINGS	Barker	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1956	Female	White		Paracetamol		1971	1971	No		Unknown 	No	No	Past	No		Present	Past	Present	Present	No	Present	No	No	No	No	No																									Beta-blockers									40									BD									01/07/2012									Yes																		Moderate corticosteroids (topical)	Potent corticosteroids (topical)	Very potent corticosteroids (topical)	Dithranol-minute	TAR (Topical)	vitamin D analogs	UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy														Prn	Prn	Prn	Prn	Prn	Prn						00/00/1993	00/00/1993	00/00/1993	00/00/1993	00/00/1993	00/00/1993	00/00/1992	00/00/2001	00/11/2011			Yes	Yes	No	No	Yes	Yes	No	No	No					00/11/2012	00/11/2012			00/00/1993	00/00/2002	00/03/2012			Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	No	No																											20/11/12	arms ; buttocks ; head ; lower back ; trunk		2 (moderate)	2 (moderate)	3 (severe)	7	2 (10%-29%)	14	1.4	2 (moderate)	1 (slight)	2 (moderate)	5	1 (1%-9%)	5	1.5	1 (slight)	1 (slight)	2 (moderate)	4	1 (1%-9%)	4	0.8	0 (none)	0 (none)	0 (none)	0	0 (0%)	0	0	3.7	2 (Pink colouration)	2 (Slight definite elevation)	4 (Moderate)	8	lower back	Chronic(>1week)					20/11/12	mild	Patient declined full body photos.	Drug Allergy	Anti-Hypertensive		Local Corticosteroids ; Local Corticosteroids ; Local Corticosteroids ; Dithranol-minute ; TAR (topical) ; Vitamin D analogs ; Phototherapy ; Phototherapy ; Phototherapy			MAARS_2_091_01	20/11/12			MAARS_2_091_02	20/11/12			MAARS_2_091_03	20/11/12			MAARS_2_091_04	20/11/12			MAARS_2_091_05	20/11/12			MAARS_2_091_06	20/11/12			MAARS_2_091_10	20/11/12			MAARS_2_091_11	20/11/12			MAARS_2_091_07	20/11/12			MAARS_2_091_08	20/11/12			MAARS_2_091_09	20/11/12		
MAARS_2_092	21/11/12	KINGS	Barker	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1981	Male	White				2007	2008	No		Unknown 	No	No	No	No		Present	Present	No	Present	No	Present	Past	No	No	No	Unknown 																																																																															Moderate corticosteroids (topical)	Potent corticosteroids (topical)	vitamin D analogs	TAR (Topical)	Very potent corticosteroids (topical)	Antibiotics (IV)	Acitretin	Acitretin									500	20	20				Prn	Prn	Prn	Prn	Prn	QDS	NK	NK				00/00/2008	00/00/2008	00/00/2008	00/00/2008	00/00/2008	27/09/2012	00/06/2011	00/11/2011				No	No	No	No	No	No	No	No				00/00/2011	00/00/2011	00/00/2011	00/00/2011	00/00/2010	04/10/2012	01/12/2011	00/00/2011				Yes	Yes	Yes	Yes	Yes	No	Yes	Yes																													09/11/12	arms ; buttocks ; head ; legs ; lower back ; posterior thigh ; trunk	1005080/archive/1003417/MAARS_2_092-Tue_Dec_10_17:53:35_CET_2013.pjpeg ; 1005080/archive/1003417/MAARS_2_092-Tue_Dec_10_17:53:44_CET_2013.pjpeg ; 1005080/archive/1003417/MAARS_2_092-Tue_Dec_10_17:53:50_CET_2013.pjpeg ; 1005080/archive/1003417/MAARS_2_092-Tue_Dec_10_17:53:59_CET_2013.pjpeg ; 1005080/archive/1003417/MAARS_2_092-Tue_Dec_10_17:54:06_CET_2013.pjpeg	1 (slight)	1 (slight)	1 (slight)	3	1 (1%-9%)	3	0.3	2 (moderate)	2 (moderate)	1 (slight)	5	3 (30%-49%)	15	4.5	2 (moderate)	2 (moderate)	1 (slight)	5	1 (1%-9%)	5	1.0	2 (moderate)	2 (moderate)	1 (slight)	5	2 (10%-29%)	10	4.0	9.8	2 (Pink colouration)	2 (Slight definite elevation)	2 (Mild)	6	lower back	Chronic(>1week)					09/11/12	moderate					Local Corticosteroids ; Local Corticosteroids ; Vitamin D analogs ; TAR (topical) ; Local Corticosteroids ; Antibiotics ; Retinoids ; Retinoids			MAARS_2_092_01	21/11/12			MAARS_2_092_02	21/11/12			MAARS_2_092_03	21/11/12			MAARS_2_092_04	21/11/12			MAARS_2_092_05	21/11/12			MAARS_2_092_06	21/11/12			MAARS_2_092_10	21/11/12			MAARS_2_092_11	21/11/12			MAARS_2_092_07	21/11/12			MAARS_2_092_08	21/11/12			MAARS_2_092_09	21/11/12		
MAARS_2_093	26/11/12	KINGS	Barker	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1959	Male	White	Mother ; Brother			1993	1993	No		Unknown 	No	No	Past	No		Present	Present	Past	Present	Present	Present	Past	No	Past	Past	Unknown 																									Folice Acid									5									OD									00/00/2012									Yes																		Moderate corticosteroids (topical)	vitamin D analogs	Dithranol-minute	TAR (Topical)	PUVA - psoralen + UVA (ultraviolet A-phototherapy)	TLO1	Acitretin																Prn	Prn	Prn	Prn								00/00/1993	00/04/2011	00/00/1993	00/00/1993	00/00/1999	00/00/2001	00/11/2002					Yes	Yes	Yes		No	No	No									00/00/2000	00/02/2001	00/00/2004					Yes	Yes	Yes	Yes	No	No	No																														26/11/12	arms ; head ; legs ; lower back ; trunk	1005080/archive/1003419/MAARS_2_093-Wed_Dec_11_11:06:27_CET_2013.jpeg ; 1005080/archive/1003419/MAARS_2_093-Wed_Dec_11_11:06:33_CET_2013.jpeg ; 1005080/archive/1003419/MAARS_2_093-Wed_Dec_11_11:06:37_CET_2013.jpeg ; 1005080/archive/1003419/MAARS_2_093-Wed_Dec_11_11:06:41_CET_2013.jpeg ; 1005080/archive/1003419/MAARS_2_093-Wed_Dec_11_11:06:45_CET_2013.jpeg	2 (moderate)	1 (slight)	2 (moderate)	5	2 (10%-29%)	10	1	1 (slight)	1 (slight)	1 (slight)	3	2 (10%-29%)	6	1.8	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	2.4	2 (moderate)	1 (slight)	1 (slight)	4	2 (10%-29%)	8	3.2	8.4	2 (Pink colouration)	2 (Slight definite elevation)	2 (Mild)	6	lower back	Chronic(>1week)					26/11/12	moderate	Pt says he forgot to use the Dove soap a couple of times in the last week, but used it 'most days'.| || |Other prep adhered to: dry >24 hours + no topical therapy applied for 2/52.		Others		Local Corticosteroids ; Vitamin D analogs ; Dithranol-minute ; TAR (topical) ; Photochemotherapy ; Others ; Retinoids			MAARS_2_093_01	26/11/12			MAARS_2_093_02	26/11/12			MAARS_2_093_03	26/11/12			MAARS_2_093_04	26/11/12			MAARS_2_093_05	26/11/12			MAARS_2_093_06	26/11/12			MAARS_2_093_10	26/11/12			MAARS_2_093_11	26/11/12			MAARS_2_093_07	26/11/12			MAARS_2_093_08	26/11/12			MAARS_2_093_09	26/11/12		
MAARS_2_094	28/11/12	KINGS	Barker	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1968	Male	White	Father ; Brother	Shell Fish		1983	1983	No		Unknown 	No	No	Past	No		Present	Present	Present	Present	Present	Present	Past	No	No	No	Unknown 																									Thyroid hormones									50									OD									00/00/2006									Yes																		Potent corticosteroids (topical)	vitamin D analogs	TAR (Topical)	Acitretin	UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy	Methotrexate	Cyclosporin										25					Prn	Prn	Prn - scalp only				Weekly					00/00/1983	00/00/2011	00/03/2011	00/00/1989	00/00/1993	00/00/2002	00/05/2008	00/00/2005				Yes	No	Yes	No	No	No	No	No							00/00/1989	00/00/1993	00/00/2002	00/10/2011	00/00/2005				Yes	Yes	Yes				No	Yes																													28/11/12	arms ; buttocks ; head ; legs ; lower back ; posterior thigh ; trunk		2 (moderate)	2 (moderate)	1 (slight)	5	2 (10%-29%)	10	1	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	3.6	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	2.4	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	4.8	11.8	4 (Red colouration)	4 (Moderate elevation)	4 (Moderate)	12	lower back	Chronic(>1week)					28/11/12	moderate-severe		Food	Thyroid hormones		Local Corticosteroids ; Vitamin D analogs ; TAR (topical) ; Retinoids ; Phototherapy ; Phototherapy ; Methotrexate ; Cyclosporin			MAARS_2_094_01				MAARS_2_094_02				MAARS_2_094_03				MAARS_2_094_04				MAARS_2_094_05				MAARS_2_094_06				MAARS_2_094_10				MAARS_2_094_11				MAARS_2_094_07				MAARS_2_094_08				MAARS_2_094_09			
MAARS_2_095	20/12/12	KINGS	Barker	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1992	Male	White				2012	2012	No		Unknown 	No	No	No	No		Past	Past	Past	Past	No	Past	No	No	No	No	Unknown 																																																																															Moderate corticosteroids (topical)	vitamin D analogs																					Prn	Prn										00/08/2012											Yes	No																					Yes	No																																			20/12/12	arms ; head ; legs ; lower back ; posterior thigh ; trunk		1 (slight)	1 (slight)	1 (slight)	3	1 (1%-9%)	3	0.3	1 (slight)	1 (slight)	2 (moderate)	4	1 (1%-9%)	4	1.2	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	2.4	2 (moderate)	2 (moderate)	3 (severe)	7	1 (1%-9%)	7	2.8	6.7	2 (Pink colouration)	2 (Slight definite elevation)	2 (Mild)	6	lower back	Chronic(>1week)					20/12/12	moderate	Checked with Prof Barker if okay to include patient as psoriasis started <6/12 ago: approx 5/12 ago, advised yes, proceed to sampling.				Local Corticosteroids ; Vitamin D analogs			MAARS_2_095_01	20/12/12			MAARS_2_095_02	20/12/12			MAARS_2_095_03	20/12/12			MAARS_2_095_04	20/12/12			MAARS_2_095_05	20/12/12			MAARS_2_095_06	20/12/12			MAARS_2_095_10	20/12/12			MAARS_2_095_11	20/12/12			MAARS_2_095_07	20/12/12			MAARS_2_095_08	20/12/12			MAARS_2_095_09	20/12/12		
MAARS_2_096	04/01/13	KINGS	Barker	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1961	Female	White	Father	penicillin		2008	2010	No		Unknown 	Present	No	No	No		Present	Present	Present	No	Past	Present	No	No	No	No	Unknown 																									Diuretics	ACE inhibitors								2.5	2.5								OD	OD								00/00/2002	00/00/2002								Yes	Yes																	Moderate corticosteroids (topical)	Potent corticosteroids (topical)	vitamin D analogs	Dithranol-minute	TAR (Topical)	Very potent corticosteroids (topical)	TLO1	TLO1															Prn	Prn	Prn	Prn	Prn	Prn						00/00/2008	00/00/2008	00/00/2008	00/00/2008	00/00/2008	00/03/2012	00/06/2010	00/04/2012				No	No	No	No	No	No	No	No										20/09/2010	00/08/2012				No	No	No	No	No	No	Yes	Yes																													18/12/12	arms ; buttocks ; head ; legs ; lower back ; posterior thigh ; trunk	1005080/archive/1003428/MAARS_2_096-Wed_Dec_11_11:20:53_CET_2013.bmp ; 1005080/archive/1003428/MAARS_2_096-Wed_Dec_11_11:20:59_CET_2013.bmp ; 1005080/archive/1003428/MAARS_2_096-Wed_Dec_11_11:21:04_CET_2013.bmp	3 (severe)	3 (severe)	3 (severe)	9	3 (30%-49%)	27	2.7	2 (moderate)	2 (moderate)	2 (moderate)	6	1 (1%-9%)	6	1.8	2 (moderate)	2 (moderate)	2 (moderate)	6	1 (1%-9%)	6	1.2	3 (severe)	1 (slight)	2 (moderate)	6	1 (1%-9%)	6	2.4	8.1	4 (Red colouration)	4 (Moderate elevation)	4 (Moderate)	12	lower back	Chronic(>1week)					18/12/12	moderate		Drug Allergy	Anti-Hypertensive ; Anti-Hypertensive		Local Corticosteroids ; Local Corticosteroids ; Vitamin D analogs ; Dithranol-minute ; TAR (topical) ; Local Corticosteroids ; Others ; Others			MAARS_2_096_01	04/01/13			MAARS_2_096_02	04/01/13			MAARS_2_096_03	04/01/13			MAARS_2_096_04	04/01/13			MAARS_2_096_05	04/01/13			MAARS_2_096_06	04/01/13			MAARS_2_096_10	04/01/13			MAARS_2_096_11	04/01/13			MAARS_2_096_07	04/01/13			MAARS_2_096_08	04/01/13			MAARS_2_096_09	04/01/13		
MAARS_2_097	07/02/13	KINGS	Barker	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1965	Male	White				1993	2013	No		Unknown 	No	No	No	No		Present	Present	Present	No	Present	Past	No	No	No	No	Unknown 																									Selective serotonin reuptake inhibitors									40									OD									00/00/2008									Yes																		vitamin D analogs	TAR (Topical)	UVB - Ultraviolet B phototherapy																				Prn	Prn - Scalp only	Scalp only									00/00/2009	00/00/1993	00/06/2006									Yes	Yes	No											00/09/2006									Yes	Yes	No																																		07/02/13	arms ; head ; legs ; lower back ; posterior thigh ; trunk		2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	1.2	2 (moderate)	1 (slight)	2 (moderate)	5	1 (1%-9%)	5	1.5	1 (slight)	0 (none)	1 (slight)	2	1 (1%-9%)	2	0.4	2 (moderate)	1 (slight)	2 (moderate)	5	1 (1%-9%)	5	2	5.1	4 (Red colouration)	2 (Slight definite elevation)	4 (Moderate)	10	upper back	Chronic(>1week)					07/02/13	mild			Others		Vitamin D analogs ; TAR (topical) ; Phototherapy			MAARS_2_097_01	07/02/13			MAARS_2_097_02	07/02/13			MAARS_2_097_03	07/02/13			MAARS_2_097_04	07/02/13			MAARS_2_097_05	07/02/13			MAARS_2_097_06	07/02/13			MAARS_2_097_10	07/02/13			MAARS_2_097_11	07/02/13			MAARS_2_097_07	07/02/13			MAARS_2_097_08	07/02/13			MAARS_2_097_09	07/02/13		
MAARS_2_099	15/02/13	KINGS	Barker	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1986	Female	White				1995	2008	No		Unknown 	No	No	No	No		Present	Present	Present	Present	No	Present	No	No	No	No	Unknown 																									Contraceptive Pill	Selective serotonin reuptake inhibitors									10								OD	OD								00/01/2013	00/12/2012								Yes	Yes																	UVB - Ultraviolet B phototherapy	Moderate corticosteroids (topical)																					1 course	Prn										00/06/2008	00/00/2008										No	No										00/09/2008											Yes	No																																			15/02/13	arms ; buttocks ; head ; legs ; lower back ; posterior thigh ; trunk		2 (moderate)	1 (slight)	2 (moderate)	5	2 (10%-29%)	10	1	2 (moderate)	2 (moderate)	2 (moderate)	6	1 (1%-9%)	6	1.8	2 (moderate)	2 (moderate)	1 (slight)	5	2 (10%-29%)	10	2	4 (very severe)	2 (moderate)	3 (severe)	9	2 (10%-29%)	18	7.2	12	2 (Pink colouration)	4 (Moderate elevation)	4 (Moderate)	10	upper back	Chronic(>1week)					15/02/13	moderate-severe	Patient declined full body photos		Other hormones ; Others		Phototherapy ; Local Corticosteroids			MAARS_2_099_01	15/02/13			MAARS_2_099_02	15/02/13			MAARS_2_099_03	15/02/13			MAARS_2_099_04	15/02/13			MAARS_2_099_05	15/02/13			MAARS_2_099_06	15/02/13			MAARS_2_099_10	15/02/13			MAARS_2_099_11	15/02/13			MAARS_2_099_07	15/02/13			MAARS_2_099_08	15/02/13			MAARS_2_099_09	15/02/13		
MAARS_2_103	25/02/13	KINGS	Barker	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1978	Female	White				2000	2002	No		Unknown 	No	No	No	No		Present	Present	Past	Present	Past	Present	No	Past	No	No	Unknown 																									Contraceptive Pill																		OD									00/01/2013									Yes																		TAR (Topical)	vitamin D analogs	Moderate corticosteroids (topical)	Potent corticosteroids (topical)																			Prn	Prn	Prn	Prn								00/00/2000	00/00/2000	00/00/2000	00/00/2000								Yes	Yes	Yes	Yes																			Yes	Yes	Yes	Yes																																	25/02/13	arms ; head ; legs ; posterior thigh ; trunk		2 (moderate)	1 (slight)	2 (moderate)	5	2 (10%-29%)	10	1	2 (moderate)	2 (moderate)	2 (moderate)	6	1 (1%-9%)	6	1.8	1 (slight)	1 (slight)	1 (slight)	3	1 (1%-9%)	3	0.6	2 (moderate)	2 (moderate)	1 (slight)	5	1 (1%-9%)	5	2	5.4	4 (Red colouration)	4 (Moderate elevation)	4 (Moderate)	12	upper back	Chronic(>1week)					25/02/13	mild			Other hormones		TAR (topical) ; Vitamin D analogs ; Local Corticosteroids ; Local Corticosteroids			MAARS_2_103_01	25/02/13			MAARS_2_103_02	25/02/13			MAARS_2_103_03	25/02/13			MAARS_2_103_04	25/02/13			MAARS_2_103_05	25/02/13			MAARS_2_103_06	25/02/13			MAARS_2_103_10	25/02/13			MAARS_2_103_11	25/02/13			MAARS_2_103_07	25/02/13			MAARS_2_103_08	25/02/13			MAARS_2_103_09	25/02/13		
MAARS_3_002	15/09/11	UH	Lauerma	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1941	Male	White	Sister		1005080/archive/1000477/MAARS_3_002-Tue_Feb_19_09:16:18_CET_2013.pjpeg ; 1005080/archive/1000477/MAARS_3_002-Tue_Feb_19_09:16:30_CET_2013.pjpeg ; 1005080/archive/1000477/MAARS_3_002-Tue_Feb_19_09:16:42_CET_2013.pjpeg ; 1005080/archive/1000477/MAARS_3_002-Tue_Feb_19_09:16:55_CET_2013.pjpeg ; 1005080/archive/1000477/MAARS_3_002-Tue_Feb_19_09:17:06_CET_2013.pjpeg ; 1005080/archive/1000477/MAARS_3_002-Tue_Feb_19_09:17:26_CET_2013.pjpeg ; 1005080/archive/1000477/MAARS_3_002-Tue_Feb_19_09:17:37_CET_2013.pjpeg ; 1005080/archive/1000477/MAARS_3_002-Tue_Feb_19_09:17:50_CET_2013.pjpeg	1980	1980	No		No	No	No	No	No		Present	Present	Present	No	Past	Present	No	No	No	No	Present						No																			ACE inhibitors	Diuretics																																			Yes	Yes																	vitamin D analogs	Potent corticosteroids (topical)	UVB - Ultraviolet B phototherapy	SUP - selective ultraviolet phototherapy																					30 times	also in past 2-3 phototerapies										00/11/2008									Yes	Yes	No	No										00/03/2009									Yes	Yes	Yes	Yes								Hypertension															Yes										05/10/11	posterior thigh ;  lower back ;  buttocks ; trunk ; arms ; head ; legs	1005080/archive/1000479/MAARS_3_002-Tue_Feb_19_09:20:37_CET_2013.pjpeg	1 (slight)	1 (slight)	1 (slight)	3	1 (1%-9%)	3	0.3	1 (slight)	2 (moderate)	2 (moderate)	5	1 (1%-9%)	5	1.5	1 (slight)	2 (moderate)	1 (slight)	4	2 (10%-29%)	8	1.6	2 (moderate)	2 (moderate)	1 (slight)	5	2 (10%-29%)	10	4.0	7.4	2 (Pink colouration)	4 (Moderate elevation)	2 (Mild)	8	lower back	Chronic(>1week)				lower back	05/10/11	moderate	frozen biopsy in OCT.		Anti-Hypertensive ; Anti-Hypertensive	Hypertension	Vitamin D analogs ; Local Corticosteroids ; Phototherapy ; Phototherapy			MAARS_3_002_01	05/10/11			MAARS_3_002_02	05/10/11			MAARS_3_002_03	05/10/11			MAARS_3_002_04	05/10/11			MAARS_3_002_05	05/10/11			MAARS_3_002_06	05/10/11											MAARS_3_002_07	05/10/11			MAARS_3_002_08	05/10/11			MAARS_3_002_09	05/10/11		
MAARS_3_003	26/09/11	UH	Lauerma	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1965	Male	White	Mother		1005080/archive/1000480/MAARS_3_003-Tue_Feb_19_09:22:29_CET_2013.pjpeg ; 1005080/archive/1000480/MAARS_3_003-Tue_Feb_19_09:22:40_CET_2013.pjpeg ; 1005080/archive/1000480/MAARS_3_003-Tue_Feb_19_09:22:51_CET_2013.pjpeg ; 1005080/archive/1000480/MAARS_3_003-Tue_Feb_19_09:23:00_CET_2013.pjpeg ; 1005080/archive/1000480/MAARS_3_003-Tue_Feb_19_09:23:11_CET_2013.pjpeg ; 1005080/archive/1000480/MAARS_3_003-Tue_Feb_19_09:23:25_CET_2013.pjpeg	1976	1976	Yes	00/00/1976	Yes	No	No	Past	Past	5	Present	Present	Present	Present	No	Past	No	No	Present	No	No																									Magnesium	Acetylsalicylic acid	Proton pump inhibitors	Angiotensin-receptor blocker and diuretic	Hydroxyzine						50												needed														Yes	Yes	No	Yes	Yes														vitamin D analogs	Potent corticosteroids (topical)	UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy	PUVA - psoralen + UVA (ultraviolet A-phototherapy)	PUVA - psoralen + UVA (ultraviolet A-phototherapy)	SUP - selective ultraviolet phototherapy	Dithranol-minute															22 times.	22 times	22 times	23 times								00/00/1996	00/07/2006	00/03/2007	00/10/2007	00/00/1981	00/00/1982	00/00/1980	00/00/1980		Yes	Yes	No	No	No	No	No	No	No							00/06/2007							Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes			Hypertension	Alopecia														Yes	Yes									05/10/11	posterior thigh ;  lower back ;  buttocks ; trunk ; legs ; arms ; head	1005080/archive/1000004/MAARS_3_003-Wed_Jan_23_13:43:52_CET_2013.pjpeg	0 (none)	0 (none)	0 (none)	0	0 (0%)	0	0	3 (severe)	2 (moderate)	1 (slight)	6	3 (30%-49%)	18	5.4	2 (moderate)	2 (moderate)	1 (slight)	5	3 (30%-49%)	15	3.0	3 (severe)	2 (moderate)	1 (slight)	6	2 (10%-29%)	12	4.8	13.2	6 (Very red colouration)	4 (Moderate elevation)	2 (Mild)	12	lower back	Chronic(>1week)				lower back	05/10/11	moderate-severe	frozen biopsy in OCT		Others ; Anti-Inflammatory(non steroid) ; Others ; Anti-Hypertensive ; Others	Hypertension ; Others	Vitamin D analogs ; Local Corticosteroids ; Phototherapy ; Phototherapy ; Phototherapy ; Phototherapy ; Photochemotherapy ; Photochemotherapy ; Phototherapy ; Dithranol-minute			MAARS_3_003_01	05/10/11			MAARS_3_003_02	05/10/11			MAARS_3_003_03	05/10/11			MAARS_3_003_04	05/10/11			MAARS_3_003_05	05/10/11			MAARS_3_003_06	05/10/11											MAARS_3_003_07	05/10/11			MAARS_3_003_08	05/10/11			MAARS_3_003_09	05/10/11		
MAARS_3_005	28/09/11	UH	Lauerma	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1983	Male	White	Father	walnut	1005080/archive/1000483/MAARS_3_005-Tue_Feb_19_09:27:47_CET_2013.pjpeg ; 1005080/archive/1000483/MAARS_3_005-Tue_Feb_19_09:27:59_CET_2013.pjpeg ; 1005080/archive/1000483/MAARS_3_005-Tue_Feb_19_09:28:10_CET_2013.pjpeg ; 1005080/archive/1000483/MAARS_3_005-Tue_Feb_19_09:28:19_CET_2013.pjpeg ; 1005080/archive/1000483/MAARS_3_005-Tue_Feb_19_09:28:31_CET_2013.pjpeg ; 1005080/archive/1000483/MAARS_3_005-Tue_Feb_19_09:28:45_CET_2013.pjpeg	2005	2005	No		No	No	No	Past	No		Present	Present	Present	No	Present	Present	No	No	Present	No	Present																																																																															vitamin D analogs	Potent corticosteroids (topical)	UVB - Ultraviolet B phototherapy																						26 times											00/10/2010									Yes	Yes	No											00/12/2010									Yes	Yes	Yes									Liver function failure																									11/10/11	posterior thigh ;  lower back ;  buttocks ; trunk ; arms ; head ; legs	1005080/archive/1000378/MAARS_3_005-Mon_Feb_18_09:12:58_CET_2013.pjpeg	3 (severe)	2 (moderate)	2 (moderate)	7	3 (30%-49%)	21	2.1	2 (moderate)	3 (severe)	2 (moderate)	7	2 (10%-29%)	14	4.2	2 (moderate)	3 (severe)	2 (moderate)	7	2 (10%-29%)	14	2.8	2 (moderate)	3 (severe)	2 (moderate)	7	2 (10%-29%)	14	5.6	14.7	4 (Red colouration)	6 (Marked elevation)	4 (Moderate)	14	lower back	Chronic(>1week)				lower back	11/10/11	moderate	frozen biopsy in OCT	Food		Others	Vitamin D analogs ; Local Corticosteroids ; Phototherapy			MAARS_3_005_01	11/10/11			MAARS_3_005_02	11/10/11			MAARS_3_005_03	11/10/11			MAARS_3_005_04	11/10/11			MAARS_3_005_05	11/10/11			MAARS_3_005_06	11/10/11											MAARS_3_005_07	11/10/11			MAARS_3_005_08	11/10/11			MAARS_3_005_09	11/10/11		
MAARS_3_006	04/10/11	UH	Lauerma	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1965	Male	White			1005080/archive/1000484/MAARS_3_006-Tue_Feb_19_09:30:11_CET_2013.pjpeg ; 1005080/archive/1000484/MAARS_3_006-Tue_Feb_19_09:30:22_CET_2013.pjpeg ; 1005080/archive/1000484/MAARS_3_006-Tue_Feb_19_09:30:33_CET_2013.pjpeg ; 1005080/archive/1000484/MAARS_3_006-Tue_Feb_19_09:30:46_CET_2013.pjpeg	1995	1995	No		Yes	Present	Past	Past	No		Present	No	Present	Present	No	Present	No	No	No	No	Present																									Hydroxyzine	Tramadol																																			Yes	Yes																	Salazopyrin	Methotrexate	UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy	vitamin D analogs	Potent corticosteroids (topical)																											00/00/2000	00/04/2003	00/01/2009	00/01/2010	00/01/2011							No	No	No	No	No	Yes	Yes						00/00/2007	00/04/2009	00/04/2010	00/04/2011							No	Yes	Yes	Yes	Yes	No	No																														19/10/11	posterior thigh ;  buttocks ; legs ; head	1005080/archive/1000384/MAARS_3_006-Mon_Feb_18_09:53:04_CET_2013.pjpeg	3 (severe)	2 (moderate)	2 (moderate)	7	2 (10%-29%)	14	1.4	0 (none)	0 (none)	0 (none)	0	0 (0%)	0	0	3 (severe)	3 (severe)	3 (severe)	9	2 (10%-29%)	18	3.6	3 (severe)	2 (moderate)	3 (severe)	9	2 (10%-29%)	18	7.2	12.2	6 (Very red colouration)	6 (Marked elevation)	4 (Moderate)	16	buttocks	Chronic(>1week)				buttocks	19/10/11	moderate	frozen biobsy in OCT		Others ; Others		Others ; Methotrexate ; Phototherapy ; Phototherapy ; Phototherapy ; Vitamin D analogs ; Local Corticosteroids			MAARS_3_006_01	19/10/11	Yes	"sequencing result (Karolinska): too few reads - 669"	MAARS_3_006_02	19/10/11			MAARS_3_006_03	19/10/11			MAARS_3_006_04	19/10/11			MAARS_3_006_05	19/10/11			MAARS_3_006_06	19/10/11											MAARS_3_006_07	19/10/11			MAARS_3_006_08	19/10/11			MAARS_3_006_09	19/10/11		
MAARS_3_008	07/10/11	UH	Lauerma	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1955	Male	White	Father ; Sister		1005080/archive/1000485/MAARS_3_008-Tue_Feb_19_09:33:21_CET_2013.pjpeg ; 1005080/archive/1000485/MAARS_3_008-Tue_Feb_19_09:33:34_CET_2013.pjpeg ; 1005080/archive/1000485/MAARS_3_008-Tue_Feb_19_09:33:52_CET_2013.pjpeg ; 1005080/archive/1000485/MAARS_3_008-Tue_Feb_19_09:34:06_CET_2013.pjpeg	1986	1986	No		No	No	No	No	No		Present	Present	Present	No	No	No	No	Present	Present	No	Present																									ACE inhibitors	Beta-blockers																																			Yes	Yes																	vitamin D analogs	Potent corticosteroids (topical)	Very potent corticosteroids (topical)	SUP - selective ultraviolet phototherapy	UVB - Ultraviolet B phototherapy	PUVA - psoralen + UVA (ultraviolet A-phototherapy)	UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy																													00/00/1986	00/00/2000	00/00/2002	00/00/2006	00/00/2008				Yes	Yes	Yes	No	No	No	No	No															Yes	Yes	Yes	No	Yes	Yes	Yes	Yes				Hypertension															Yes										19/10/11	posterior thigh ;  lower back ;  buttocks ; legs ; arms	1005080/archive/1000386/MAARS_3_008-Mon_Feb_18_09:59:16_CET_2013.pjpeg	0 (none)	0 (none)	0 (none)	0	0 (0%)	0	0	2 (moderate)	2 (moderate)	1 (slight)	5	2 (10%-29%)	10	3.0	2 (moderate)	2 (moderate)	1 (slight)	5	2 (10%-29%)	10	2.0	2 (moderate)	2 (moderate)	1 (slight)	5	4 (50%-69%)	20	8.0	13	3	3	2 (Mild)	8	buttocks	Chronic(>1week)				buttocks	19/10/11	moderate-severe	frozen biobsy in OCT		Anti-Hypertensive ; Anti-Hypertensive	Hypertension	Vitamin D analogs ; Local Corticosteroids ; Local Corticosteroids ; Phototherapy ; Phototherapy ; Photochemotherapy ; Phototherapy ; Phototherapy			MAARS_3_008_01	19/10/11			MAARS_3_008_02	19/10/11			MAARS_3_008_03	19/10/11			MAARS_3_008_04	19/10/11			MAARS_3_008_05	19/10/11			MAARS_3_008_06	19/10/11											MAARS_3_008_07	19/10/11			MAARS_3_008_08	19/10/11			MAARS_3_008_09	19/10/11		
MAARS_3_010	20/10/11	UH	Lauerma	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1946	Male	White			1005080/archive/1000490/MAARS_3_010-Tue_Feb_19_09:46:04_CET_2013.pjpeg ; 1005080/archive/1000490/MAARS_3_010-Tue_Feb_19_09:46:16_CET_2013.pjpeg ; 1005080/archive/1000490/MAARS_3_010-Tue_Feb_19_09:46:28_CET_2013.pjpeg ; 1005080/archive/1000490/MAARS_3_010-Tue_Feb_19_09:46:40_CET_2013.pjpeg ; 1005080/archive/1000490/MAARS_3_010-Tue_Feb_19_09:46:51_CET_2013.pjpeg	1990	1990	No		No	No	No	No	No		Present	Present	Past	No	No	Present	No	Present	Present	No	No																Prostate			Yes			27/03/2006			Statins		Magnesium																																		Yes	Yes	Yes																vitamin D analogs	Potent corticosteroids (topical)	UVB - Ultraviolet B phototherapy	PUVA - psoralen + UVA (ultraviolet A-phototherapy)	UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy	Potent corticosteroids (topical)																	2 times										00/00/1999	00/00/1998	00/00/2006	00/00/2008	00/00/2009	00/02/2010				Yes	Yes	No	No	No	No	No	No											00/04/2010				Yes	Yes	Yes		Yes	Yes	Yes	Yes				Hyperlipidemia	Gout														Yes	Yes									30/10/11	posterior thigh ;  lower back ;  buttocks ; head ; arms ; legs ; trunk	1005080/archive/1000391/MAARS_3_010-Mon_Feb_18_10:06:50_CET_2013.pjpeg	2 (moderate)	1 (slight)	2 (moderate)	5	1 (1%-9%)	5	0.5	3 (severe)	2 (moderate)	1 (slight)	6	2 (10%-29%)	12	3.6	2 (moderate)	1 (slight)	1 (slight)	4	1 (1%-9%)	4	0.8	3 (severe)	2 (moderate)	2 (moderate)	7	2 (10%-29%)	14	5.6	10.5	5	5	4 (Moderate)	14	buttocks	Chronic(>1week)					30/10/11	moderate	frozen biopsy in OCT		Statins ; Others	Hyperlipidemia ; Others	Vitamin D analogs ; Local Corticosteroids ; Phototherapy ; Photochemotherapy ; Phototherapy ; Phototherapy ; Phototherapy ; Phototherapy ; Local Corticosteroids			MAARS_3_010_01	30/10/11			MAARS_3_010_02	31/10/11			MAARS_3_010_03	31/10/11			MAARS_3_010_04	31/10/11			MAARS_3_010_05	31/10/11			MAARS_3_010_06	31/10/11											MAARS_3_010_07	31/10/11			MAARS_3_010_08	31/10/11			MAARS_3_010_09	31/10/11		
MAARS_3_012	02/11/11	UH	Pajunen	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1942	Female	White			1005080/archive/1000491/MAARS_3_012-Tue_Feb_19_09:50:36_CET_2013.pjpeg ; 1005080/archive/1000491/MAARS_3_012-Tue_Feb_19_09:50:48_CET_2013.pjpeg ; 1005080/archive/1000491/MAARS_3_012-Tue_Feb_19_09:51:00_CET_2013.pjpeg ; 1005080/archive/1000491/MAARS_3_012-Tue_Feb_19_09:51:11_CET_2013.pjpeg ; 1005080/archive/1000491/MAARS_3_012-Tue_Feb_19_09:51:24_CET_2013.pjpeg	2000	2007	No		Yes	No	No	No	No		Present	Present	Present	Present	No	Present	Present	Present	No	No	Present																									Thyroid hormones																																				Yes																		vitamin D analogs	Potent corticosteroids (topical)	UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy																		17 times	18 times	15-20 times	15-20 times	22 times							00/07/2007	00/06/2008	00/09/2009	00/03/2010	00/11/2010					Yes	Yes	No	No	No	No	No																Yes	Yes	Yes	Yes	Yes	Yes	No					Thyroid dysfunction										01/01/2000					Yes										16/11/11	posterior thigh ;  lower back ;  buttocks ; arms ; legs ; head ; trunk	1005080/archive/1000393/MAARS_3_012-Mon_Feb_18_10:19:37_CET_2013.pjpeg	1 (slight)	1 (slight)	1 (slight)	3	3 (30%-49%)	9	0.9	2 (moderate)	3 (severe)	2 (moderate)	7	2 (10%-29%)	14	4.2	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	2.4	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	4.8	12.3	4 (Red colouration)	6 (Marked elevation)	4 (Moderate)	14	lower back	Chronic(>1week)				lower back	16/11/11	moderate	frozen biopsy in OCT		Thyroid hormones	Thyroid dysfunction	Vitamin D analogs ; Local Corticosteroids ; Phototherapy ; Phototherapy ; Phototherapy ; Phototherapy ; Phototherapy			MAARS_3_012_01	19/10/11			MAARS_3_012_02	19/10/11			MAARS_3_012_03	19/10/11			MAARS_3_012_04	19/10/11			MAARS_3_012_05	19/10/11			MAARS_3_012_06	19/10/11											MAARS_3_012_07	19/10/11			MAARS_3_012_08	19/10/11			MAARS_3_012_09	19/10/11		
MAARS_3_013	04/11/11	UH	Pajunen	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1993	Female	White			1005080/archive/1000492/MAARS_3_013-Tue_Feb_19_09:52:54_CET_2013.pjpeg ; 1005080/archive/1000492/MAARS_3_013-Tue_Feb_19_09:53:05_CET_2013.pjpeg ; 1005080/archive/1000492/MAARS_3_013-Tue_Feb_19_09:53:17_CET_2013.pjpeg ; 1005080/archive/1000492/MAARS_3_013-Tue_Feb_19_09:53:28_CET_2013.pjpeg ; 1005080/archive/1000492/MAARS_3_013-Tue_Feb_19_09:53:44_CET_2013.pjpeg	2010	2010	No		Yes	No	No	Present	No		Present	Present	Present	Present	Present	Present	No	Present	Present	No	Present																									Drospirenone and estrogen																																				Yes																		vitamin D analogs	Potent corticosteroids (topical)	Very potent corticosteroids (topical)																																										Yes	Yes	Yes																				Yes	Yes	Yes																																		16/11/11	posterior thigh ;  lower back ;  buttocks ; legs ; arms ; trunk ; head	1005080/archive/1000395/MAARS_3_013-Mon_Feb_18_10:25:52_CET_2013.pjpeg	2 (moderate)	2 (moderate)	2 (moderate)	6	3 (30%-49%)	18	1.8	2 (moderate)	1 (slight)	2 (moderate)	5	3 (30%-49%)	15	4.5	2 (moderate)	2 (moderate)	2 (moderate)	6	3 (30%-49%)	18	3.6	3 (severe)	2 (moderate)	2 (moderate)	7	2 (10%-29%)	14	5.6	15.5	6 (Very red colouration)	4 (Moderate elevation)	4 (Moderate)	14	buttocks	Chronic(>1week)				buttocks	16/11/11	moderate-severe	frozen biopsy in OCT		Other hormones		Vitamin D analogs ; Local Corticosteroids ; Local Corticosteroids			MAARS_3_013_01	19/10/11			MAARS_3_013_02	19/10/11			MAARS_3_013_03	19/10/11			MAARS_3_013_04	19/10/11			MAARS_3_013_05	19/10/11			MAARS_3_013_06	19/10/11											MAARS_3_013_07	19/10/11			MAARS_3_013_08	19/10/11			MAARS_3_013_09	19/10/11		
MAARS_3_014	04/11/11	UH	Pajunen	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1989	Male	White		Grasses ; ragweed	1005080/archive/1000493/MAARS_3_014-Tue_Feb_19_09:55:18_CET_2013.pjpeg ; 1005080/archive/1000493/MAARS_3_014-Tue_Feb_19_09:55:33_CET_2013.pjpeg ; 1005080/archive/1000493/MAARS_3_014-Tue_Feb_19_09:55:44_CET_2013.pjpeg ; 1005080/archive/1000493/MAARS_3_014-Tue_Feb_19_09:55:57_CET_2013.pjpeg ; 1005080/archive/1000493/MAARS_3_014-Tue_Feb_19_09:56:14_CET_2013.pjpeg ; 1005080/archive/1000493/MAARS_3_014-Tue_Feb_19_09:56:26_CET_2013.pjpeg	2004	2004	No		Yes	Past	Past	No	No		Present	Present	Present	Present	No	Present	No	Present	Present	No	Present																																																																															vitamin D analogs	Potent corticosteroids (topical)	Neotigason	UVB - Ultraviolet B phototherapy																					25 mg /day	21 times										00/07/2009	00/04/2011								Yes	Yes	No	No										00/10/2009									No	Yes	Yes	Yes								psoriasis artritis															No										21/11/11	posterior thigh ;  lower back ; head ; legs ; trunk	1005080/archive/1000397/MAARS_3_014-Mon_Feb_18_10:33:49_CET_2013.pjpeg	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	1.2	3 (severe)	3 (severe)	3 (severe)	9	2 (10%-29%)	18	5.4	3 (severe)	3 (severe)	2 (moderate)	8	3 (30%-49%)	24	4.8	2 (moderate)	2 (moderate)	2 (moderate)	6	3 (30%-49%)	18	7.2	18.6	4 (Red colouration)	6 (Marked elevation)	6 (Severe)	16	lower back	Chronic(>1week)				lower back	21/11/11	moderate-severe	frozen biopsy in OCT	Pollen		Others	Vitamin D analogs ; Local Corticosteroids ; Retinoids ; Phototherapy	Yes	"psoriasis artritis has been added to exclusion criteria for any subject (Helsinki visit, 07/01/14)"	MAARS_3_014_01	21/11/11			MAARS_3_014_02	21/11/11			MAARS_3_014_03	21/11/11			MAARS_3_014_04	21/11/11			MAARS_3_014_05	21/11/11			MAARS_3_014_06	21/11/11											MAARS_3_014_07	21/11/11			MAARS_3_014_08	21/11/11			MAARS_3_014_09	21/11/11		
MAARS_3_015	09/11/11	UH	Pajunen	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1970	Male	White			1005080/archive/1000494/MAARS_3_015-Tue_Feb_19_10:00:00_CET_2013.pjpeg ; 1005080/archive/1000494/MAARS_3_015-Tue_Feb_19_10:00:13_CET_2013.pjpeg ; 1005080/archive/1000494/MAARS_3_015-Tue_Feb_19_10:00:27_CET_2013.pjpeg ; 1005080/archive/1000494/MAARS_3_015-Tue_Feb_19_10:00:42_CET_2013.pjpeg ; 1005080/archive/1000494/MAARS_3_015-Tue_Feb_19_10:00:56_CET_2013.pjpeg	1990	1990	No		No	Present	No	No	No		Present	Present	Present	Present	No	Past	No	Present	No	No	Present																																																																															vitamin D analogs	Potent corticosteroids (topical)	UVB - Ultraviolet B phototherapy																						lamp at home -long treatments for 10 years											00/00/2000									Yes	Yes	No											00/11/2011									Yes	Yes	Yes																																		21/11/11	posterior thigh ;  lower back ;  buttocks ; arms ; trunk ; legs	1005080/archive/1000399/MAARS_3_015-Mon_Feb_18_10:38:19_CET_2013.pjpeg	0 (none)	0 (none)	0 (none)	0	0 (0%)	0	0	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	3.6	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	2.4	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	4.8	10.8	4 (Red colouration)	4 (Moderate elevation)	4 (Moderate)	12	lower back	Chronic(>1week)				lower back	21/11/11	moderate	frozen biopsy in OCT				Vitamin D analogs ; Local Corticosteroids ; Phototherapy			MAARS_3_015_01	21/11/11			MAARS_3_015_02	21/11/11			MAARS_3_015_03	21/11/11			MAARS_3_015_04	21/11/11			MAARS_3_015_05	21/11/11			MAARS_3_015_06	21/11/11											MAARS_3_015_07	21/11/11			MAARS_3_015_08	21/11/11			MAARS_3_015_09	21/11/11		
MAARS_3_017	04/11/11	UH	Pajunen	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1940	Male	White			1005080/archive/1000495/MAARS_3_017-Tue_Feb_19_10:02:42_CET_2013.pjpeg ; 1005080/archive/1000495/MAARS_3_017-Tue_Feb_19_10:02:58_CET_2013.pjpeg ; 1005080/archive/1000495/MAARS_3_017-Tue_Feb_19_10:03:14_CET_2013.pjpeg ; 1005080/archive/1000495/MAARS_3_017-Tue_Feb_19_10:03:25_CET_2013.pjpeg ; 1005080/archive/1000495/MAARS_3_017-Tue_Feb_19_10:03:37_CET_2013.pjpeg ; 1005080/archive/1000495/MAARS_3_017-Tue_Feb_19_10:03:49_CET_2013.pjpeg ; 1005080/archive/1000495/MAARS_3_017-Tue_Feb_19_10:04:01_CET_2013.pjpeg	1990	2007	No		Yes	No	No	No	No		Present	Present	Present	No	No	Past	Past	Past	No	No	Present																									Diuretics	ACE inhibitors	Beta-blockers	Metformin	DPP-4 inhibitors	Proton pump inhibitors	Beta-2-agonists	Glucocorticoids	Allopurinol-gout medicin																		if needed										Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes										vitamin D analogs	Potent corticosteroids (topical)																																											Yes	Yes																					Yes	Yes										Asthma	Cardiomyopathy	Diabetes (non-insulin)	Hypertension	Gout											Yes	Yes	Yes	Yes	Yes						23/11/11	posterior thigh ;  buttocks ; legs ; head	1005080/archive/1000401/MAARS_3_017-Mon_Feb_18_10:43:47_CET_2013.pjpeg	2 (moderate)	1 (slight)	1 (slight)	4	1 (1%-9%)	4	0.4	0 (none)	0 (none)	0 (none)	0	0 (0%)	0	0	2 (moderate)	3 (severe)	2 (moderate)	7	2 (10%-29%)	14	2.8	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	4.8	8	2 (Pink colouration)	3	4 (Moderate)	9	buttocks	Chronic(>1week)				buttocks	23/11/11	moderate	frozen biopsy in OCT		Anti-Hypertensive ; Anti-Hypertensive ; Anti-Hypertensive ; Others ; Others ; Others ; Others ; Others ; Others	Asthma ; Others ; Diabetes (non-insulin) ; Hypertension ; Others	Vitamin D analogs ; Local Corticosteroids	Yes	"excluded by Antti and Ioannis (21/01/14): glucocorticoids inhalators is relative to immuosuppressive systemic treatment wich is an exclusion criteria."	MAARS_3_017_01	23/11/11			MAARS_3_017_02	23/11/11			MAARS_3_017_03	23/11/11			MAARS_3_017_04	23/11/11			MAARS_3_017_05	23/11/11			MAARS_3_017_06	23/11/11											MAARS_3_017_07	23/11/11			MAARS_3_017_08	23/11/11			MAARS_3_017_09	23/11/11		
MAARS_3_019	13/01/12	UH	Pajunen	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1956	Male	White			1005080/archive/1000496/MAARS_3_019-Tue_Feb_19_10:05:40_CET_2013.pjpeg ; 1005080/archive/1000496/MAARS_3_019-Tue_Feb_19_10:05:52_CET_2013.pjpeg ; 1005080/archive/1000496/MAARS_3_019-Tue_Feb_19_10:06:06_CET_2013.pjpeg ; 1005080/archive/1000496/MAARS_3_019-Tue_Feb_19_10:06:18_CET_2013.pjpeg	1995	1995	Yes	00/00/1995	Yes	No	No	No	No		Present	Present	Present	No	Present	Present	Present	Present	Present	No	Present																									Anticholinergics	Long-acting beta-2-agonist and glucocorticoid	ACE inhibitors	Beta-2-agonists																																	Yes	Yes	Yes	Yes															vitamin D analogs	Potent corticosteroids (topical)	PUVA - psoralen + UVA (ultraviolet A-phototherapy)	UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy																12 times	15 times	30 times	15 times	15 times	15 times	20 times					00/00/1997	00/02/2005	00/01/2006	00/10/2006	00/12/2009	00/06/2010	00/02/2011			Yes	Yes	No	No	No	No	No	No	No						00/03/2005	00/03/2006	00/12/2006	00/02/2010					Yes	Yes		Yes	No	Yes	Yes	Yes	Yes			COPD	Hypertension	fatty liver					caused by alcohol								Yes	Yes	Yes								30/01/12	posterior thigh ;  lower back ;  buttocks ; head ; arms ; trunk ; legs	1005080/archive/1000405/MAARS_3_019-Mon_Feb_18_10:57:35_CET_2013.pjpeg	1 (slight)	1 (slight)	2 (moderate)	4	2 (10%-29%)	8	0.8	2 (moderate)	1 (slight)	2 (moderate)	5	4 (50%-69%)	20	6	2 (moderate)	2 (moderate)	2 (moderate)	6	3 (30%-49%)	18	3.6	3 (severe)	2 (moderate)	2 (moderate)	7	4 (50%-69%)	28	11.2	21.6	2 (Pink colouration)	2 (Slight definite elevation)	3 (Mild-Moderate)	7	buttocks	Chronic(>1week)				buttocks	30/01/12	moderate-severe	frozen biopsy in OCT		Others ; Others ; Anti-Hypertensive ; Others	Others ; Hypertension ; Others	Vitamin D analogs ; Local Corticosteroids ; Photochemotherapy ; Phototherapy ; Phototherapy ; Phototherapy ; Phototherapy ; Phototherapy ; Phototherapy			MAARS_3_019_01	30/01/12			MAARS_3_019_02	30/01/12			MAARS_3_019_03	30/01/12			MAARS_3_019_04	30/01/12			MAARS_3_019_05	30/01/12			MAARS_3_019_06	30/01/12											MAARS_3_019_07	30/01/12			MAARS_3_019_08	30/01/12			MAARS_3_019_09	30/01/12		
MAARS_3_020	24/01/12	UH	Lauerma	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1948	Female	White			1005080/archive/1000497/MAARS_3_020-Tue_Feb_19_10:07:47_CET_2013.pjpeg ; 1005080/archive/1000497/MAARS_3_020-Tue_Feb_19_10:07:59_CET_2013.pjpeg ; 1005080/archive/1000497/MAARS_3_020-Tue_Feb_19_10:08:13_CET_2013.pjpeg ; 1005080/archive/1000497/MAARS_3_020-Tue_Feb_19_10:08:26_CET_2013.pjpeg ; 1005080/archive/1000497/MAARS_3_020-Tue_Feb_19_10:08:40_CET_2013.pjpeg	2009	2009	Yes	00/04/2009	No	No	No	No	No		Present	Present	Present	Present	No	Present	No	Present	Past	No	Present																									Angiotensin-receptor blocker and diuretic	Beta-blockers	Acetylsalicylic acid	Ibuprofen	Allopurinol-gout medicin																																Yes	Yes	Yes	Yes	Yes														vitamin D analogs	Potent corticosteroids (topical)	Mild corticosteroids (topical)	UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy																					24 times	20 times.										00/11/2009	00/01/2011							Yes	Yes	No	No	No										00/02/2010	00/03/2011							Yes	Yes	Yes	Yes	Yes							Hypertension	Diabetes (non-insulin)	Gout	Arthrosis												Yes	Yes	Yes	Yes							06/02/12	posterior thigh ;  buttocks ; arms ; head	1005080/archive/1000408/MAARS_3_020-Mon_Feb_18_11:04:04_CET_2013.pjpeg	2 (moderate)	2 (moderate)	2 (moderate)	6	1 (1%-9%)	6	0.6	1 (slight)	1 (slight)	1 (slight)	3	1 (1%-9%)	3	0.9	2 (moderate)	3 (severe)	3 (severe)	8	2 (10%-29%)	16	3.2	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	4.8	9.5	4 (Red colouration)	4 (Moderate elevation)	4 (Moderate)	12	buttocks	Chronic(>1week)				buttocks	06/02/12	moderate	frozen biopsy in OCT		Anti-Hypertensive ; Anti-Hypertensive ; Anti-Inflammatory(non steroid) ; Anti-Inflammatory(non steroid) ; Others	Hypertension ; Diabetes (non-insulin) ; Others ; Others	Vitamin D analogs ; Local Corticosteroids ; Local Corticosteroids ; Phototherapy ; Phototherapy			MAARS_3_020_01	06/02/12			MAARS_3_020_02	06/02/12			MAARS_3_020_03	06/02/12			MAARS_3_020_04	06/02/12			MAARS_3_020_05	06/02/12			MAARS_3_020_06	06/02/12											MAARS_3_020_07	06/02/12			MAARS_3_020_08	06/02/12			MAARS_3_020_09	06/02/12		
MAARS_3_021	12/01/12	UH	Pajunen	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1948	Male	White		clindamycin	1005080/archive/1000498/MAARS_3_021-Tue_Feb_19_10:10:10_CET_2013.pjpeg ; 1005080/archive/1000498/MAARS_3_021-Tue_Feb_19_10:10:26_CET_2013.pjpeg ; 1005080/archive/1000498/MAARS_3_021-Tue_Feb_19_10:10:39_CET_2013.pjpeg ; 1005080/archive/1000498/MAARS_3_021-Tue_Feb_19_10:10:57_CET_2013.pjpeg ; 1005080/archive/1000498/MAARS_3_021-Tue_Feb_19_10:11:12_CET_2013.pjpeg ; 1005080/archive/1000498/MAARS_3_021-Tue_Feb_19_10:11:26_CET_2013.pjpeg	2005	2005	Yes	00/02/2005	No	Past	Past	No	No		Present	Present	Present	No	Present	Present	No	No	No	No	Present																									Sulfonylureas	Metformin	ACE inhibitors																																		Yes	Yes	Yes																vitamin D analogs	Potent corticosteroids (topical)	UVB - Ultraviolet B phototherapy	Methotrexate																					20 times	12.5 mg/w										00/01/2011	00/01/2006								Yes	Yes	No	No										00/03/2011	00/00/2007								Yes	Yes	Yes									Diabetes (non-insulin)	Hypertension														Yes	Yes									15/02/12	 buttocks ; legs ; head	1005080/archive/1000410/MAARS_3_021-Mon_Feb_18_11:14:39_CET_2013.pjpeg	1 (slight)	1 (slight)	1 (slight)	3	1 (1%-9%)	3	0.3	0 (none)	0 (none)	0 (none)	0	0 (0%)	0	0	1 (slight)	1 (slight)	1 (slight)	3	1 (1%-9%)	3	0.6	2 (moderate)	2 (moderate)	1 (slight)	5	2 (10%-29%)	10	4	4.9	2 (Pink colouration)	2 (Slight definite elevation)	2 (Mild)	6	buttocks	Chronic(>1week)				buttocks	15/02/12	mild	Biopsies, as well as non-lesiosta lesiosta that one piece of OCT for frozen and one live without the oct's.Non lesion OCT-piece unsterile, hit the assisting nurse glove.	Drug Allergy	Others ; Others ; Anti-Hypertensive	Diabetes (non-insulin) ; Hypertension	Vitamin D analogs ; Local Corticosteroids ; Phototherapy ; Methotrexate			MAARS_3_021_01	15/02/12			MAARS_3_021_02	15/02/12			MAARS_3_021_03	15/02/12			MAARS_3_021_04	15/02/12			MAARS_3_021_05	15/02/12			MAARS_3_021_06	15/02/12											MAARS_3_021_07	15/02/12			MAARS_3_021_08	15/02/12			MAARS_3_021_09	15/02/12		
MAARS_3_028	27/10/11	UH	Pajunen	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1976	Male	White			1005080/archive/1000499/MAARS_3_028-Tue_Feb_19_10:13:04_CET_2013.pjpeg ; 1005080/archive/1000499/MAARS_3_028-Tue_Feb_19_10:13:17_CET_2013.pjpeg ; 1005080/archive/1000499/MAARS_3_028-Tue_Feb_19_10:13:29_CET_2013.pjpeg ; 1005080/archive/1000499/MAARS_3_028-Tue_Feb_19_10:13:43_CET_2013.pjpeg ; 1005080/archive/1000499/MAARS_3_028-Tue_Feb_19_10:13:56_CET_2013.pjpeg	2006	2007	No		Yes	No	No	Present	No		Present	Present	Present	Present	No	Present	No	Present	Present	No	Present																									Benzodiazepines	Thyroid hormones																	occasionally																		Yes	Yes																	vitamin D analogs	Potent corticosteroids (topical)	UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy																																00/04/2010	00/01/2011								Yes	Yes	No	No										00/06/2010	00/03/2011								Yes	Yes	Yes									Thyroid dysfunction	Obesity	Keratoconus													Yes	Yes	Yes								27/02/12	posterior thigh ;  lower back ;  buttocks ; head ; trunk ; legs ; arms	1005080/archive/1000501/MAARS_3_028-Tue_Feb_19_10:17:08_CET_2013.pjpeg	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	1.2	3 (severe)	2 (moderate)	2 (moderate)	7	2 (10%-29%)	14	4.2	3 (severe)	3 (severe)	2 (moderate)	8	2 (10%-29%)	16	3.2	3 (severe)	3 (severe)	3 (severe)	9	3 (30%-49%)	27	10.8	19.4	5	6 (Marked elevation)	6 (Severe)	17	buttocks	Chronic(>1week)				buttocks	27/02/12	moderate			Others ; Thyroid hormones	Thyroid dysfunction ; Others ; Others	Vitamin D analogs ; Local Corticosteroids ; Phototherapy ; Phototherapy			MAARS_3_028_01	27/02/12			MAARS_3_028_02	27/02/12			MAARS_3_028_03	27/02/12			MAARS_3_028_04	27/02/12			MAARS_3_028_05	27/02/12			MAARS_3_028_06	27/02/12											MAARS_3_028_07	27/02/12			MAARS_3_028_08	27/02/12			MAARS_3_028_09	27/02/12		
MAARS_3_039	13/03/12	UH	Pajunen	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1953	Male	White			1005080/archive/1000502/MAARS_3_039-Tue_Feb_19_11:08:39_CET_2013.pjpeg ; 1005080/archive/1000502/MAARS_3_039-Tue_Feb_19_11:08:57_CET_2013.pjpeg ; 1005080/archive/1000502/MAARS_3_039-Tue_Feb_19_11:09:13_CET_2013.pjpeg ; 1005080/archive/1000502/MAARS_3_039-Tue_Feb_19_11:09:33_CET_2013.pjpeg ; 1005080/archive/1000502/MAARS_3_039-Tue_Feb_19_11:09:50_CET_2013.pjpeg	2002	2012	No		No	Present	No	No	No		Present	Present	Present	No	No	No	No	No	No	No	Present																																																																															vitamin D analogs	Potent corticosteroids (topical)																																											Yes	Yes																					Yes	Yes																																			26/03/12	posterior thigh ;  buttocks ; head ; arms	1005080/archive/1000414/MAARS_3_039-Mon_Feb_18_11:31:45_CET_2013.pjpeg	0 (none)	0 (none)	1 (slight)	1	3 (30%-49%)	3	0.3	0 (none)	0 (none)	0 (none)	0	0 (0%)	0	0	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	2.4	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	4.8	7.5	4 (Red colouration)	4 (Moderate elevation)	5 (Moderate-Severe)	13	buttocks	Chronic(>1week)				buttocks	26/03/12	moderate	patient was in shower 13h prior to sampling| |				Vitamin D analogs ; Local Corticosteroids			MAARS_3_039_01	26/03/12			MAARS_3_039_02	26/03/12			MAARS_3_039_03	26/03/12			MAARS_3_039_04	26/03/12			MAARS_3_039_05	26/03/12			MAARS_3_039_06	26/03/12											MAARS_3_039_07	26/03/12			MAARS_3_039_08	26/03/12			MAARS_3_039_09	26/03/12		
MAARS_3_045	12/04/12	UH	Pajunen	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1969	Male	White	Father		1005080/archive/1000503/MAARS_3_045-Tue_Feb_19_11:11:42_CET_2013.pjpeg ; 1005080/archive/1000503/MAARS_3_045-Tue_Feb_19_11:12:02_CET_2013.pjpeg ; 1005080/archive/1000503/MAARS_3_045-Tue_Feb_19_11:12:20_CET_2013.pjpeg ; 1005080/archive/1000503/MAARS_3_045-Tue_Feb_19_11:12:47_CET_2013.pjpeg ; 1005080/archive/1000503/MAARS_3_045-Tue_Feb_19_11:12:59_CET_2013.pjpeg ; 1005080/archive/1000503/MAARS_3_045-Tue_Feb_19_11:13:13_CET_2013.pjpeg	2000	2001	No		Yes	Present	No	Present	No		Present	Present	Present	Present	No	Present	Present	Present	Present	No	Present																									Nicotine Addiction Treatment																																				Yes																		vitamin D analogs	Potent corticosteroids (topical)	Moderate corticosteroids (topical)	UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy																														00/00/2008	00/00/2009	00/00/2010	00/00/2011					Yes	Yes	Yes	No	No	No	No																Yes	Yes	Yes	Yes	Yes	Yes	Yes																														23/04/12	posterior thigh ;  buttocks ; head ; legs ; arms	1005080/archive/1000416/MAARS_3_045-Mon_Feb_18_11:35:24_CET_2013.pjpeg	1 (slight)	2 (moderate)	2 (moderate)	5	2 (10%-29%)	10	1.0	0 (none)	0 (none)	0 (none)	0	0 (0%)	0	0	3 (severe)	2 (moderate)	2 (moderate)	7	2 (10%-29%)	14	2.8	3 (severe)	2 (moderate)	2 (moderate)	7	2 (10%-29%)	14	5.6	9.4	4 (Red colouration)	4 (Moderate elevation)	5 (Moderate-Severe)	13	buttocks	Chronic(>1week)				buttocks	23/04/12	moderate-severe			Others		Vitamin D analogs ; Local Corticosteroids ; Local Corticosteroids ; Phototherapy ; Phototherapy ; Phototherapy ; Phototherapy			MAARS_3_045_01	23/04/12			MAARS_3_045_02	23/04/12			MAARS_3_045_03	23/04/12			MAARS_3_045_04	23/04/12			MAARS_3_045_05	23/04/12			MAARS_3_045_06	23/04/12			MAARS_3_045_10	23/04/12			MAARS_3_045_11	23/04/12			MAARS_3_045_07	23/04/12			MAARS_3_045_08	23/04/12			MAARS_3_045_09	23/04/12		
MAARS_3_047	10/04/12	UH	Pajunen	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1967	Male	White			1005080/archive/1000504/MAARS_3_047-Tue_Feb_19_11:15:08_CET_2013.pjpeg ; 1005080/archive/1000504/MAARS_3_047-Tue_Feb_19_11:15:28_CET_2013.pjpeg ; 1005080/archive/1000504/MAARS_3_047-Tue_Feb_19_11:15:46_CET_2013.pjpeg ; 1005080/archive/1000504/MAARS_3_047-Tue_Feb_19_11:16:02_CET_2013.pjpeg ; 1005080/archive/1000504/MAARS_3_047-Tue_Feb_19_11:16:18_CET_2013.pjpeg ; 1005080/archive/1000504/MAARS_3_047-Tue_Feb_19_11:16:35_CET_2013.pjpeg ; 1005080/archive/1000504/MAARS_3_047-Tue_Feb_19_11:16:48_CET_2013.pjpeg	1993	2011	Yes	00/00/1997	No	Past	No	No	No		Present	Present	Present	No	No	Present	No	Present	No	No	Present																									ACE inhibitors																		the patient doesnt remember the name of the medicine ,so it can be also other hypertension mecinine group.!																		Yes																		vitamin D analogs	Potent corticosteroids (topical)	UVB - Ultraviolet B phototherapy																						17 times											00/04/2011									Yes	Yes	No											00/06/2011									Yes	Yes	Yes									Hypertension															Yes										25/04/12	posterior thigh ;  lower back ;  buttocks ; arms ; legs ; head	1005080/archive/1000422/MAARS_3_047-Mon_Feb_18_11:43:06_CET_2013.pjpeg	1 (slight)	1 (slight)	2 (moderate)	4	2 (10%-29%)	8	0.8	2 (moderate)	3 (severe)	3 (severe)	8	2 (10%-29%)	16	4.8	3 (severe)	3 (severe)	3 (severe)	9	4 (50%-69%)	36	7.2	3 (severe)	3 (severe)	3 (severe)	9	5 (70%-89%)	45	18	30.8	3	5	6 (Severe)	14	lower back	Chronic(>1week)				lower back	25/04/12	Severe			Anti-Hypertensive	Hypertension	Vitamin D analogs ; Local Corticosteroids ; Phototherapy			MAARS_3_047_01	25/04/12			MAARS_3_047_02	25/04/12			MAARS_3_047_03	25/04/12			MAARS_3_047_04	25/04/12			MAARS_3_047_05	25/04/12			MAARS_3_047_06	25/04/12			MAARS_3_047_10	25/04/12			MAARS_3_047_11	25/04/12			MAARS_3_047_07	25/04/12			MAARS_3_047_08	25/04/12			MAARS_3_047_09	25/04/12		
MAARS_3_048	13/04/12	UH	Pajunen	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1943	Male	White	Father		1005080/archive/1000505/MAARS_3_048-Tue_Feb_19_11:20:22_CET_2013.pjpeg ; 1005080/archive/1000505/MAARS_3_048-Tue_Feb_19_11:20:39_CET_2013.pjpeg ; 1005080/archive/1000505/MAARS_3_048-Tue_Feb_19_11:20:56_CET_2013.pjpeg ; 1005080/archive/1000505/MAARS_3_048-Tue_Feb_19_11:21:17_CET_2013.pjpeg ; 1005080/archive/1000505/MAARS_3_048-Tue_Feb_19_11:21:33_CET_2013.pjpeg ; 1005080/archive/1000505/MAARS_3_048-Tue_Feb_19_11:21:47_CET_2013.pjpeg ; 1005080/archive/1000505/MAARS_3_048-Tue_Feb_19_11:22:05_CET_2013.pjpeg ; 1005080/archive/1000505/MAARS_3_048-Tue_Feb_19_11:22:21_CET_2013.pjpeg ; 1005080/archive/1000505/MAARS_3_048-Tue_Feb_19_11:22:37_CET_2013.pjpeg ; 1005080/archive/1000505/MAARS_3_048-Tue_Feb_19_11:22:54_CET_2013.pjpeg	1970	1970	Yes		No	No	No	No	Past	1	Present	Present	Present	No	Present	Present	Present	No	Past	Past	Present	basal cell carcinoma	basal cell carcinoma	lentigo maligna	morbus Bowen	Spinocellular Ca	Yes	Yes	Yes	Yes	Yes	01/01/2000	16/08/2006	16/08/2006	25/11/2009	04/08/2010																																																																vitamin D analogs	Potent corticosteroids (topical)	Neotigason	UVB - Ultraviolet B phototherapy	PUVA - psoralen + UVA (ultraviolet A-phototherapy)																				25mg x 1	a lot of treatments in the past	a lot of treatments in the past									00/04/2011									Yes	Yes	No	No	No									00/06/2011									Yes	Yes	No	Yes	Yes																																25/04/12	posterior thigh ;  lower back ;  buttocks ; legs ; head ; arms ; trunk	1005080/archive/1000424/MAARS_3_048-Mon_Feb_18_11:48:00_CET_2013.pjpeg	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	1.2	2 (moderate)	2 (moderate)	2 (moderate)	6	4 (50%-69%)	24	7.2	2 (moderate)	1 (slight)	2 (moderate)	5	4 (50%-69%)	20	4	2 (moderate)	1 (slight)	2 (moderate)	5	5 (70%-89%)	25	10	22.4	2 (Pink colouration)	3	3 (Mild-Moderate)	8	lower back	Chronic(>1week)				lower back	25/04/12	Severe					Vitamin D analogs ; Local Corticosteroids ; Retinoids ; Phototherapy ; Photochemotherapy			MAARS_3_048_01	25/04/12			MAARS_3_048_02	25/04/12			MAARS_3_048_03	25/04/12			MAARS_3_048_04	25/04/12			MAARS_3_048_05	25/04/12			MAARS_3_048_06	25/04/12			MAARS_3_048_10	25/04/12			MAARS_3_048_11	25/04/12			MAARS_3_048_07	25/04/12			MAARS_3_048_08	25/04/12			MAARS_3_048_09	25/04/12		
MAARS_3_055	26/04/12	UH	Pajunen	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1982	Male	White	Father		1005080/archive/1000506/MAARS_3_055-Tue_Feb_19_11:25:00_CET_2013.pjpeg ; 1005080/archive/1000506/MAARS_3_055-Tue_Feb_19_11:25:21_CET_2013.pjpeg ; 1005080/archive/1000506/MAARS_3_055-Tue_Feb_19_11:25:43_CET_2013.pjpeg ; 1005080/archive/1000506/MAARS_3_055-Tue_Feb_19_11:25:59_CET_2013.pjpeg ; 1005080/archive/1000506/MAARS_3_055-Tue_Feb_19_11:26:17_CET_2013.pjpeg ; 1005080/archive/1000506/MAARS_3_055-Tue_Feb_19_11:26:34_CET_2013.pjpeg ; 1005080/archive/1000506/MAARS_3_055-Tue_Feb_19_11:26:49_CET_2013.pjpeg ; 1005080/archive/1000506/MAARS_3_055-Tue_Feb_19_11:27:05_CET_2013.pjpeg	2010	2012	No		Yes	Present	No	Present	No		Present	Present	Present	No	No	Present	No	Present	No	No	Present																									Other anti-epileptic drugs																																				Yes																		vitamin D analogs	Potent corticosteroids (topical)																																											Yes	Yes																					Yes	Yes										Gout															Yes										09/05/12	posterior thigh ;  lower back ;  buttocks ; legs ; head ; arms ; trunk	1005080/archive/1000426/MAARS_3_055-Mon_Feb_18_11:50:11_CET_2013.pjpeg	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	1.2	2 (moderate)	2 (moderate)	2 (moderate)	6	1 (1%-9%)	6	1.8	2 (moderate)	3 (severe)	3 (severe)	8	2 (10%-29%)	16	3.2	3 (severe)	2 (moderate)	2 (moderate)	7	2 (10%-29%)	14	5.6	11.8	5	4 (Moderate elevation)	4 (Moderate)	13	lower back	Chronic(>1week)				lower back	09/05/12	moderate-severe	Hepatitis C positive		Others	Others	Vitamin D analogs ; Local Corticosteroids			MAARS_3_055_01	09/05/12			MAARS_3_055_02	09/05/12			MAARS_3_055_03	09/05/12			MAARS_3_055_04	09/05/12			MAARS_3_055_05	09/05/12			MAARS_3_055_06	09/05/12			MAARS_3_055_10	09/05/12			MAARS_3_055_11	09/05/12			MAARS_3_055_07	09/05/12			MAARS_3_055_08	09/05/12			MAARS_3_055_09	09/05/12		
MAARS_3_056	24/04/12	UH	Pajunen	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1955	Male	White			1005080/archive/1000507/MAARS_3_056-Tue_Feb_19_11:29:45_CET_2013.pjpeg ; 1005080/archive/1000507/MAARS_3_056-Tue_Feb_19_11:30:03_CET_2013.pjpeg ; 1005080/archive/1000507/MAARS_3_056-Tue_Feb_19_11:30:20_CET_2013.pjpeg ; 1005080/archive/1000507/MAARS_3_056-Tue_Feb_19_11:30:45_CET_2013.pjpeg ; 1005080/archive/1000507/MAARS_3_056-Tue_Feb_19_11:31:01_CET_2013.pjpeg ; 1005080/archive/1000507/MAARS_3_056-Tue_Feb_19_11:31:16_CET_2013.pjpeg ; 1005080/archive/1000507/MAARS_3_056-Tue_Feb_19_11:31:39_CET_2013.pjpeg ; 1005080/archive/1000507/MAARS_3_056-Tue_Feb_19_11:31:59_CET_2013.pjpeg ; 1005080/archive/1000507/MAARS_3_056-Tue_Feb_19_11:32:15_CET_2013.pjpeg ; 1005080/archive/1000507/MAARS_3_056-Tue_Feb_19_11:32:28_CET_2013.pjpeg	2008	2008	No		No	No	No	No	No		Present	Present	Present	Present	Present	Present	No	No	No	No	Present																									Acetylsalicylic acid	Sulfonylureas	Beta-blockers	DPP-4 inhibitors	Statins																																Yes	Yes	Yes	Yes	Yes														Potent corticosteroids (topical)	UVB - Ultraviolet B phototherapy																						20 times											00/01/2010										Yes	No																					Yes	Yes										Hyperlipidemia	Hypertension	Diabetes (non-insulin)													Yes	Yes	Yes								14/05/12	posterior thigh ;  lower back ;  buttocks ; arms ; head ; legs ; trunk	1005080/archive/1000428/MAARS_3_056-Mon_Feb_18_11:53:25_CET_2013.pjpeg	1 (slight)	1 (slight)	2 (moderate)	4	4 (50%-69%)	16	1.6	3 (severe)	2 (moderate)	2 (moderate)	7	3 (30%-49%)	21	6.3	3 (severe)	3 (severe)	3 (severe)	9	3 (30%-49%)	27	5.4	3 (severe)	3 (severe)	3 (severe)	9	3 (30%-49%)	27	10.8	24.1	5	4 (Moderate elevation)	6 (Severe)	15	lower back	Chronic(>1week)				lower back	14/05/12	moderate-severe	Patient got a reaction after first biopsy, lesional biopsy has not been taken. Non-lesional biopsy stood on the table 15min before separating to tubes. Microbiome-samples were in a fridge 24hrs before putting to freezer. Pt did also have a shower 6hrs before biopsy.		Anti-Inflammatory(non steroid) ; Others ; Anti-Hypertensive ; Others ; Statins	Hyperlipidemia ; Hypertension ; Diabetes (non-insulin)	Local Corticosteroids ; Phototherapy			MAARS_3_056_01	14/05/12			MAARS_3_056_02	14/05/12							MAARS_3_056_04	14/05/12							MAARS_3_056_06	14/05/12							MAARS_3_056_11	14/05/12			MAARS_3_056_07	14/05/12			MAARS_3_056_08	14/05/12			MAARS_3_056_09	14/05/12		
MAARS_3_064	04/09/12	UH	Tessas	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1968	Male	White		birch ; timothy ; hay ; cat	1005080/archive/1000508/MAARS_3_064-Tue_Feb_19_11:34:21_CET_2013.pjpeg ; 1005080/archive/1000508/MAARS_3_064-Tue_Feb_19_11:34:45_CET_2013.pjpeg ; 1005080/archive/1000508/MAARS_3_064-Tue_Feb_19_11:35:02_CET_2013.pjpeg ; 1005080/archive/1000508/MAARS_3_064-Tue_Feb_19_11:35:22_CET_2013.pjpeg ; 1005080/archive/1000508/MAARS_3_064-Tue_Feb_19_11:35:44_CET_2013.pjpeg ; 1005080/archive/1000508/MAARS_3_064-Tue_Feb_19_11:36:06_CET_2013.pjpeg ; 1005080/archive/1000508/MAARS_3_064-Tue_Feb_19_11:36:32_CET_2013.pjpeg ; 1005080/archive/1000508/MAARS_3_064-Tue_Feb_19_11:36:57_CET_2013.pjpeg ; 1005080/archive/1000508/MAARS_3_064-Tue_Feb_19_11:37:13_CET_2013.pjpeg ; 1005080/archive/1000508/MAARS_3_064-Tue_Feb_19_11:37:28_CET_2013.pjpeg	1987	2011	No		No	No	No	No	No		Present	Present	Present	Present	No	Present	No	Present	No	No	Present																																																																															vitamin D analogs	Potent corticosteroids (topical)	UVB - Ultraviolet B phototherapy																						21 times											00/11/2011									Yes	Yes	No											00/03/2012									Yes	Yes	Yes																																		12/09/12	 lower back ;  buttocks ; head ; trunk ; legs ; arms	1005080/archive/1000430/MAARS_3_064-Mon_Feb_18_11:56:32_CET_2013.pjpeg	1 (slight)	0 (none)	1 (slight)	2	1 (1%-9%)	2	0.2	2 (moderate)	0 (none)	2 (moderate)	4	2 (10%-29%)	8	2.4	1 (slight)	0 (none)	2 (moderate)	3	2 (10%-29%)	6	1.2	1 (slight)	0 (none)	2 (moderate)	3	2 (10%-29%)	6	2.4	6.2	3	3	4 (Moderate)	10	buttocks	Chronic(>1week)				buttocks	12/09/12	moderate		Pollen ; Animal			Vitamin D analogs ; Local Corticosteroids ; Phototherapy			MAARS_3_064_01	12/09/12			MAARS_3_064_02	12/09/12			MAARS_3_064_03	12/09/12			MAARS_3_064_04	12/09/12			MAARS_3_064_05	12/09/12			MAARS_3_064_06	12/09/12			MAARS_3_064_10	12/09/12			MAARS_3_064_11	12/09/12			MAARS_3_064_07	12/09/12			MAARS_3_064_08	12/09/12			MAARS_3_064_09	12/09/12		
MAARS_3_065	10/09/12	UH	Tessas	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1949	Male	White	Father		1005080/archive/1000509/MAARS_3_065-Tue_Feb_19_11:40:18_CET_2013.pjpeg ; 1005080/archive/1000509/MAARS_3_065-Tue_Feb_19_11:40:34_CET_2013.pjpeg ; 1005080/archive/1000509/MAARS_3_065-Tue_Feb_19_11:40:54_CET_2013.pjpeg ; 1005080/archive/1000509/MAARS_3_065-Tue_Feb_19_11:41:11_CET_2013.pjpeg ; 1005080/archive/1000509/MAARS_3_065-Tue_Feb_19_11:41:30_CET_2013.pjpeg ; 1005080/archive/1000509/MAARS_3_065-Tue_Feb_19_11:41:54_CET_2013.pjpeg ; 1005080/archive/1000509/MAARS_3_065-Tue_Feb_19_11:42:09_CET_2013.pjpeg	2009	2009	No		Yes	No	No	No	No		Present	Present	Present	Present	No	Present	Present	No	No	No	Present																									Angiotensin receptor blockers	Beta-blockers	Diuretics	Acetylsalicylic acid																		on break a week before biopsias															Yes	Yes	Yes	Yes															vitamin D analogs	Potent corticosteroids (topical)	UVB - Ultraviolet B phototherapy																						20 times											00/12/2011									Yes	Yes	No											00/01/2012									Yes	Yes	Yes									Hypertension	Obesity	Cardiomyopathy	Diabetes (non-insulin)												Yes	Yes	Yes	Yes							17/09/12	posterior thigh ;  lower back ;  buttocks ; trunk ; head ; legs	1005080/archive/1000511/MAARS_3_065-Tue_Feb_19_11:43:50_CET_2013.pjpeg	1 (slight)	0 (none)	1 (slight)	2	1 (1%-9%)	2	0.2	2 (moderate)	3 (severe)	3 (severe)	8	3 (30%-49%)	24	7.2	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	2.4	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	4.8	14.6	4 (Red colouration)	6 (Marked elevation)	6 (Severe)	16	buttocks	Chronic(>1week)				buttocks	17/09/12	moderate			Anti-Hypertensive ; Anti-Hypertensive ; Anti-Hypertensive ; Anti-Inflammatory(non steroid)	Hypertension ; Others ; Others ; Diabetes (non-insulin)	Vitamin D analogs ; Local Corticosteroids ; Phototherapy			MAARS_3_065_01	17/09/12			MAARS_3_065_02	17/09/12			MAARS_3_065_03	17/09/12			MAARS_3_065_04	17/09/12			MAARS_3_065_05	17/09/12			MAARS_3_065_06	17/09/12			MAARS_3_065_10	17/09/12			MAARS_3_065_11	17/09/12			MAARS_3_065_07	17/09/12			MAARS_3_065_08	17/09/12			MAARS_3_065_09	17/09/12		
MAARS_3_066	06/09/12	UH	Tessas	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1947	Male	White			1005080/archive/1000512/MAARS_3_066-Tue_Feb_19_11:46:12_CET_2013.pjpeg ; 1005080/archive/1000512/MAARS_3_066-Tue_Feb_19_11:46:31_CET_2013.pjpeg ; 1005080/archive/1000512/MAARS_3_066-Tue_Feb_19_11:46:51_CET_2013.pjpeg ; 1005080/archive/1000512/MAARS_3_066-Tue_Feb_19_11:47:20_CET_2013.pjpeg ; 1005080/archive/1000512/MAARS_3_066-Tue_Feb_19_11:47:40_CET_2013.pjpeg	2003	2003	No		Yes	No	No	No	No		Present	Present	Present	Present	No	No	Present	No	No	Present	Present																									Beta-blockers	Calcium Channel Blockers	Statins																																		Yes	Yes	Yes																vitamin D analogs	Potent corticosteroids (topical)	Very potent corticosteroids (topical)	UVB - Ultraviolet B phototherapy	Neotigason	UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy	PUVA - psoralen + UVA (ultraviolet A-phototherapy)																		26 times	25 mg x 1	25 times.	24 times	hands and legs treatment in past							00/12/2008	00/02/2009	00/11/2009	00/03/2011					Yes	Yes	Yes	No	No	No	No	No							00/01/2009	00/03/2009	00/02/2010	00/05/2011					Yes	Yes	Yes	Yes	No	Yes	Yes	Yes				Hyperlipidemia	Hypertension														Yes	Yes									17/09/12	posterior thigh ;  lower back ;  buttocks ; legs ; trunk	1005080/archive/1000514/MAARS_3_066-Tue_Feb_19_11:53:51_CET_2013.pjpeg	1 (slight)	0 (none)	0 (none)	1	1 (1%-9%)	1	0.1	2 (moderate)	3 (severe)	2 (moderate)	7	3 (30%-49%)	21	6.3	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	2.4	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	4.8	13.6	4 (Red colouration)	4 (Moderate elevation)	5 (Moderate-Severe)	13	buttocks	Chronic(>1week)				buttocks	17/09/12	moderate-severe			Anti-Hypertensive ; Anti-Hypertensive ; Statins	Hyperlipidemia ; Hypertension	Vitamin D analogs ; Local Corticosteroids ; Local Corticosteroids ; Phototherapy ; Retinoids ; Phototherapy ; Phototherapy ; Photochemotherapy			MAARS_3_066_01	17/09/12			MAARS_3_066_02	17/09/12			MAARS_3_066_03	17/09/12			MAARS_3_066_04	17/09/12			MAARS_3_066_05	17/09/12			MAARS_3_066_06	17/09/12			MAARS_3_066_10	17/09/12			MAARS_3_066_11	17/09/12			MAARS_3_066_07	17/09/12			MAARS_3_066_08	17/09/12			MAARS_3_066_09	17/09/12		
MAARS_3_068	07/09/12	UH	Tessas	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1965	Male	White	Father		1005080/archive/1000515/MAARS_3_068-Tue_Feb_19_11:55:54_CET_2013.pjpeg ; 1005080/archive/1000515/MAARS_3_068-Tue_Feb_19_11:56:13_CET_2013.pjpeg ; 1005080/archive/1000515/MAARS_3_068-Tue_Feb_19_11:56:29_CET_2013.pjpeg ; 1005080/archive/1000515/MAARS_3_068-Tue_Feb_19_11:56:48_CET_2013.pjpeg ; 1005080/archive/1000515/MAARS_3_068-Tue_Feb_19_11:57:10_CET_2013.pjpeg	2005	2005	No		No	No	No	No	No		Present	Present	Present	No	No	Present	No	Present	No	Present	No																																																																															vitamin D analogs	Potent corticosteroids (topical)	UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy																			21 times	15 times	19 times									00/03/2005	00/03/2007	00/03/2008	00/05/2010						Yes	Yes	No	No	No	No								00/05/2005	00/05/2007	00/05/2008							Yes	Yes	Yes	Yes	Yes	Yes																															24/09/12	posterior thigh ;  lower back ;  buttocks ; legs ; trunk ; head	1005080/archive/1000517/MAARS_3_068-Tue_Feb_19_12:01:18_CET_2013.pjpeg	1 (slight)	0 (none)	1 (slight)	2	1 (1%-9%)	2	0.2	2 (moderate)	0 (none)	3 (severe)	5	2 (10%-29%)	10	3	2 (moderate)	0 (none)	3 (severe)	5	2 (10%-29%)	10	2	2 (moderate)	0 (none)	3 (severe)	5	2 (10%-29%)	10	4	9.2	2 (Pink colouration)	1	4 (Moderate)	7	lower back	Chronic(>1week)				lower back	24/09/12	mild					Vitamin D analogs ; Local Corticosteroids ; Phototherapy ; Phototherapy ; Phototherapy ; Phototherapy			MAARS_3_068_01	24/09/12			MAARS_3_068_02	24/09/12			MAARS_3_068_03	24/09/12			MAARS_3_068_04	24/09/12			MAARS_3_068_05	24/09/12			MAARS_3_068_06	24/09/12			MAARS_3_068_10	24/09/12			MAARS_3_068_11	24/09/12			MAARS_3_068_07	24/09/12			MAARS_3_068_08	24/09/12			MAARS_3_068_09	24/09/12		
MAARS_3_072	25/09/12	UH	Tessas	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1948	Male	White			1005080/archive/1000518/MAARS_3_072-Tue_Feb_19_12:05:17_CET_2013.pjpeg ; 1005080/archive/1000518/MAARS_3_072-Tue_Feb_19_12:05:31_CET_2013.pjpeg ; 1005080/archive/1000518/MAARS_3_072-Tue_Feb_19_12:05:43_CET_2013.pjpeg ; 1005080/archive/1000518/MAARS_3_072-Tue_Feb_19_12:05:58_CET_2013.pjpeg ; 1005080/archive/1000518/MAARS_3_072-Tue_Feb_19_12:06:11_CET_2013.pjpeg ; 1005080/archive/1000518/MAARS_3_072-Tue_Feb_19_12:06:29_CET_2013.pjpeg	1996	2004	Yes	01/01/1997	Unknown 	No	No	Past	No		Present	No	Present	No	No	Present	No	No	No	No	Present																									ACE inhibitors	Alpha-adrenergic blockers	Acetylsalicylic acid	Alpha-adrenergic blockers																	ASA eas on break 1 week before the biopsias																Yes	Yes	Yes																vitamin D analogs	Potent corticosteroids (topical)	UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy																			20 times	16 times	15 times	15 times								00/05/2004	00/12/2004	00/11/2005	00/10/2006						Yes	Yes	No	No	No	No								00/06/2004	00/01/2005	00/01/2006	00/12/2006						Yes	Yes	Yes	Yes	Yes	Yes						Diabetes (non-insulin)	Prostata hyperplasia	Hypertension													Yes	Yes	Yes								03/10/12	 buttocks ; legs ; head	1005080/archive/1000521/MAARS_3_072-Tue_Feb_19_12:12:54_CET_2013.pjpeg	1 (slight)	0 (none)	1 (slight)	2	1 (1%-9%)	2	0.2	1 (slight)	0 (none)	2 (moderate)	3	1 (1%-9%)	3	0.9	1 (slight)	0 (none)	2 (moderate)	3	1 (1%-9%)	3	0.6	1 (slight)	0 (none)	2 (moderate)	3	1 (1%-9%)	3	1.2	2.9	3	1	2 (Mild)	6	buttocks	Chronic(>1week)				buttocks	03/10/12	mild			Anti-Hypertensive ; Anti-Hypertensive ; Anti-Inflammatory(non steroid) ; Anti-Hypertensive	Diabetes (non-insulin) ; Others ; Hypertension	Vitamin D analogs ; Local Corticosteroids ; Phototherapy ; Phototherapy ; Phototherapy ; Phototherapy			MAARS_3_072_01	03/10/12			MAARS_3_072_02	03/10/12			MAARS_3_072_03	03/10/12			MAARS_3_072_04	03/10/12			MAARS_3_072_05	03/10/12			MAARS_3_072_06	03/10/12			MAARS_3_072_10	03/10/12			MAARS_3_072_11	03/10/12			MAARS_3_072_07	03/10/12			MAARS_3_072_08	03/10/12			MAARS_3_072_09	03/10/12		
MAARS_3_073	19/09/12	UH	Tessas	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1980	Male	White		Pollen ; hay ; cat ; dog	1005080/archive/1000522/MAARS_3_073-Tue_Feb_19_12:15:04_CET_2013.pjpeg ; 1005080/archive/1000522/MAARS_3_073-Tue_Feb_19_12:15:19_CET_2013.pjpeg ; 1005080/archive/1000522/MAARS_3_073-Tue_Feb_19_12:15:36_CET_2013.pjpeg ; 1005080/archive/1000522/MAARS_3_073-Tue_Feb_19_12:15:52_CET_2013.pjpeg ; 1005080/archive/1000522/MAARS_3_073-Tue_Feb_19_12:16:07_CET_2013.pjpeg	2008	2008	No		Yes	No	No	Past	No		Present	Present	Present	No	No	Present	Present	Present	No	No	Present																																																																															vitamin D analogs	Potent corticosteroids (topical)	Methotrexate	Neotigason	Cyclosporin	UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy																		10-20 mg/w(help just in the begin of the treatment)	25 mg x 1	200mg x 1		14 times							00/12/2008	00/12/2009	00/01/2011	00/08/2010	00/04/2008					Yes	Yes	No	No	No	No	No							00/12/2009	00/05/2010	00/11/2011		00/06/2008					Yes	Yes	No	No	No	No	Yes					Asthma															Yes										03/10/12	posterior thigh ;  lower back ;  buttocks ; legs ; arms ; trunk ; head	1005080/archive/1000524/MAARS_3_073-Tue_Feb_19_12:21:04_CET_2013.pjpeg	2 (moderate)	1 (slight)	2 (moderate)	5	3 (30%-49%)	15	1.5	2 (moderate)	0 (none)	1 (slight)	3	3 (30%-49%)	9	2.7	2 (moderate)	0 (none)	2 (moderate)	4	2 (10%-29%)	8	1.6	2 (moderate)	1 (slight)	2 (moderate)	5	2 (10%-29%)	10	4	9.8	2 (Pink colouration)	2 (Slight definite elevation)	2 (Mild)	6	lower back	Chronic(>1week)				lower back	03/10/12	moderate		Pollen ; Animal		Asthma	Vitamin D analogs ; Local Corticosteroids ; Methotrexate ; Retinoids ; Cyclosporin ; Phototherapy ; Phototherapy			MAARS_3_073_01	03/10/12			MAARS_3_073_02	03/10/12			MAARS_3_073_03	03/10/12			MAARS_3_073_04	03/10/12			MAARS_3_073_05	03/10/12			MAARS_3_073_06	03/10/12			MAARS_3_073_10	03/10/12			MAARS_3_073_11	03/10/12			MAARS_3_073_07	03/10/12			MAARS_3_073_08	03/10/12			MAARS_3_073_09	03/10/12		
MAARS_3_075	26/09/12	UH	Tessas	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1956	Female	White			1005080/archive/1000525/MAARS_3_075-Tue_Feb_19_12:23:09_CET_2013.pjpeg ; 1005080/archive/1000525/MAARS_3_075-Tue_Feb_19_12:23:26_CET_2013.pjpeg ; 1005080/archive/1000525/MAARS_3_075-Tue_Feb_19_12:23:41_CET_2013.pjpeg ; 1005080/archive/1000525/MAARS_3_075-Tue_Feb_19_12:23:54_CET_2013.pjpeg ; 1005080/archive/1000525/MAARS_3_075-Tue_Feb_19_12:24:09_CET_2013.pjpeg	1980	2004	No		No	No	No	Past	No		Present	Present	Present	Past	No	Present	No	No	No	No	Present																																																																															Very potent corticosteroids (topical)	Neotigason	Methotrexate	Methotrexate	Cyclosporin	PUVA - psoralen + UVA (ultraviolet A-phototherapy)	UVB - Ultraviolet B phototherapy																	10mg x 1	17.5mg/w	17.5mg/w	100mg x 2	several times in past	several times in past						00/11/2007	00/03/2009	00/09/2009	00/11/2010							Yes	No	No	No	No	No	No						00/12/2008	00/07/2009	00/11/2010	00/03/2011							Yes	No	No	No		Yes	Yes																														10/10/12	posterior thigh ;  lower back ;  buttocks ; head ; trunk ; arms	1005080/archive/1000527/MAARS_3_075-Tue_Feb_19_12:29:46_CET_2013.pjpeg	1 (slight)	0 (none)	1 (slight)	2	1 (1%-9%)	2	0.2	2 (moderate)	0 (none)	2 (moderate)	4	2 (10%-29%)	8	2.4	2 (moderate)	0 (none)	2 (moderate)	4	2 (10%-29%)	8	1.6	2 (moderate)	0 (none)	2 (moderate)	4	1 (1%-9%)	4	1.6	5.8	2 (Pink colouration)	2 (Slight definite elevation)	2 (Mild)	6	buttocks	Chronic(>1week)				buttocks	10/10/12	mild	Not blood exams				Local Corticosteroids ; Retinoids ; Methotrexate ; Methotrexate ; Cyclosporin ; Photochemotherapy ; Phototherapy			MAARS_3_075_01	10/10/12			MAARS_3_075_02	10/10/12			MAARS_3_075_03	10/10/12			MAARS_3_075_04	10/10/12			MAARS_3_075_05	10/10/12			MAARS_3_075_06	10/10/12			MAARS_3_075_10	10/10/12			MAARS_3_075_11	10/10/12														
MAARS_3_080	05/10/12	UH	Tessas	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1958	Male	White	Mother		1005080/archive/1000528/MAARS_3_080-Tue_Feb_19_12:34:15_CET_2013.pjpeg ; 1005080/archive/1000528/MAARS_3_080-Tue_Feb_19_12:34:36_CET_2013.pjpeg ; 1005080/archive/1000528/MAARS_3_080-Tue_Feb_19_12:34:52_CET_2013.pjpeg ; 1005080/archive/1000528/MAARS_3_080-Tue_Feb_19_12:35:11_CET_2013.pjpeg ; 1005080/archive/1000528/MAARS_3_080-Tue_Feb_19_12:35:28_CET_2013.pjpeg	1980	2012	No		No	No	No	No	No		Present	Present	Present	Present	No	Past	No	Present	No	Present	Present																									Angiotensin receptor blockers	Calcium Channel Blockers																																			Yes	Yes																	vitamin D analogs	Potent corticosteroids (topical)																																											Yes	Yes																					Yes	Yes										Hypertension															Yes										17/10/12	posterior thigh ;  lower back ;  buttocks ; arms ; legs ; trunk	1005080/archive/1000530/MAARS_3_080-Tue_Feb_19_12:37:48_CET_2013.pjpeg	0 (none)	0 (none)	0 (none)	0	1 (1%-9%)	0	0	2 (moderate)	1 (slight)	2 (moderate)	5	2 (10%-29%)	10	3	2 (moderate)	1 (slight)	2 (moderate)	5	3 (30%-49%)	15	3	2 (moderate)	0 (none)	2 (moderate)	4	2 (10%-29%)	8	3.2	9.2	3	1	2 (Mild)	6	lower back	Chronic(>1week)				lower back	17/10/12	moderate			Anti-Hypertensive ; Anti-Hypertensive	Hypertension	Vitamin D analogs ; Local Corticosteroids			MAARS_3_080_01	17/10/12			MAARS_3_080_02	17/10/12			MAARS_3_080_03	17/10/12			MAARS_3_080_04	17/10/12			MAARS_3_080_05	17/10/12			MAARS_3_080_06	17/10/12			MAARS_3_080_10	17/10/12			MAARS_3_080_11	17/10/12			MAARS_3_080_07	17/10/12			MAARS_3_080_08	17/10/12			MAARS_3_080_09	17/10/12		
MAARS_3_084	10/10/12	UH	Tessas	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1948	Male	White	Father		1005080/archive/1000531/MAARS_3_084-Tue_Feb_19_12:40:52_CET_2013.pjpeg ; 1005080/archive/1000531/MAARS_3_084-Tue_Feb_19_12:41:12_CET_2013.pjpeg ; 1005080/archive/1000531/MAARS_3_084-Tue_Feb_19_12:41:59_CET_2013.pjpeg ; 1005080/archive/1000531/MAARS_3_084-Tue_Feb_19_12:42:26_CET_2013.pjpeg ; 1005080/archive/1000531/MAARS_3_084-Tue_Feb_19_12:42:45_CET_2013.pjpeg ; 1005080/archive/1000531/MAARS_3_084-Tue_Feb_19_12:43:01_CET_2013.pjpeg	1986	2006	No		No	No	No	No	No		Present	Present	Present	No	No	Present	No	Past	No	No	No																									Acetylsalicylic acid	ACE inhibitors	Statins																1 week break before the biopsias																		Yes	Yes	Yes																vitamin D analogs	Potent corticosteroids (topical)	UVB - Ultraviolet B phototherapy	Tacrolimus cream																					several times in past																				Yes	Yes	No	Yes																			Yes	Yes	Yes	Yes								Hypertension	Hyperlipidemia	Transient ishemic attack (TIA)													Yes	Yes	Yes								24/10/12	posterior thigh ;  lower back ;  buttocks ; legs ; head ; trunk ; arms	1005080/archive/1000533/MAARS_3_084-Tue_Feb_19_12:45:40_CET_2013.pjpeg	1 (slight)	0 (none)	1 (slight)	2	1 (1%-9%)	2	0.2	2 (moderate)	0 (none)	2 (moderate)	4	1 (1%-9%)	4	1.2	2 (moderate)	0 (none)	3 (severe)	5	3 (30%-49%)	15	3	2 (moderate)	0 (none)	2 (moderate)	4	2 (10%-29%)	8	3.2	7.6	3	0 (No evidence of plaque)	2 (Mild)	5	lower back	Chronic(>1week)				lower back	24/10/12	moderate			Anti-Inflammatory(non steroid) ; Anti-Hypertensive ; Statins	Hypertension ; Hyperlipidemia ; Others	Vitamin D analogs ; Local Corticosteroids ; Phototherapy ; Topical calcineurin inhibitors			MAARS_3_084_01	24/10/12			MAARS_3_084_02	24/10/12			MAARS_3_084_03	24/10/12			MAARS_3_084_04	24/10/12			MAARS_3_084_05	24/10/12			MAARS_3_084_06	24/10/12			MAARS_3_084_10	24/10/12			MAARS_3_084_11	24/10/12			MAARS_3_084_07	24/10/12			MAARS_3_084_08	24/10/12			MAARS_3_084_09	24/10/12		
MAARS_3_089	19/10/12	UH	Tessas	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1957	Male	White			1005080/archive/1000534/MAARS_3_089-Tue_Feb_19_12:47:34_CET_2013.pjpeg ; 1005080/archive/1000534/MAARS_3_089-Tue_Feb_19_12:47:49_CET_2013.pjpeg ; 1005080/archive/1000534/MAARS_3_089-Tue_Feb_19_12:48:09_CET_2013.pjpeg ; 1005080/archive/1000534/MAARS_3_089-Tue_Feb_19_12:48:24_CET_2013.pjpeg ; 1005080/archive/1000534/MAARS_3_089-Tue_Feb_19_12:48:42_CET_2013.pjpeg	2001	2012	No		No	No	No	No	No		Present	Present	Present	No	No	Present	No	Present	No	No	Past																									Angiotensin receptor blockers	Beta-blockers	Calcium Channel Blockers	moxonidine																																	Yes	Yes	Yes	Yes															vitamin D analogs	Potent corticosteroids (topical)	UVB - Ultraviolet B phototherapy	PUVA - psoralen + UVA (ultraviolet A-phototherapy)																					25 times	25 times										00/05/2011	00/05/2012								Yes	Yes	No	No										00/06/2011	00/06/2012								Yes	Yes	Yes	Yes								Hypertension	Hyperlipidemia														Yes	Yes									07/11/12	posterior thigh ;  lower back ;  buttocks ; legs ; head	1005080/archive/1000536/MAARS_3_089-Tue_Feb_19_12:53:20_CET_2013.pjpeg	1 (slight)	0 (none)	1 (slight)	2	1 (1%-9%)	2	0.2	3 (severe)	1 (slight)	2 (moderate)	6	1 (1%-9%)	6	1.8	3 (severe)	0 (none)	2 (moderate)	5	1 (1%-9%)	5	1	3 (severe)	1 (slight)	2 (moderate)	6	2 (10%-29%)	12	4.8	7.8	3	1	3 (Mild-Moderate)	7	lower back	Chronic(>1week)				lower back	07/11/12	moderate			Anti-Hypertensive ; Anti-Hypertensive ; Anti-Hypertensive ; Others	Hypertension ; Hyperlipidemia	Vitamin D analogs ; Local Corticosteroids ; Phototherapy ; Photochemotherapy			MAARS_3_089_01	07/11/12			MAARS_3_089_02	07/11/12			MAARS_3_089_03	07/11/12			MAARS_3_089_04	07/11/12			MAARS_3_089_05	07/11/12			MAARS_3_089_06	07/11/12			MAARS_3_089_10	07/11/12			MAARS_3_089_11	07/11/12			MAARS_3_089_07	07/11/12			MAARS_3_089_08	07/11/12			MAARS_3_089_09	07/11/12		
MAARS_3_094	02/11/12	UH	Tessas	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1959	Female	White	Father		1005080/archive/1000537/MAARS_3_094-Tue_Feb_19_12:56:19_CET_2013.pjpeg ; 1005080/archive/1000537/MAARS_3_094-Tue_Feb_19_12:56:32_CET_2013.pjpeg ; 1005080/archive/1000537/MAARS_3_094-Tue_Feb_19_12:56:51_CET_2013.pjpeg ; 1005080/archive/1000537/MAARS_3_094-Tue_Feb_19_12:57:09_CET_2013.pjpeg ; 1005080/archive/1000537/MAARS_3_094-Tue_Feb_19_12:57:25_CET_2013.pjpeg	1982	1982	No		No	Present	Past	Present	No		Present	Present	Present	No	Present	Present	No	No	No	No	Present																									Thyroid hormones	Paracetamol																		needed																	Yes																		UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy	Methotrexate	Methotrexate	Neotigason	vitamin D analogs	Potent corticosteroids (topical)															26 times	16 times	14 times	7.5-15 mg/w	12.5-25 mg/w	Before Trexan treatment about 10 years ago						00/07/2005	00/09/2006	00/05/2007	00/08/2008	00/04/2010							No	No	No	No	No	No	Yes	Yes				00/09/2005	00/01/2007	00/06/2007	00/11/2009	00/03/2012							Yes	Yes	Yes	Yes	Yes	No	Yes	Yes				Thyroid dysfunction	rheumatoid arthritis														Yes	Yes									16/11/12	posterior thigh ;  lower back ;  buttocks ; legs ; arms ; trunk ; head	1005080/archive/1000539/MAARS_3_094-Tue_Feb_19_12:59:41_CET_2013.pjpeg	0 (none)	0 (none)	1 (slight)	1	1 (1%-9%)	1	0.1	2 (moderate)	0 (none)	2 (moderate)	4	3 (30%-49%)	12	3.6	2 (moderate)	0 (none)	2 (moderate)	4	2 (10%-29%)	8	1.6	2 (moderate)	0 (none)	2 (moderate)	2	2 (10%-29%)	4	1.6	6.9	2 (Pink colouration)	0 (No evidence of plaque)	2 (Mild)	4	lower back	Chronic(>1week)				lower back	16/11/12	moderate			Thyroid hormones ; Others	Thyroid dysfunction ; Others	Phototherapy ; Phototherapy ; Phototherapy ; Methotrexate ; Methotrexate ; Retinoids ; Vitamin D analogs ; Local Corticosteroids	Yes	"rheumatoid arthritis has been added to exclusion criteria for any subject (Helsinki visit, 07/01/14)"	MAARS_3_094_01	16/11/12			MAARS_3_094_02	16/11/12			MAARS_3_094_03	16/11/12			MAARS_3_094_04	16/11/12			MAARS_3_094_05	16/11/12			MAARS_3_094_06	16/11/12			MAARS_3_094_10	16/11/12			MAARS_3_094_11	16/11/12			MAARS_3_094_07	16/11/12			MAARS_3_094_08	16/11/12			MAARS_3_094_09	16/11/12		
MAARS_3_095	31/10/12	UH	Tessas	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1991	Male	White	Father		1005080/archive/1000540/MAARS_3_095-Tue_Feb_19_13:14:12_CET_2013.pjpeg ; 1005080/archive/1000540/MAARS_3_095-Tue_Feb_19_13:14:28_CET_2013.pjpeg ; 1005080/archive/1000540/MAARS_3_095-Tue_Feb_19_13:14:57_CET_2013.pjpeg ; 1005080/archive/1000540/MAARS_3_095-Tue_Feb_19_13:15:12_CET_2013.pjpeg ; 1005080/archive/1000540/MAARS_3_095-Tue_Feb_19_13:15:28_CET_2013.pjpeg	2005	2005	No		Yes	No	No	Present	No		Present	Present	Present	Present	Present	Present	No	Present	No	Present	No																																																																															vitamin D analogs	Potent corticosteroids (topical)	Tacrolimus cream	UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy																				15 times	20 times	25 times									00/04/2006	00/05/2011	00/01/2012						Yes	Yes	Yes	No	No	No									00/05/2006		00/03/2012						Yes	Yes	Yes	Yes	Yes	Yes																															16/11/12	posterior thigh ;  lower back ;  buttocks ; trunk ; head ; arms ; legs	1005080/archive/1000542/MAARS_3_095-Tue_Feb_19_13:18:50_CET_2013.pjpeg	1 (slight)	0 (none)	2 (moderate)	3	4 (50%-69%)	12	1.2	3 (severe)	0 (none)	2 (moderate)	5	3 (30%-49%)	15	4.5	3 (severe)	0 (none)	2 (moderate)	5	2 (10%-29%)	10	2	3 (severe)	0 (none)	2 (moderate)	2	1 (1%-9%)	2	0.4	8.5	3	0 (No evidence of plaque)	3 (Mild-Moderate)	6	lower back	Chronic(>1week)				lower back	16/11/12	moderate					Vitamin D analogs ; Local Corticosteroids ; Topical calcineurin inhibitors ; Phototherapy ; Phototherapy ; Phototherapy			MAARS_3_095_01	16/11/12			MAARS_3_095_02	16/11/12			MAARS_3_095_03	16/11/12			MAARS_3_095_04	16/11/12			MAARS_3_095_05	16/11/12			MAARS_3_095_06	16/11/12			MAARS_3_095_10	16/11/12			MAARS_3_095_11	16/11/12			MAARS_3_095_07	16/11/12			MAARS_3_095_08	16/11/12			MAARS_3_095_09	16/11/12		
MAARS_3_098	07/11/12	UH	Tessas	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1950	Male	White		Pollen ; birch ; cat ; potato	1005080/archive/1000543/MAARS_3_098-Tue_Feb_19_13:21:36_CET_2013.pjpeg ; 1005080/archive/1000543/MAARS_3_098-Tue_Feb_19_13:21:52_CET_2013.pjpeg ; 1005080/archive/1000543/MAARS_3_098-Tue_Feb_19_13:22:09_CET_2013.pjpeg ; 1005080/archive/1000543/MAARS_3_098-Tue_Feb_19_13:22:30_CET_2013.pjpeg ; 1005080/archive/1000543/MAARS_3_098-Tue_Feb_19_13:22:48_CET_2013.pjpeg	1980	1988	No		Yes	No	No	Past	No		Present	Present	Present	No	No	No	No	Present	No	No	Present																									Angiotensin-receptor blocker and diuretic	Statins																																			Yes	Yes																	vitamin D analogs	Potent corticosteroids (topical)	Very potent corticosteroids (topical)	SUP - selective ultraviolet phototherapy	UVB - Ultraviolet B phototherapy	Methotrexate	Neotigason	PUVA - psoralen + UVA (ultraviolet A-phototherapy)																			several times in past 	7.5-10mg/w									00/00/2004	00/00/2003	00/02/2009	00/03/2010	00/06/2010				Yes	Yes	Yes	No	No	No	No	No								00/00/2008	00/03/2010	00/04/2010					Yes	Yes	Yes	Yes	Yes	Yes	No	No				Hyperlipidemia	Hypertension														Yes	Yes									21/11/12	posterior thigh ;  buttocks ; head ; legs ; arms ; trunk	1005080/archive/1000545/MAARS_3_098-Tue_Feb_19_13:28:29_CET_2013.pjpeg	1 (slight)	1 (slight)	1 (slight)	3	1 (1%-9%)	3	0.3	2 (moderate)	1 (slight)	1 (slight)	4	2 (10%-29%)	8	2.4	2 (moderate)	1 (slight)	1 (slight)	4	2 (10%-29%)	8	1.6	2 (moderate)	1 (slight)	1 (slight)	4	2 (10%-29%)	8	3.2	7.5	2 (Pink colouration)	1	2 (Mild)	5	buttocks	Chronic(>1week)				buttocks	21/11/12	moderate		Pollen ; Animal ; Food	Anti-Hypertensive ; Statins	Hyperlipidemia ; Hypertension	Vitamin D analogs ; Local Corticosteroids ; Local Corticosteroids ; Phototherapy ; Phototherapy ; Methotrexate ; Retinoids ; Photochemotherapy			MAARS_3_098_01	21/11/12			MAARS_3_098_02	21/11/12			MAARS_3_098_03	21/11/12			MAARS_3_098_04	21/11/12			MAARS_3_098_05	21/11/12			MAARS_3_098_06	21/11/12			MAARS_3_098_10	21/11/12			MAARS_3_098_11	21/11/12			MAARS_3_098_07	21/11/12			MAARS_3_098_08	21/11/12			MAARS_3_098_09	21/11/12		
MAARS_3_099	13/11/12	UH	Tessas	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1980	Male	White			1005080/archive/1000546/MAARS_3_099-Tue_Feb_19_13:35:28_CET_2013.pjpeg ; 1005080/archive/1000546/MAARS_3_099-Tue_Feb_19_13:35:48_CET_2013.pjpeg ; 1005080/archive/1000546/MAARS_3_099-Tue_Feb_19_13:36:03_CET_2013.pjpeg ; 1005080/archive/1000546/MAARS_3_099-Tue_Feb_19_13:36:23_CET_2013.pjpeg ; 1005080/archive/1000546/MAARS_3_099-Tue_Feb_19_13:36:39_CET_2013.pjpeg	1995	1995	No		Yes	No	No	Past	Past	5	Present	Present	Present	No	Present	Present	No	No	No	No	Present																																																																															vitamin D analogs	Potent corticosteroids (topical)	UVB - Ultraviolet B phototherapy																																	00/00/1999											No																				Yes	Yes	Yes																																		21/11/12	posterior thigh ;  lower back ;  buttocks ; head ; arms ; trunk ; legs	1005080/archive/1000548/MAARS_3_099-Tue_Feb_19_13:38:37_CET_2013.pjpeg	2 (moderate)	1 (slight)	1 (slight)	4	3 (30%-49%)	12	1.2	3 (severe)	2 (moderate)	2 (moderate)	7	4 (50%-69%)	28	8.4	3 (severe)	2 (moderate)	3 (severe)	8	2 (10%-29%)	16	3.2	3 (severe)	2 (moderate)	2 (moderate)	7	2 (10%-29%)	14	5.6	18.4	3	4 (Moderate elevation)	3 (Mild-Moderate)	10	lower back	Chronic(>1week)				lower back	21/11/12	moderate-severe					Vitamin D analogs ; Local Corticosteroids ; Phototherapy			MAARS_3_099_01	21/11/12			MAARS_3_099_02	21/11/12			MAARS_3_099_03	21/11/12			MAARS_3_099_04	21/11/12			MAARS_3_099_05	21/11/12			MAARS_3_099_06	21/11/12			MAARS_3_099_10	21/11/12			MAARS_3_099_11	21/11/12			MAARS_3_099_07	21/11/12			MAARS_3_099_08	21/11/12			MAARS_3_099_09	21/11/12		
MAARS_3_100	09/11/12	UH	Tessas	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1964	Male	White		orange	1005080/archive/1000570/MAARS_3_100-Thu_Feb_21_07:20:35_CET_2013.pjpeg ; 1005080/archive/1000570/MAARS_3_100-Thu_Feb_21_07:20:50_CET_2013.pjpeg ; 1005080/archive/1000570/MAARS_3_100-Thu_Feb_21_07:21:08_CET_2013.pjpeg ; 1005080/archive/1000570/MAARS_3_100-Thu_Feb_21_07:21:27_CET_2013.pjpeg ; 1005080/archive/1000570/MAARS_3_100-Thu_Feb_21_07:21:41_CET_2013.pjpeg	1995	1995	Yes	01/08/1998	No	No	No	Past	No		Present	Present	Present	No	No	No	No	Present	No	No	No																									Insulin glargine	Insulin aspart	venlafaxine																																		Yes	Yes	Yes																UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy	SUP - selective ultraviolet phototherapy	vitamin D analogs	Potent corticosteroids (topical)																	15 times	31 times										00/05/2007	00/00/1998	00/00/1999	00/00/1999								No	No	No	No	No	Yes						00/07/2007											Yes	Yes	Yes	No	Yes	Yes						Diabetes mellitus type 1 (DMI)	Depression														Yes	Yes									26/11/12	posterior thigh ;  lower back ;  buttocks ; trunk ; arms ; legs	1005080/archive/1000572/MAARS_3_100-Thu_Feb_21_07:26:13_CET_2013.pjpeg	0 (none)	1 (slight)	0 (none)	1	1 (1%-9%)	1	0.1	1 (slight)	1 (slight)	2 (moderate)	4	3 (30%-49%)	12	3.6	1 (slight)	1 (slight)	2 (moderate)	4	2 (10%-29%)	8	1.6	1 (slight)	1 (slight)	1 (slight)	3	1 (1%-9%)	3	1.2	6.5	2 (Pink colouration)	2 (Slight definite elevation)	2 (Mild)	6	buttocks	Chronic(>1week)				buttocks	26/11/12	moderate		Food	Insulin ; Insulin ; Others	Others ; Others	Phototherapy ; Phototherapy ; Phototherapy ; Phototherapy ; Vitamin D analogs ; Local Corticosteroids	Yes	"Diabetes mellitus type 1 (DMI) has been added to exclusion criteria for any subject (Helsinki visit, 07/01/14)"	MAARS_3_100_01	26/11/12			MAARS_3_100_02	26/11/12			MAARS_3_100_03	26/11/12			MAARS_3_100_04	26/11/12			MAARS_3_100_05	26/11/12			MAARS_3_100_06	26/11/12			MAARS_3_100_10	26/11/12			MAARS_3_100_11	26/11/12			MAARS_3_100_07	26/11/12			MAARS_3_100_08	26/11/12			MAARS_3_100_09	26/11/12		
MAARS_3_103	20/11/12	UH	Tessas	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1967	Male	White	Father	kefalexin	1005080/archive/1000573/MAARS_3_103-Thu_Feb_21_07:28:20_CET_2013.pjpeg ; 1005080/archive/1000573/MAARS_3_103-Thu_Feb_21_07:28:38_CET_2013.pjpeg ; 1005080/archive/1000573/MAARS_3_103-Thu_Feb_21_07:28:57_CET_2013.pjpeg ; 1005080/archive/1000573/MAARS_3_103-Thu_Feb_21_07:29:14_CET_2013.pjpeg ; 1005080/archive/1000573/MAARS_3_103-Thu_Feb_21_07:29:30_CET_2013.pjpeg	1998	1999	No		Yes	No	No	No	Past	1	Present	Present	Present	Present	Present	Present	No	No	No	Present	Present																																																																															UVB - Ultraviolet B phototherapy	SUP - selective ultraviolet phototherapy	vitamin D analogs	Potent corticosteroids (topical)	Moderate corticosteroids (topical)	Mild corticosteroids (topical)																	12 times	before year 2000 3 treatments										00/12/2011											No	No	Yes	Yes	Yes	Yes						00/01/2012											Yes	No	Yes	Yes	Yes	Yes	Yes																														28/11/12	posterior thigh ;  lower back ;  buttocks ; arms ; legs ; trunk ; head	1005080/archive/1000577/MAARS_3_103-Thu_Feb_21_07:34:44_CET_2013.pjpeg	1 (slight)	1 (slight)	1 (slight)	2	3 (30%-49%)	6	0.6	2 (moderate)	2 (moderate)	2 (moderate)	6	4 (50%-69%)	24	7.2	2 (moderate)	2 (moderate)	2 (moderate)	6	3 (30%-49%)	18	3.6	3 (severe)	2 (moderate)	2 (moderate)	7	3 (30%-49%)	21	8.4	19.8	2 (Pink colouration)	2 (Slight definite elevation)	2 (Mild)	6	lower back	Chronic(>1week)				lower back	28/11/12	Severe		Drug Allergy			Phototherapy ; Phototherapy ; Vitamin D analogs ; Local Corticosteroids ; Local Corticosteroids ; Local Corticosteroids			MAARS_3_103_01	28/11/12			MAARS_3_103_02	28/11/12			MAARS_3_103_03	28/11/12			MAARS_3_103_04	28/11/12			MAARS_3_103_05	28/11/12			MAARS_3_103_06	28/11/12			MAARS_3_103_10	28/11/12			MAARS_3_103_11	28/11/12			MAARS_3_103_07	28/11/12			MAARS_3_103_08	28/11/12			MAARS_3_103_09	28/11/12		
MAARS_3_108	02/01/13	UH	Tessas	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1974	Male	White			1005080/archive/1000578/MAARS_3_108-Thu_Feb_21_07:36:59_CET_2013.pjpeg ; 1005080/archive/1000578/MAARS_3_108-Thu_Feb_21_07:37:13_CET_2013.pjpeg ; 1005080/archive/1000578/MAARS_3_108-Thu_Feb_21_07:37:28_CET_2013.pjpeg ; 1005080/archive/1000578/MAARS_3_108-Thu_Feb_21_07:37:43_CET_2013.pjpeg ; 1005080/archive/1000578/MAARS_3_108-Thu_Feb_21_07:37:55_CET_2013.pjpeg	2008	2011	Yes	00/00/2008	Yes	No	No	Present	No		Present	Present	Present	No	Present	No	No	No	No	No	Present																																																																															UVB - Ultraviolet B phototherapy	Neotigason	vitamin D analogs	Potent corticosteroids (topical)																			24 times											00/10/2011	00/02/2012										No	No	Yes	Yes								00/01/2012	00/04/2012										No	No	Yes	Yes								Rosacea															Yes										16/01/13	posterior thigh ;  lower back ;  buttocks ; arms ; trunk ; legs	1005080/archive/1000580/MAARS_3_108-Thu_Feb_21_07:39:29_CET_2013.pjpeg	0 (none)	0 (none)	1 (slight)	0	0 (0%)	0	0	2 (moderate)	0 (none)	2 (moderate)	4	1 (1%-9%)	4	1.2	2 (moderate)	0 (none)	2 (moderate)	4	2 (10%-29%)	8	1.6	2 (moderate)	0 (none)	2 (moderate)	4	3 (30%-49%)	12	4.8	7.6	2 (Pink colouration)	2 (Slight definite elevation)	2 (Mild)	6	buttocks	Chronic(>1week)				buttocks	16/01/13	moderate				Others	Phototherapy ; Retinoids ; Vitamin D analogs ; Local Corticosteroids			MAARS_3_108_01	16/01/13			MAARS_3_108_02	16/01/13			MAARS_3_108_03	16/01/13			MAARS_3_108_04	16/01/13			MAARS_3_108_05	16/01/13			MAARS_3_108_06	16/01/13			MAARS_3_108_10	16/01/13			MAARS_3_108_11	16/01/13			MAARS_3_108_07	16/01/13			MAARS_3_108_08	16/01/13			MAARS_3_108_09	16/01/13		
MAARS_3_109	02/01/13	UH	Tessas	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1950	Female	White			1005080/archive/1000581/MAARS_3_109-Thu_Feb_21_07:41:49_CET_2013.pjpeg ; 1005080/archive/1000581/MAARS_3_109-Thu_Feb_21_07:42:06_CET_2013.pjpeg ; 1005080/archive/1000581/MAARS_3_109-Thu_Feb_21_07:42:21_CET_2013.pjpeg ; 1005080/archive/1000581/MAARS_3_109-Thu_Feb_21_07:42:36_CET_2013.pjpeg ; 1005080/archive/1000581/MAARS_3_109-Thu_Feb_21_07:42:50_CET_2013.pjpeg	1994	1995	No		Yes	No	No	Past	No		Present	Present	Present	Present	Present	Present	Present	Present	No	No	Present																																																																															Neotigason	Methotrexate	PUVA - psoralen + UVA (ultraviolet A-phototherapy)	UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy	vitamin D analogs	Potent corticosteroids (topical)															25mg x 1	7.5mg/w										00/03/2002	00/04/2002	00/00/2002	00/00/2004	00/00/2005	00/00/2007						No	No	No	No	No	No	Yes	Yes				00/04/2002	00/06/2002										No	No	No	Yes	Yes	Yes	Yes	Yes																													18/01/13	posterior thigh ;  lower back ;  buttocks ; trunk ; legs ; head	1005080/archive/1000583/MAARS_3_109-Thu_Feb_21_07:44:15_CET_2013.pjpeg	1 (slight)	0 (none)	1 (slight)	2	1 (1%-9%)	2	0.2	1 (slight)	0 (none)	2 (moderate)	3	1 (1%-9%)	3	0.9	2 (moderate)	0 (none)	2 (moderate)	4	2 (10%-29%)	8	1.6	2 (moderate)	0 (none)	2 (moderate)	4	2 (10%-29%)	8	3.2	5.9	2 (Pink colouration)	2 (Slight definite elevation)	2 (Mild)	6	buttocks	Chronic(>1week)				buttocks	18/01/13	mild					Retinoids ; Methotrexate ; Photochemotherapy ; Phototherapy ; Phototherapy ; Phototherapy ; Vitamin D analogs ; Local Corticosteroids			MAARS_3_109_01	18/01/13			MAARS_3_109_02	18/01/13			MAARS_3_109_03	18/01/13			MAARS_3_109_04	18/01/13			MAARS_3_109_05	18/01/13			MAARS_3_109_06	18/01/13			MAARS_3_109_10	18/01/13			MAARS_3_109_11	18/01/13			MAARS_3_109_07	18/01/13			MAARS_3_109_08	18/01/13			MAARS_3_109_09	18/01/13		
MAARS_3_110	03/01/13	UH	Tessas	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1950	Female	White	Sister		1005080/archive/1000584/MAARS_3_110-Thu_Feb_21_07:46:28_CET_2013.pjpeg ; 1005080/archive/1000584/MAARS_3_110-Thu_Feb_21_07:46:43_CET_2013.pjpeg ; 1005080/archive/1000584/MAARS_3_110-Thu_Feb_21_07:46:59_CET_2013.pjpeg ; 1005080/archive/1000584/MAARS_3_110-Thu_Feb_21_07:47:15_CET_2013.pjpeg ; 1005080/archive/1000584/MAARS_3_110-Thu_Feb_21_07:47:33_CET_2013.pjpeg	1961	1964	No		Yes	Present	Past	Present	Past	10	Present	Present	Present	No	Past	Past	No	No	No	No	Present																oral ca			Yes			00/03/2011			ACE inhibitors	Pitofenoni and analgesic																	20 mg x 1	needed																	Yes																		PUVA - psoralen + UVA (ultraviolet A-phototherapy)	UVB - Ultraviolet B phototherapy	Potent corticosteroids (topical)																				several times many years before	23 times											00/11/2011										No	No	Yes										00/02/2012										Yes	Yes	Yes									Hypertension	Diabetes (non-insulin)	rheumatoid arthritis													Yes	Yes	Yes								23/01/13	posterior thigh ;  lower back ;  buttocks ; legs ; arms ; trunk	1005080/archive/1000586/MAARS_3_110-Thu_Feb_21_07:49:18_CET_2013.pjpeg	1 (slight)	0 (none)	0 (none)	1	1 (1%-9%)	1	0.1	2 (moderate)	1 (slight)	2 (moderate)	5	3 (30%-49%)	15	4.5	2 (moderate)	0 (none)	1 (slight)	3	3 (30%-49%)	9	1.8	2 (moderate)	0 (none)	1 (slight)	3	3 (30%-49%)	9	3.6	10	2 (Pink colouration)	2 (Slight definite elevation)	2 (Mild)	7	upper back	Chronic(>1week)					23/01/13	moderate	samples(leesion -non leesio) from Upper back		Anti-Hypertensive ; Others	Hypertension ; Diabetes (non-insulin) ; Others	Photochemotherapy ; Phototherapy ; Local Corticosteroids	Yes	"rheumatoid arthritis has been added to exclusion criteria for any subject (Helsinki visit, 07/01/14)"	MAARS_3_110_01	23/01/13			MAARS_3_110_02	23/01/13			MAARS_3_110_03	23/01/13			MAARS_3_110_04	23/01/13			MAARS_3_110_05	23/01/13			MAARS_3_110_06	23/01/13			MAARS_3_110_10	23/01/13			MAARS_3_110_11	23/01/13			MAARS_3_110_07	23/01/13			MAARS_3_110_08	23/01/13			MAARS_3_110_09	23/01/13		
MAARS_3_112	25/01/13	UH	Tessas	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1947	Female	White			1005080/archive/1000587/MAARS_3_112-Thu_Feb_21_07:53:28_CET_2013.pjpeg ; 1005080/archive/1000587/MAARS_3_112-Thu_Feb_21_07:53:40_CET_2013.pjpeg ; 1005080/archive/1000587/MAARS_3_112-Thu_Feb_21_07:53:53_CET_2013.pjpeg ; 1005080/archive/1000587/MAARS_3_112-Thu_Feb_21_07:54:09_CET_2013.pjpeg ; 1005080/archive/1000587/MAARS_3_112-Thu_Feb_21_07:54:28_CET_2013.pjpeg	1975	1975	No		No	No	No	No	No		Present	Present	Present	Present	No	Present	No	No	No	Present	Present																									Angiotensin receptor blockers	amitriptyline																		needed																	Yes	Yes																	PUVA - psoralen + UVA (ultraviolet A-phototherapy)	PUVA - psoralen + UVA (ultraviolet A-phototherapy)	UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy	PUVA - psoralen + UVA (ultraviolet A-phototherapy)	UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy	vitamin D analogs	Potent corticosteroids (topical)	Dithranol-minute													16 times				23 times	15 times	20 times			4 times		00/00/1987	00/00/1998	00/00/1984	00/00/1998	00/02/2005	00/10/2005	00/02/2007			00/00/1984		No	No	No	No	No	No	No	Yes	Yes	No						00/03/2005	00/12/2005	00/05/2007					Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes	Yes		Hypertension															Yes										06/02/13	 buttocks ;  lower back ; arms ; head ; legs ; posterior thigh ; trunk	1005080/archive/1000589/MAARS_3_112-Thu_Feb_21_07:58:07_CET_2013.pjpeg	2 (moderate)	1 (slight)	3 (severe)	6	4 (50%-69%)	24	2.4	3 (severe)	2 (moderate)	2 (moderate)	7	3 (30%-49%)	21	6.3	2 (moderate)	2 (moderate)	3 (severe)	7	2 (10%-29%)	14	2.8	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	4.8	16.3	3	3	2 (Mild)	8	upper back	Chronic(>1week)				upper back	06/02/13	moderate	Samples and biopsias had been taken from Upper back		Anti-Hypertensive ; Anti-Hypertensive	Hypertension	Photochemotherapy ; Photochemotherapy ; Phototherapy ; Phototherapy ; Photochemotherapy ; Phototherapy ; Phototherapy ; Vitamin D analogs ; Local Corticosteroids ; Dithranol-minute			MAARS_3_112_01	06/02/13			MAARS_3_112_02	06/02/13			MAARS_3_112_03	06/02/13			MAARS_3_112_04	06/02/13			MAARS_3_112_05	06/02/13			MAARS_3_112_06	06/02/13			MAARS_3_112_10	06/02/13			MAARS_3_112_11	06/02/13			MAARS_3_112_07	06/02/13			MAARS_3_112_08	06/02/13			MAARS_3_112_09	06/02/13		
MAARS_3_114	25/01/13	UH	Tessas	Yes	Yes	Yes	No	No	No	No	No	No	No	No	No	No	1969	Male	White	Father		1005080/archive/1000242/MAARS_3_114-Fri_Feb_08_11:46:42_CET_2013.pjpeg ; 1005080/archive/1000242/MAARS_3_114-Fri_Feb_08_11:47:10_CET_2013.pjpeg ; 1005080/archive/1000242/MAARS_3_114-Fri_Feb_08_11:47:22_CET_2013.pjpeg ; 1005080/archive/1000242/MAARS_3_114-Fri_Feb_08_11:47:38_CET_2013.pjpeg ; 1005080/archive/1000242/MAARS_3_114-Fri_Feb_08_11:47:53_CET_2013.pjpeg	1988	1992	No		No	No	No	No	No		Present	Present	Present	Present	Present	Present	No	No	No	Present	No																									Beta-blockers																																				Yes																		UVB - Ultraviolet B phototherapy	Methotrexate	UVB - Ultraviolet B phototherapy	Methotrexate	UVB - Ultraviolet B phototherapy	UVB - Ultraviolet B phototherapy	vitamin D analogs	Potent corticosteroids (topical)	Very potent corticosteroids (topical)														15 times	10-17.5 mg/w	28 times	10-15 mg/w	20 times	30 times						00/09/2002	00/07/2009	00/10/2009	00/03/2010	00/05/2011	00/02/2012						No	No	No	No	No	No	Yes	Yes	Yes			00/01/2003	00/10/2009	00/03/2010	00/06/2010	00/06/2011	00/05/2012						Yes	No	Yes	No	Yes	Yes	Yes	Yes	Yes			Hypertension															Yes										08/02/13	 buttocks ;  lower back ; arms ; head ; legs ; posterior thigh ; trunk	1005080/archive/1000243/MAARS_3_114-Fri_Feb_08_11:55:55_CET_2013.pjpeg	2 (moderate)	0 (none)	1 (slight)	3	2 (10%-29%)	6	0.6	1 (slight)	2 (moderate)	2 (moderate)	5	2 (10%-29%)	10	3	1 (slight)	2 (moderate)	2 (moderate)	5	2 (10%-29%)	10	2	2 (moderate)	2 (moderate)	2 (moderate)	6	2 (10%-29%)	12	4.8	10.4	3	3	2 (Mild)	8	upper back	Chronic(>1week)				upper back	08/02/13	moderate	Upper Back		Anti-Hypertensive	Hypertension	Phototherapy ; Methotrexate ; Phototherapy ; Methotrexate ; Phototherapy ; Phototherapy ; Vitamin D analogs ; Local Corticosteroids ; Local Corticosteroids			MAARS_3_114_01	08/02/13			MAARS_3_114_02	08/02/13			MAARS_3_114_03	08/02/13			MAARS_3_114_04	08/02/13			MAARS_3_114_05	08/02/13			MAARS_3_114_06	08/02/13			MAARS_3_114_10	08/02/13			MAARS_3_114_11	08/02/13			MAARS_3_114_07	08/02/13			MAARS_3_114_08	08/02/13			MAARS_3_114_09	08/02/13		
